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General introduction
Host pathogen interaction and co-evolution
Interactions between host organisms and their pathogens are among the most 
prevalent and evolutionary important biological interactions known today. Although 
a matter of life and death, these interactions are also drivers of evolution and have 
shaped the biodiversity of our planet (Filee et al., 2003; Koonin, 2016; Koonin and 
Dolja, 2013; Stern and Sorek, 2011). The most prevalent host-pathogen interaction 
in nature is the predation of prokaryotic microorganisms, especially bacteria, by 
their viruses. These so-called bacteriophages (phages) were discovered at the 
beginning of the last century by Twort in 1915 and independently by d’Herelle in 
1917 (Summers, 2011). However, it took another 60-70 years to fully appreciate 
the abundance and the impact of these viruses. Throughout the 80s ever higher 
titres of phages were reported in natural environments, ranging from 104 to 107 ml-1 
(Bitton, 1987; Torrella and Morita, 1979). Another ten years later phages were found 
to considerably outnumber bacteria in aquatic systems (10:1), where they cause 
significant prokaryotic death (Bergh et al., 1989; Lutze and Ewing, 1990; Proctor 
et al., 1988; Proctor and Fuhrman, 1990; Sieburth et al., 1988). Today, we consider 
phages the most abundant and diverse biological entities on the planet (Koonin 
and Dolja, 2013; Suttle, 2007). The remarkable diversity of viruses reflects their 
high mutation rates, which cause rapid evolution when facing selective pressure 
from antiviral barriers (Labrie et al., 2010). Viruses and their prokaryotic hosts have 
been found in almost every possible ecosystem, being involved in perpetual cycles 
of co-evolution (Samson et al., 2013). During this constant arms race, emerging 
virus-resistant hosts will become the dominant lineages, while viruses are forced 
to develop counter resistance. This reciprocal selection and development of 
prokaryotic defence mechanisms against their viral predators plays a key role in 
regulating populations in most ecological niches, rendering viral resistance a crucial 
survival phenotype. 
Influence of mobile genetic elements
Next to phages, there are other mobile genetic elements (MGE) that can prove a 
burden to prokaryotic cells. Plasmids are transmissible between cells and require 
energy and resources for their replication. Often plasmids also encode for proteins, 
which increases their metabolic burden. Naturally occurring plasmids usually carry 
systems that ensure their stable replication within cells, such as toxin anti-toxin 
systems or antibiotic resistance systems (Jalasvuori and Koonin, 2015). Apart from 
being a burden on the cell, plasmids can also bring benefits. Antibiotic resistance 
genes on plasmids can be very beneficial for cells that are exposed to antibiotics in 
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their environment. This has become particularly troublesome in today’s medicine 
where the increasing antibiotic resistance reservoir has led to the development of 
microbial pathogens that persist in hospitals due to the resistance they gained to 
most known antibiotics. 
 Also viruses can be beneficial for their host organism. Temperate viruses 
insert their genetic material into the host genome (prophage/provirus), thereby 
transferring their genetic information to the host. Some viral genes can give 
a fitness advantage to the host, e.g. by protecting the host from additional viral 
infection (superinfection exclusion) or providing virulence factors to pathogenic 
hosts (Boyd and Brussow, 2002; Brussow et al., 2004; Labrie et al., 2010). Prophages 
are often stably maintained in bacterial lineages over long time spans, or, in case of 
inactivation of the provirus by mutations, the host has the opportunity to stably fix 
the newly acquired traits in its lineage (Canchaya et al., 2003). It has been shown for 
example that elimination of all prophages in E. coli reduces bacterial fitness (Wang 
et al., 2010). 
 In conclusion, MGEs can contribute to prokaryote evolution via two basic 
principles: the arms race that requires the cells to undergo major innovation cycles, 
or the direct transfer of innovative genetic information from the MGE to the cell 
(Koonin, 2016). Despite the occasional benefits, prokaryotes counteract the threat 
of mobile genetic elements through a set of fast evolving defence strategies that 
may act at virtually all stages of the invaders’ life cycles. These defence systems 
encompass (i) blocking, modification and loss of phage receptors, (ii) production 
of extracellular matrix, (iii) superinfection exclusion (Sie) systems, (iv) restriction-
modification (R-M) systems, (v) Argonaute-based (Ago) defence, (vi) toxin-antitoxin 
(TA) systems, (vii) abortive infection (Abi) systems, (viii) the bacteriophage exclusion 
(BREX) system,  and (ix) the clustered regularly interspaced short palindromic 
repeats and associated genes (CRISPR-Cas) system (Goldfarb et al., 2015; Labrie et 
al., 2010; Swarts et al., 2014; Westra et al., 2012b). Most of these systems function 
by innate immunity, therefore being non-specific and non-adaptive. It was thought 
for a long time, that prokaryotes do not possess an adaptive and targeted immune 
system. This changed with the discovery of the CRISPR-Cas immune system, which 
provides bacteria and archaea with adaptive and heritable immunity against MGEs. 
Brief History of CRISPR-Cas
The story of CRISPR began already in 1987 when Ishino and colleagues discovered 
the typical repeat array downstream of the E. coli iap gene (Ishino et al., 1987; 
Nakata et al., 1989). Subsequently, similar repeat arrays were discovered in a range 
of prokaryotes, both bacteria and archaea (Groenen et al., 1993; Hoe et al., 1999; 
Masepohl et al., 1996; Mojica et al., 1995; van Embden et al., 2000). However, 
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there was only speculation on the function of these arrays and even the systematic 
discovery of similar arrays in many published genome sequences did not reveal 
a function (Jansen et al., 2002b; Mojica et al., 2000). The name CRISPR was first 
introduced by Jansen and colleagues, who also discovered that CRISPRs are often 
co-localizing with specific CRISPR associated (cas) genes (Jansen et al., 2002a). In 
2005 three groups independently discovered that many of the spacer sequences 
in between the repeats matched the sequences of MGEs, suggesting they were 
derived from MGEs (Bolotin et al., 2005; Mojica et al., 2005; Pourcel et al., 2005). 
Finally, the detection of defined CRISPR array transcripts and the in silico prediction 
of cas gene functions led to the hypothesis that CRISPR-Cas acts as an RNA-based 
interference system similar to RNAi (Makarova et al., 2006). This hypothesis kicked 
off the molecular research into the function of CRISPR-Cas, which soon thereafter 
confirmed the function as a small RNA-based defence system (Barrangou et al., 
2007; Brouns et al., 2008a). 
CRISPR-Cas, an overview
CRISPR-Cas systems are best known for their function as an adaptive immune system, 
although recent studies suggest a number of non-defence roles (Vercoe et al., 
2013; Westra et al., 2014). Non-defence roles include endogenous gene regulation, 
often coupled to virulence of bacterial pathogens (Gunderson and Cianciotto, 
2013; Louwen et al., 2013; Louwen et al., 2014; Sampson et al., 2014; Sampson 
et al., 2013; Toledo-Arana et al., 2009), regulation of fruiting body formation in 
Myoxococcus xanthus (Viswanathan et al., 2007) and regulation of group behaviour, 
such as biofilm formation, in Pseudomonas aeruginosa (Zegans et al., 2009).
 Today, CRISPR-Cas systems are still exclusively found in prokaryotes and are 
present in around 50 % of sequenced bacterial and 85 % of sequenced archaeal 
genomes (Grissa et al., 2007). However, a recent study analysing the genomes 
of unculturable microbes from environmental samples revealed a CRISPR-Cas 
abundance of only 9-10% in bacteria and archaea (Burstein et al., 2016). This might 
suggest that the real abundance of CRISPR-Cas systems in nature is lower than 
previously thought.
 A typical CRISPR array consists of repeating sequences of usually around 
30 bp length and these are interspaced by similarly sized spacer sequences (Figure 
1). Often spacers can be mapped to MGEs, but spacers matching the host genome 
(self-targeting spacers) can also be observed at low frequencies (Stern et al., 2010). 
The number of spacers in CRISPR arrays varies from just a couple to dozens, or 
(rarely) several hundreds. The CRISPR array is preceded by a leader sequence. This 
AT rich sequence contains promotor elements to drive transcription of the array and 
it contains binding sites for other regulatory elements (Hale et al., 2012; Lillestol et 
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al., 2009; Pougach et al., 2010; Pul et al., 2010). The CRISPR proximal end of the 
leader is involved in the spacer integration process, as will be discussed below.
Protospacer Cas1-Cas2 
complex
Leader CRISPR-arraycas genes
pre-crRNA transcription
naive spacer acquisition
crRNA maturation
RNP assembly
Cas6 tracrRNA
RNaseIII
Cpf1
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Expression
Figure 1 – Three stages of CRISPR-Cas defense. Schematic overview of the three stages in CRISPR-Cas 
immunity of the four most prominent systems (type I, type II, type III, type V). From top to bottom: 
1) Phage or plasmid DNA enters the cell. A protospacer is selected by the acquisition machinery, 
including the Cas1-2 complex, and integrated as a new spacer in the CRISPR array. 2) CRISPR array is 
transcribed into pre-crRNA from the leader and cas genes are expressed. The pre-crRNA is processed 
into mature crRNA by Cas proteins and host factors as indicated, crRNA assembles with the effector 
proteins to form RNA guided effector complexes. 3) RNA guided effector proteins detect invaders by 
base pairing of the guide RNA with the target DNA. The target DNA gets cleaved (indicated by black 
and red triangles) by the effector complex or Cas3 (type I).
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Briefly, CRISPR-Cas functions in three stages (Figure 1): (1) the adaptation stage, 
during which new memory is added to the CRISPR array in form of spacers; (2) 
the expression stage, when the cas genes are expressed and the CRISPR array is 
transcribed into precursor CRISPR RNA (pre-crRNA) that is processed into mature 
crRNAs by Cas proteins and/or host factors. The mature crRNA associates with the 
effector protein-(complex) to form an effector ribonucleoprotein complex (RNP); (3) 
the interference stage, during which the effector-RNP scans the nucleic acids in the 
cell for potential invaders. Upon a match of crRNA and target nucleic acid, the target 
is cleaved or degraded by the RNP or an accessory nuclease.
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Figure 2 – Overview of known CRISPR-Cas systems. Adapted from (Makarova et al., 2017a, b). 
Schematic overview of the genomic loci of all currently identified CRISPR-Cas systems, showing the 
typical operon organization. The target nucleic acid of each system is indicated on the left. Genes 
are color-coded by homology and gene family names are given, in some cases the common name is 
given as well. Class 1 systems encode multisubunit effector protein complexes, while Class 2 systems 
encode single effector proteins.  The beige background highlights genes encoding parts of the effector 
complexes. Genes with multiple colors are multidomain genes that can occur separately.
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CRISPR-Cas classification
The cas genes are very diverse and form the basis of the classification system used 
to distinguish CRISPR-Cas systems. This classification evolves as new genomic 
information becomes available and new systems are being discovered. The most 
recent classification distinguishes class 1 and class 2 systems, which differ very 
much with respect to the architecture of their RNA-guided effector proteins 
(Figure 2) (Makarova et al., 2015; Makarova et al., 2017a, b). Class 1 systems utilize 
multiprotein complexes, while class 2 systems utilize single proteins. There are 
currently 6 types and >25 subtypes of CRISPR-Cas systems, with type I, type III and 
type IV being class 1 systems, and type II, type V and type VI being class 2 systems 
(Koonin et al., 2017). Cas genes can be divided by their functional association 
with the three stages of CRISPR-Cas. The adaptation module, including cas1, cas2 
and sometimes cas4, is the most uniform/conserved functional module between 
the diverse CRISPR-Cas systems (Jackson et al., 2017). The expression module is 
represented by cas6 genes in type I and type III systems, which are essential for 
crRNA maturation. Type II systems make use of host RNase III, a trans-acting RNA 
(tracrRNA) and other unknown factors, while type V and type VI systems integrate 
crRNA processing into the effector protein. The interference module contains the 
effector genes. These are single genes in case of type II, type V and type VI systems 
(cas9, cas12 (cpf1) and cas13 (c2c2) respectively), or multigene operons for type I, 
type III and type IV systems. The latter operons encode the multiprotein effector 
complexes, which share striking similarities in their structural architecture, despite 
a low sequence similarity (e.g. Cascade in type I systems and CSM/CMR in type 
III systems) (Figure 3B). Common genes are cas7, which encodes the backbone 
protein of the effector complex, cas5, a small subunit and a large subunit. In some 
cases the cas6 gene products are also part of the final effector complex, however, 
Cas6 function is often independent of the complex. Type I systems are the only 
systems with an additional effector gene, namely cas3, which is a helicase-nuclease 
responsible for target DNA degradation. The Cas3 protein is not part of the effector 
complex and is recruited in trans after target DNA recognition by Cascade. All other 
systems incorporate the nuclease functionality within their effector complex. The 
majority of CRISPR-Cas systems target DNA, however, type III systems target RNA 
sequence specifically and in addition degrade DNA non-specifically in an RNA-target 
dependent manner, while type VI systems target RNA only. 
 In the following paragraphs CRISPR-Cas mechanisms will be explained in 
more detail. The focus will be on type I systems and more specifically the type I-E 
system of E. coli. It is one of the best understood and most abundant CRISPR-Cas 
type in nature and is the focus of this thesis.
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Figure 3 – Mechanism of spacer integration. Schematic of the current model of spacer integration 
in the type I-E system. The general mechanism likely applies to other systems as well. From top to 
bottom: Spacer precursors are generated via multiple pathways. During naïve acquisition precursors 
are thought to be generated dominantly by the RecBCD complex during DSB repair at stalled replication 
forks during degradation of linear dsDNA (e.g. phage DNA). During primed acquisition, precursors are 
thought to be generated by any combination of the Cascade complex, Cas3 and the Cas1-2 complex. 
Next, precursors are selected, bound and processed by the Cas1-2 complex to generate mature 
spacers containing a canonical PAM (CTT) in the 3’ end of one strand. Integration host factor (IHF) 
binds to the leader and induces a bend, which allows proper docking of the Cas1-2 complex. The PAM 
on the precursor is cleaved to generate a C on the 3’ end at some point during spacer integration. The 
3’-OH of the spacer precursor carries out a Cas1-2 catalyzed nucleophilic attack on the first repeat of 
the array. This happens sequentially, first at the leader proximal end and then at the penultimate base 
of the leader distal end. This forms a stable spacer integration intermediate. Next, the remaining gaps 
are filled in by DNA polymerase and repaired by ligation.
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CRISPR adaptation
The adaptation stage was for a long time the least understood, but recently a lot of 
progress has been made (Jackson et al., 2017). Adaptation is the integration of new 
spacer sequences into the CRISPR array during or after exposure to MGEs. Spacers 
are usually sampled from MGEs but occasionally also from the host genome. 
Integration occurs at the leader proximal end of the array and therefore spacers 
represent a chronological archive of encountered invaders (Barrangou et al., 2007; 
Garneau et al., 2010; Sternberg et al., 2016). 
Self/non-self discrimination during adaptation
In type I, type II and type V systems, invader target sequences (protospacers) 
carry an additional adjacent short sequence motif (2-7 nt), called the protospacer 
adjacent motif (PAM) (Deveau et al., 2008; Garneau et al., 2010; Horvath et al., 
2008b; Jinek et al., 2012; Mojica et al., 2009a; Sapranauskas et al., 2011; Zetsche et 
al., 2015). The PAM plays an important role in CRISPR adaptation and interference. 
During interference the PAM is used for authentication of the invader DNA target 
(in addition to base-pairing between crRNA and protospacer) and therefore allows 
self/non-self discrimination (Marraffini and Sontheimer, 2010b). Self-targeting is a 
potential risk, because the crRNA can also pair with the corresponding CRISPR spacer 
in the host genome. This is prevented due to the absence of the PAM sequence in 
the CRISPR array. Since the PAM is required during interference, only acquisition of 
spacers with a PAM is effective. Indeed, when naturally occurring spacer sequences 
can be mapped to target sites in MGEs, a PAM is very often observed (Horvath et 
al., 2008b; Mojica et al., 2009a). This can, however, also be the product of selection 
for cells with functional spacers due to increased chance of survival. Therefore, high 
throughput spacer acquisition experiments in the absence of selection pressure 
have been carried out and revealed PAM specific spacer acquisition (Heler et al., 
2015; Savitskaya et al., 2013; Shmakov et al., 2014; Yosef et al., 2012; Yosef et al., 
2013). The degree of PAM specificity varies between systems, producing only ~35 
% of spacers with a correct PAM in the type I-E system of E. coli (Yosef et al., 2012), 
while producing more than 99 % of spacers with a correct PAM in the type II-A 
system of Streptococcus pyogenes (Heler et al., 2015). PAM selection during spacer 
acquisition has been shown to be an inherent feature of Cas1 in the type I-E system 
and this likely holds true for other type I systems as well (Wang et al., 2015; Yosef 
et al., 2012). Type II-A systems have been shown to require Cas9, trans activating 
crRNA (tracrRNA) and Csn2 for spacer acquisition in addition to Cas1-2 (Heler et 
al., 2015; Heler et al., 2017; Wei et al., 2015b). Specifically, Cas9 has been shown 
to be required for selection of protospacers with the correct PAM and this function 
is believed to be universal among type II systems. The involvement of Cas9 in PAM 
selection in type II systems therefore may suggest that Cas1 does not possess any 
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PAM specificity in these systems. Cas4, which is present in type I-ABCDU and II-B and 
V systems, is another protein predicted to be associated with spacer acquisition. The 
cas4 gene is always localized together with cas1 and cas2 and even fused to cas1 
in type I-U and V-B (Makarova et al., 2015; Shmakov et al., 2017). The involvement 
of Cas4 in spacer acquisition has been shown experimentally for type I-B (Li et al., 
2014). 
 The small size of the PAM allows for sufficient discrimination power to 
prevent auto-immunity, while retaining a large number of potential target sites in an 
invader genome. While the PAM prevents self-targeting of the CRISPR array, it does 
not prevent acquisition of spacers from the host genome. Acquisition of self-spacers 
is either lethal or coincides with a non-tolerated PAM, the loss/modification of the 
target sequence or inactivation of CRISPR effector genes to prevent cell death (Dy et 
al., 2013; Paez-Espino et al., 2013; Wei et al., 2015b). Concomitantly, the acquisition 
of self-spacers in E. coli and S. thermophilus has been shown to be increased when 
the effector complex was either absent or inactivated (Wei et al., 2015b; Yosef et al., 
2012). However, even in the absence of interference and potential autoimmunity, 
spacers are sampled from MGEs with a much higher frequency than from the 
genome (Diez-Villasenor et al., 2013a; Nunez et al., 2014; Yosef et al., 2012). A 
mechanism for this has recently been described for spacer acquisition in E. coli, 
which is dependent on the active replication of the source DNA (Levy et al., 2015). 
Indeed, the ratio of self vs. non-self spacers is directly linked to the replication 
frequency of the host genome vs. MGEs, respectively. While the genome is only 
present in one copy and replicates once per cell cycle, plasmids and phages are 
more actively replicating and reach far higher copy numbers. The E. coli CRISPR-Cas 
system derives the spacers from DNA fragments that are produced during RecBCD-
catalysed repair of double stranded breaks (DSB) at stalled replication forks (Levy 
et al., 2015). This form of spacer acquisition requires Cas1 and Cas2 as the only Cas 
proteins and is termed naïve acquisition (Fineran and Charpentier, 2012; Yosef et 
al., 2012). However, naïve acquisition is not completely abrogated in the absence 
of RecBCD, suggesting alternative mechanisms, or other possible sources for spacer 
molecules such as DNA fragments generated by RM systems (Dupuis et al., 2013). 
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Figure 4 – Architecture of Cascade effector complex. Adapted from (Jackson et al., 2014; Jackson 
and Wiedenheft, 2015). A) Genomic locus architecture of the type I-E system in E. coli, showing the 
separate cas3 gene, the operon encoding for the Cas proteins forming the Cascade complex (Cse1, 
Cse2, Cas7, Cas5, Cas6e), the cas1 and cas2 genes, the leader sequence and an array with two repeats 
and a spacer. Next to the array is a depiction of a mature crRNA. B) Schematics of the structures of 
the type I-E Cascade complex from E. coli and the type III-B Cmr complex from Pyrococcus furiosus. 
Both complexes show a similar architecture. Cas7 family subunits (Cas7, Cmr4) for a helical backbone 
around the crRNA which is capped at both ends by head and tail subunits. Both complexes contain 
additional subunits in the middle (Cse2, Cmr5) and both bind the 5’ end of the crRNA in a subunit 
at the bottom (Cas5, Cmr3). In addition, both complexes contain a ‘large subunit’ at the bottom 
(Cse1, Cmr2). The short Cmr4 backbone in the Cmr complex is supplemented by structurally similar 
Cmr6 and Cmr1 subunits. Cascade contains the Cas6 subunit at the head of the complex, while Cmr 
contains no head subunit and has a trimmed crRNA 3’end. C) Three views of the crystal structure of 
the Cascade complex.
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Mechanism of spacer integration
While there is still much uncertainty as to the origin and selection of new spacer 
molecules, our knowledge of the mechanism of spacer integration has vastly 
improved over the last few years. Most of this work has been done in the type I-E 
system of E. coli, but the general mechanism of spacer integration is likely universal 
(Figure 4). Cas1 and Cas2 are at the centre of this mechanism and have been shown 
to form a complex of two Cas1 dimers flanking a central Cas2 dimer in the type I-E 
system of E. coli (Nunez et al., 2014). Other systems likely also form complexes of 
Cas1-2, however they might differ in structure or carry additional protein subunits. 
Cas1 and Cas2 are both nucleases, however, it has been shown that the nuclease 
activity of Cas2 is dispensable for spacer acquisition (Babu et al., 2011). Spacer 
integration occurs at the leader end of a CRISPR array and includes the duplication 
of the first repeat. Both the leader and the first repeat have been shown to be 
essential and are interacting with either Cas1-2 or other integration factors (Moch 
et al., 2016; Wei et al., 2015a; Wright and Doudna, 2016; Yosef et al., 2012). 
Specifically, only 40 to 43 bp of the leader upstream of the first repeat are required 
for spacer acquisition (Diez-Villasenor et al., 2013a) and this region has been shown 
to bind the E. coli integration host factor (IHF) (Nunez et al., 2016; Yoganand et al., 
2017). IHF binding induces a sharp bend in the DNA, which brings another upstream 
sequence motif, the integrase anchoring site (IAS), close to the first repeat and allows 
binding of the Cas1-2 complex to form a supercomplex (Yoganand et al., 2017). 
Binding of Cas1-2 is reinforced when it carries a spacer precursor molecule (Moch 
et al., 2016) and it has been shown that dsDNA is the preferred substrate (Nunez 
et al., 2015b; Rollie et al., 2015; Wang et al., 2015). Furthermore it has been shown 
that the ideal spacer precursor has 3’ overhangs and carries the PAM sequence in 
one of its 3’ termini. Spacer precursors are likely matured by the Cas1 subunits that 
cleave 3’ of the first C nucleotide of the CTT PAM and at a fixed distance on the 
other 3’end to create a 33 nt long spacer (Wang et al., 2015). The 3’-OH termini on 
the precursor are essential, since they each perform a Cas1-2 catalysed nucleophilic 
attack on one strand of the first repeat during integration. This process resembles 
that of retroviral integrases and transposases (Nunez et al., 2015b). Initially, a stable 
spacer integration intermediate was detected in vivo, which suggested a staggered 
cut at the two ends of the first repeat and subsequent integration of the double 
stranded spacer (Arslan et al., 2014). More recently, in vitro assays mimicking spacer 
integration have provided more details about the process (Nunez et al., 2015b; Rollie 
et al., 2015; Wright and Doudna, 2016). Although these assays are each limited in 
their reproduction of the situation in vivo, combined they have led to the following 
model. Cas1-2 first catalyses the nucleophilic attack of the 3’-OH of the spacer end 
that does not carry the CTT PAM. This initial nucleophilic attack occurs at the leader 
proximal end of the repeat. The second nucleophilic attack is carried out by the 3’-
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OH of the C nucleotide left over from the PAM, which gets integrated at the leader 
distal end of the repeat. This second integration site is at the penultimate base of 
the original repeat, therefore replacing the terminal C nucleotide of the repeat with 
the incoming C from the spacer. The C of the original repeat then becomes the last 
nucleotide of the second repeat. After the spacer is coupled at both ends to one of 
the strands of the repeat, DNA polymerase I fills in the gaps to restore the repeats 
and cellular ligases likely repair the remaining nicks (Ivancic-Bace et al., 2015).
Primed acquisition
Next to naïve acquisition, primed acquisition was described for a number of type I 
systems (Datsenko et al., 2012; Li et al., 2014; Richter et al., 2014; Swarts et al., 2012; 
Vorontsova et al., 2015). Priming acquisition requires all cas genes and the presence 
of a spacer already targeting the MGE. Thus, priming serves as a positive feedback 
loop that strengthens the defence by facilitating additional spacer acquisition. 
This is also reflected by the fact that priming acquisition is around 50 times more 
frequent than naïve acquisition in E. coli (Datsenko et al., 2012). Priming in E. coli 
is a very robust process, tolerating up to 13 mutations in the priming protospacer 
(out of 32), as well as many possible PAM mutations (Fineran et al., 2014; Xue et al., 
2015). Furthermore, priming results in a much higher percentage of spacers with 
the canonical PAM (>95 %) than naïve acquisition (37 %) (Shmakov et al., 2014; 
Yosef et al., 2013). Another hallmark of priming in type I-E systems of E. coli is the 
strand bias observed with newly acquired spacers. Around 90 % of newly acquired 
spacers target the same DNA strand as the original spacer that triggered priming 
(Datsenko et al., 2012; Shmakov et al., 2014). Naïve acquisition on the other hand 
results in a 50/50 strand distribution of spacers. The priming strand bias is, however, 
not universal across type I systems and this is related to mechanistic differences 
(Li et al., 2014; Richter et al., 2014). The mechanism of priming is still not fully 
understood and there is evidence supporting different models. The model that was 
first proposed for E. coli assumes that DNA degradation fragments generated during 
direct interference serve as spacer precursors during priming (Swarts et al., 2012). 
Another model proposes the formation of a Cas1-2-3 supercomplex, triggered by 
escape mutants, that scans the target DNA for potential new spacers (Redding et 
al., 2015). The mechanism of priming is the subject of Chapter 5 and is further 
discussed in Chapter 8 (general discussion). 
Biogenesis of crRNA and effector complex formation
This process is often referred to as the expression stage of CRISPR-Cas defence, 
which refers to the expression of cas genes and transcription of the CRISPR array 
(Figure 1). Most important in this process is the biogenesis of the crRNA and the 
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subsequent formation of the effector complexes. The mature crRNA which contains 
a single spacer sequence and varying repeat flanks is at the centre of CRISPR-Cas 
immune systems, providing the targeting information that makes these systems so 
specific and versatile. The CRISPR array is initially transcribed into one long precursor 
(pre-crRNA), which contains hairpin elements if the CRISPR repeats are palindromic 
(Brouns et al., 2008a; Charpentier et al., 2015; Jore et al., 2011a). After pre-crRNA 
transcription each system processes the RNA in a different way to create mature 
crRNAs of 30 – 65 nt length. Class 1 and class 2 systems differ fundamentally in 
their crRNA biogenesis. Class 1 systems make use of proteins from the Cas6 family 
of ribonucleases that recognize the repeat sequences and/or hairpin structures 
and cleave at a specific position (Brouns et al., 2008a; Carte et al., 2010; Carte 
et al., 2008). Some class 1 systems undergo a second step of maturation, but the 
mechanism is unknown (Charpentier et al., 2015). DNA-targeting class 2 systems 
have to be separated into type II systems and type V systems, which differ in crRNA 
maturation. Type II systems (Cas9) make use of trans-acting CRISPR RNAs (tracrRNA), 
which form partial duplexes with the pre-crRNA and direct housekeeping RNase 
III to cleave within the repeats (Deltcheva et al., 2011). Type V-A systems (Cpf1/
Cas12a) do not require a tracrRNA; instead the Cpf1 protein has intrinsic RNase 
activity that allows it to process its own pre-crRNA to mature crRNAs (Fonfara et al., 
2016; Swarts et al., 2017). Type V-B systems (C2c2/Cas12b) also have intrinsic guide 
processing, but also make use of tracrRNA (Abudayyeh et al., 2016; East-Seletsky 
et al., 2016). Still, both type II and type V-A require a second crRNA maturation 
step that trims the 5’ end (type II) or the 3’ end (type V). The mechanism and the 
involved components of this secondary processing are still unknown (Charpentier 
et al., 2015), but most likely involve a non-Cas exo-ribonuclease.
 Cas6 family proteins are metal-independent endo-ribonucleases that 
contain two RRM-type RNA-binding domains. In type I systems, cleavage of the 
pre-crRNA typically occurs 8 nt upstream of the repeat-spacer boundary, creating 
an 8-nt 5’ handle, followed by the spacer and a longer 3’ handle that often forms 
a stem loop (Brouns et al., 2008a; Carte et al., 2008; Jore et al., 2011a). Type I 
systems typically encode the CRISPR-associated ribonucleoprotein (RNP) complex 
for antiviral defence (Cascade). This complex carries the crRNA and the RNA is likely 
to serve as a scaffold for complex assembly. Cas6 stays associated to the crRNA in 
type I-E and I-F systems and is a single-turnover enzyme, and a stably-associated 
subunit of the Cascade complex (Jore et al., 2011a; Wiedenheft et al., 2011a). 
In type I-A, I-B, I-D and type III systems, Cas6 is a multiple turnover enzyme that 
does not associate with the corresponding RNP complex after cleaving the crRNA 
(Plagens et al., 2014; Richter et al., 2013; Richter et al., 2012b; Scholz et al., 2013). 
The absence of Cas6 in the final RNP complex coincides with the lack of a stem 
loop in these systems. Type I-C systems lack a cas6 gene entirely and its function 
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is taken over by cas5 (Nam et al., 2012a). There are many organisms with multiple 
different class I CRISPR-Cas systems, such as Thermus thermophilus and Pyrococcus 
furiosus. In these organisms, not all CRISPR loci contain the necessary cas6 gene for 
crRNA processing. Instead, crRNAs can be provided in trans by other CRISPR loci or 
standalone cas6 genes, even if these are part of a different subtype (Majumdar et 
al., 2015; Staals et al., 2014).
Structure of the Cascade complex
The type I-E Cascade complex consists of five different protein subunits in uneven 
stoichiometry (Cse11, Cse22, Cas76, Cas51, Cas6e1) and a 61 nt crRNA (Figure 
3) (Brouns et al., 2008a; Jore et al., 2011a). The complex structure resembles a 
seahorse shape, with the six Cas7 proteins forming the helical backbone (Wiedenheft 
et al., 2011a). The Cas7 proteins make direct contact with the 32 nt spacer part 
of the crRNA, which is arranged in short helical segments (Jackson et al., 2014; 
Mulepati et al., 2014; Zhao et al., 2014). These 6 nt helical segments are interrupted 
by a “thumb”-like structure of the Cas7 proteins that hold on to the crRNA. This 
interaction results in the flipping of the underlying RNA base, which therefore is 
not available for base-pairing with a DNA target. The head protein (Cas6e) makes 
contact with the conserved stem loop at the 3’ end of the crRNA, while the foot 
proteins (Cse1, Cas5) make contact with the conserved 5’ end, the PAM and the 
seed sequence of the crRNA. Although Cas6e is part of the final Cascade complex, 
it is not essential for activity. It was demonstrated that when mature crRNA is 
supplied in a Cas6e independent manner, Cascade activity is not impaired in the 
absence of Cas6 (Semenova et al., 2015). Specifically, Δcas6e-Cascade was able to 
trigger both direct interference as well as primed acquisition. Furthermore, in the 
absence of Cas6e, also the 3’ stem-loop of the crRNA is dispensable at least in vitro. 
Finally, the Cascade architecture has been shown to depend on the crRNA length. 
Lengthening or shortening the spacer part of the crRNA leads to Cascade complexes 
with extra or fewer Cas7 backbone subunits respectively (Gleditzsch et al., 2016; 
Kuznedelov et al., 2016; Luo et al., 2016). Elongated complexes are fully functional 
and even sensitive to target mismatches within the elongated part of the crRNA. 
Shortened complexes are fully functional as well, when the spacer part is at least 
20 nt. A spacer of 14 nt appeared unable to drive direct interference, while still 
causing primed acquisition. Type I Cascade complexes with altered crRNA length 
and architecture have not been found in nature and the crRNA length in type I-E 
systems is largely fixed (Diez-Villasenor et al., 2010). However, type III complexes 
are naturally ambiguous in their architecture, because they are supplied with crRNA 
of various lengths (Hale et al., 2008; Hale et al., 2009; Staals et al., 2013; Tamulaitis 
et al., 2014). Since all class I complexes share remarkable structural similarities, it 
is likely that in all respective systems complexes are assembled around the crRNA 
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and that the crRNA length determines the complex architecture (Jackson and 
Wiedenheft, 2015). Despite the important function of crRNA in complex assembly, 
crRNA independent complex formation has also been observed, although complex 
architecture was less defined (Beloglazova et al., 2015). This shows that the Cas 
proteins are capable of self-assembly and that the general complex architecture is a 
result of the protein interactions.
Direct Interference
Direct interference is the detection and destruction of invading nucleic acids by Cas 
nucleases. At the centre of this process are the RNP complexes that are programmed 
by their guide RNAs to target complementary sequences (Figure 1). Binding of a 
cognate target site leads to the formation of an R-loop, where one DNA strand is 
paired with the RNA while the other DNA strand is displaced. The identification and 
destruction of a canonical target depends on two main factors. The target sequence 
(protospacer) needs to be sufficiently complementary to the spacer portion of 
the crRNA, and, with the exception of RNA targeting type III systems, all systems 
require the presence of a short protospacer adjacent motif (PAM) (Barrangou et al., 
2007; Brouns et al., 2008a; Garneau et al., 2010; Westra et al., 2012c; Zetsche et 
al., 2015). The PAM is the most important element of a potential target site. Even 
if the protospacer is perfectly matching the crRNA, an incorrect PAM will prevent 
interference activity in most systems. Some type I systems are more promiscuous 
towards the PAM sequence, tolerating degenerative PAM motifs. The type I-E 
system, for example, tolerates five different PAM sequences for direct interference, 
while nearly all PAM sequences can lead to primed acquisition (Fineran et al., 2014; 
Westra et al., 2012c). However, a PAM sequence identical to the sequence of the 
repeat that is adjacent to the spacer in the CRISPR array is not tolerated (Xue et 
al., 2015). This exemplifies the role of the PAM as a safety feature to prevent auto-
immunity. In addition, the PAM is thought to function as a means to speed up the 
target search of the crRNP in the vast amount of cellular DNA (Künne et al., 2014; 
Redding et al., 2015; Sternberg et al., 2014). Continuously initiating base-pairing 
between crRNA and DNA in order to find a complementary site would significantly 
slow down the search, especially because the DNA strands need to be separated 
first. Instead, crRNPs have been shown to initially scan for PAM sequences and 
initiate base-pairing when a bona fide PAM has been encountered (Redding et al., 
2015; Sternberg et al., 2014). Furthermore, the PAM-protein interaction has been 
shown to aid in the local unwinding of the dsDNA to initiate crRNA-DNA (target 
strand) base-pairing, which is important since crRNPs do not contain ATP-powered 
helicases. Despite this mechanism, PAM-independent target binding has also been 
demonstrated for type I-E Cascade (Blosser et al., 2015). This coincides with the 
fact that Cascade strongly favours negatively supercoiled (nSC) target DNA over 
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relaxed or linear DNA and that the supercoiling energy aids in the local unwinding 
of the DNA (Westra et al., 2012c). Other crRNPs such as Cas9 strictly require the 
presence of a PAM for target binding and cleavage activity and do not prefer 
nSC DNA (Jinek et al., 2012). Cascade recognizes the PAM by direct protein-DNA 
interactions, specifically the minor grove of the double stranded PAM sequence is 
interacting with three structural features of the Cse1 subunit (Hayes et al., 2016). 
The promiscuity of Cascade towards the PAM sequence is explained by the inherent 
promiscuity of DNA minor grove recognition. After PAM recognition, a wedge is 
inserted that initiates directional DNA strand unwinding, followed by segmental 
base-pairing of crRNA and the target strand (Blosser et al., 2015; Hayes et al., 2016; 
Rutkauskas et al., 2015). The non-target strand is displaced and locked behind the 
Cse2 subunit dimer.
The seed sequence
The extent of mismatch tolerance between protospacer and crRNA varies between 
systems, however, type I and type II systems both contain a region that tolerates 
mutations to a far lesser extent than the rest of the protospacer/crRNA. This region 
is called “the seed” and usually encompasses seven base-pairs (type I) or seven to 
twelve base-pairs (type II and type V) at the PAM proximal end of the protospacer 
(Jinek et al., 2012; Künne et al., 2014; Semenova et al., 2011; Wiedenheft et al., 
2011b; Zetsche et al., 2015). Recently, comprehensive studies of many different 
spacer sequences have revealed a flexibility in the definition of the seed based on 
the individual sequence and the experimental conditions (Cong et al., 2013; Jiang 
et al., 2013; Kuscu et al., 2014; O’Geen et al., 2015; Pattanayak et al., 2013; Wu 
et al., 2014a; Wu et al., 2014b; Xue et al., 2015). However, the seed is not only 
defined by its mutation intolerance, but also by structural or mechanistic features 
that allow for the initial interaction (base pairing) between crRNA and DNA target. 
Recent single molecule studies have shown that several RNPs initiate interactions 
with target DNA at the PAM site by protein-DNA interactions, this is followed by 
base-pairing of the PAM proximal parts (seed) and subsequently base-pairing 
continues in a zipper-like manner (Rutkauskas et al., 2015; Sternberg et al., 2014). 
This directional binding starting at the seed is likely what makes the seed so 
essential. Seed sequences have also been described for miRNA/siRNA and bacterial 
sRNA and their features have been extensively researched in miRNAs (Künne et al., 
2014). Briefly, the seed sequence can be pre-ordered in a configuration resembling 
an A-form helix, which lowers the entropic cost of duplex formation. In addition, the 
seed can be better accessible for the DNA targets, while the rest of the RNA is more 
protected/shielded by the RNP. The seed sequence is the subject of chapter 2 and 
will be more thoroughly discussed in chapter 8 (general discussion).
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Conformational effects
A number of single molecule studies on E. coli Cascade have demonstrated several 
conformational features that influence the immune response. First, cryo-EM 
structures and magnetic tweezer experiments have shown that binding of a cognate 
target site triggers a conformational change in the Cascade complex, leading to a more 
stable interaction (Rutkauskas et al., 2015; Wiedenheft et al., 2011a). This “locked” 
state has been shown to be required for recruitment and activation of the Cas3 
helicase/nuclease. Single molecule imaging of DNA and Cas proteins has revealed 
that Cascade bound to canonical targets recruits Cas3, while Cascade bound to non-
canonical targets does not. In the presence of Cas1-2, however, a nuclease-inactive 
Cas3 is recruited to non-canonical targets (Redding et al., 2015). Furthermore, a 
single molecule FRET study has demonstrated independently that Cascade exhibits 
two distinct binding modes for canonical and non-canonical targets (Blosser et al., 
2015). While only the canonical binding mode leads to direct interference, the non-
canonical binding mode is still able to trigger primed acquisition. In addition, the 
non-canonical binding mode is PAM- and seed-independent, suggesting a different 
mechanism of target binding. Finally, an additional single molecule FRET study has 
shown that upon DNA binding the Cse1 subunit of Cascade exists in an equilibrium 
between ‘closed’ and ‘open’ conformations. This equilibrium depends on the extend 
of target mutations and also correlates with the relative abundance of interference 
and priming respectively (Xue et al., 2016). The implications of Cascade binding 
modes and conformations on interference and priming are also described in chapter 
5 and discussed in detail in chapter 8 (general discussion).
Cleavage of foreign DNA
In type I systems, DNA that is bound by Cascade complexes is ultimately degraded 
by Cas3. E. coli Cas3 is a two-domain protein that consists of an N-terminal HD 
domain and a C-terminal superfamily-2 (SF2) helicase domain. The HD domain 
exerts cobalt-dependent nuclease activity exclusively on single-stranded DNA 
(ssDNA) (Beloglazova et al., 2011; Mulepati and Bailey, 2011; Mulepati and Bailey, 
2013; Sinkunas et al., 2011). The helicase domain exerts ATP- and magnesium-
dependent DNA-DNA and DNA-RNA unwinding activity (Beloglazova et al., 2011; 
Howard et al., 2011). Cas3 is recruited to the R-loop by the Cse1 subunit of Cascade 
(Hochstrasser et al., 2014; Mulepati and Bailey, 2013; Westra et al., 2012c). Cas3 
uses a DNA binding cleft in its C-terminal domain to bind to the single stranded 
non-target strand of the R-loop and nicks it using endonuclease activity of the 
HD domain (Gong et al., 2014; Huo et al., 2014; Mulepati and Bailey, 2013). After 
nicking, the binding cleft is transformed into a tunnel, ensuring stable binding of 
the DNA. The DNA is then threaded through the tunnel by the SF2 helicase domain, 
consuming ATP. This way, the helicase is feeding the DNA directly to the HD domain, 
General introduction and thesis outline
25
1
resulting in 3’ to 5’ exo-nucleolytic cleavage (Mulepati and Bailey, 2013; Sinkunas et 
al., 2011; Westra et al., 2012c). The precise cleavage sites of Cas3 are the subject of 
chapter 5 and are further discussed in Chapter 8.
 Only type I systems encode a cas3 gene. Instead, all other systems have 
crRNPs that have integral nuclease domains/subunits to cleave the target (Makarova 
et al., 2015). However, while Cas3 activity leads to the complete degradation of a 
target, the other crRNPs only cleave at one or a few positions to disable the invader. 
 Class 2 systems employ single protein RNPs, rather than multi-subunit class 
1 RNP complexes. Type II and type V-A/B systems code for Cas9 and Cpf1/C2c1, 
respectively. Cas9 contains two separate nuclease domains (HNH/RuvC), which 
cleave one DNA strand each to produce a blunt cut (Jinek et al., 2012). Cpf1 and 
C2c1 both contain a single nuclease domain (RuvC) that cleaves both strands and 
produces a staggered cut (Swarts et al., 2017; Yang et al., 2016; Zetsche et al., 2015). 
Interestingly, PAM sequences are located at opposite sides of the protospacer in 
Cas9 (5’ of target strand) and Cpf1/C2c1 (3’ of target strand). Furthermore, Cas9 
and C2c1 require a tracrRNA in addition to the crRNA for activity, while Cpf1 
only requires a short crRNA with a 5’ hairpin. Due to its compact, single protein 
architecture and easy programmability, Cas9 has been extensively applied for 
genome editing over the last years, and the newly discovered Cpf1 is emerging as a 
competitive alternative (Kim, 2016; Tóth et al., 2016; Wright et al., 2016).
 Type III systems encode RNP complexes that share remarkable structural 
similarities to type I RNP complexes (Jackson et al., 2014; Jackson and Wiedenheft, 
2015; Mulepati et al., 2014; Osawa et al., 2015; Rouillon et al., 2013; Spilman et al., 
2013; Taylor et al., 2015). However, they show substantial functional differences. Both, 
the Csm complex (type III-A) and the Cmr complex (type III-B) were initially shown to 
target and cleave RNA (Hale et al., 2009; Staals et al., 2013; Zebec et al., 2014). More 
recently, it was demonstrated that both complexes are also transcription dependent 
DNA nucleases, therefore being able to cleave both DNA and RNA (Deng et al., 2013; 
Elmore et al., 2016; Estrella et al., 2016; Goldberg et al., 2014; Peng et al., 2015; 
Samai et al., 2015). The complexes first identify mRNA targets via base-pairing with 
their crRNA, after which both the RNA transcript as well as the transcribed DNA are 
being cleaved. Another major difference between type I and type III complexes is the 
mechanism of self/non-self discrimination. Unlike type I systems, type III systems have 
not been shown to require PAM sequences in their targets. Instead, auto immunity 
is prevented by the recognition of the repeat sequence in the host genome via base-
pairing with the repeat part of the crRNA or via protein interactions (Marraffini and 
Sontheimer, 2010b; van der Oost et al., 2014). Type III systems therefore use a self-
inactivating mechanism, while type I systems use a non-self activating mechanism for 
direct interference (PAM) and a self-inactivating mechanism for priming (the repeat).
Chapter 1
26
1
Genome editing using crRNPs
Recently, the field of genome editing has been revolutionized by the introduction 
of RNA-guided endonucleases (RGENs), most prominently Cas9 from Streptococcus 
pyogenes (Cho et al., 2013; Cong et al., 2013; Jinek et al., 2013). RGENs are 
nucleases that make use of a guide RNA molecule that is used to identify bona fide 
target sequences via RNA-DNA base-pairing. Starting in 2013, Cas9 has been shown 
to efficiently create indels (frame-shifts) or stimulate homologous recombination 
of repair templates in a large range of cell types (Kim, 2016). Developments have 
been made to turn Cas9 into an antimicrobial or antiviral tool (Bikard et al., 2014; 
Ebina et al., 2013; Hu et al., 2014; Ramanan et al., 2015). Furthermore, catalytically 
dead Cas9 (dCas9) has been used as a targeting platform for a multitude of fused 
functional domains, such as transcriptional activators/repressors (Bikard et al., 2013; 
Gilbert et al., 2013; Konermann et al., 2013; Qi et al., 2013), fluorescent proteins 
as localization signals (Chen et al., 2013) and histone-modifying enzymes (Hilton et 
al., 2015; Kearns et al., 2015). More recently, another Cas effector protein, Cpf1, 
has been discovered as a very similar alternative to Cas9. Cpf1 has a few conceptual 
advantages, like its use of a single crRNA and its ability to process its own crRNA 
from CRISPR arrays (Fonfara et al., 2016; Zetsche et al., 2015). This could make it 
exceptionally well suited for multiplexed applications and this is beginning to be 
explored (Zetsche et al., 2017). Similar to the beginnings of Cas9, Cpf1 has already 
racked up an impressive amount of genome editing applications in a short time. 
Furthermore, since Cpf1 leaves sticky ends after cleavage, it is also being developed 
as a tool for in vitro DNA assembly (Lei et al., 2017; Li et al., 2016). At the moment, 
efforts are being made to characterize three other newly discovered Cas effector 
proteins, namely C2c1, C2c2, C2c3 (Liu et al., 2017a; Liu et al., 2017b; Shmakov 
et al., 2015; Yang et al., 2016). The unique features of C2c2 have already led to its 
development into a molecular diagnostics tool for the attomolar detection of RNA 
or DNA with single nucleotide specificity (Abudayyeh et al., 2016; Gootenberg et 
al., 2017). It is just a matter of time until more applications for these proteins will 
be developed (Lewis and Ke, 2017). In conclusion, RNA-guided proteins are of great 
interest and offer unprecedented potential for a diverse range of applications. It is 
therefore vital to extend the toolbox of these proteins and find the best solution to 
every problem.
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Thesis outline
The overall aim of this thesis is to explore the type I-E CRISPR-Cas system of 
Escherichia coli and unravel mechanistic details of both interference and primed 
acquisition. We are especially interested in the dynamic relationship between these 
two processes.
Chapter 2 reviews a fundamental feature of many small RNA guided systems, the 
‘seed’. Small RNAs, such as RNAi associated RNAs, prokaryotic small regulatory 
RNAs and crRNAs rely on protein-assisted base pairing of the guide RNA with target 
mRNA or DNA to interfere with their transcription, translation or replication. All 
three groups identify their target sequence by base pairing after finding it in a pool 
of millions of other nucleotide sequences in the cell. In this complicated target 
search process, a region of 6 to 12 nucleotides of the small RNA termed the ‘seed’ 
plays a critical role. 
Chapter 3 provides a description and protocol of the Electrophoretic Mobility 
Shift Assay (EMSA) and its use for studying crRNPs. EMSA is a straightforward and 
inexpensive method for the determination and quantification of protein–nucleic 
acid interactions. Protocols for two types of EMSA assays are described using the 
Cascade ribonucleoprotein complex from Escherichia coli as an example. The EMSA 
method and these protocols are applied throughout the other chapters of this 
thesis.
Chapter 4 focusses on the processes of interference and primed adaptation, 
specifically on their mutation tolerance. We provide a systematic analysis of the 
constraints of both direct interference and priming in E. coli. Our findings imply 
that even out-dated spacers containing many mismatches can induce a rapid 
primed CRISPR response against diversified or related invaders, giving microbes an 
advantage in the co- evolutionary arms race with their invaders.
In Chapter 5 we elucidate the mechanism of priming. Specifically, we determine how 
new spacers are produced and selected for integration into the CRISPR array during 
priming. We show that priming is directly dependent on interference. We show 
that Cas3 couples CRISPR interference to adaptation by producing DNA breakdown 
products that fuel the spacer integration process in a two-step, PAM-associated 
manner. Our results highlight that the selection of PAM-compliant spacers during 
priming is enhanced by the combined sequence specificities of Cas3 and the Cas1-2 
complex, leading to an increased propensity of integrating functional CTT-containing 
spacers.
In Chapter 6 we look deeper into a nucleotide specific effect on priming that 
was discovered in Chapter 4. Immunity is based on the complementarity of host 
encoded spacer sequences with protospacers on the foreign genetic element. The 
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efficiency of both direct interference and primed acquisition depends on the degree 
of complementarity between spacer and protospacer. We show that G substitutions 
have a profoundly negative effect on interference, while C substitutions are readily 
tolerated when in the same positions. Furthermore, we show that this effect is 
based on strongly decreased binding of the effector complex Cascade to G mutants, 
while C mutants only minimally affect binding. 
Chapter 7 describes an attempt to develop the Cascade complex into a genome 
editing tool. Recently, RNA guided endonucleases (RGENs) such as Cas9 or Cpf1 have 
revolutionized genome editing. Here, we have explored the possibility to develop 
a new genome editing tool that makes use of the Cascade complex from E. coli. 
This RNA guided protein complex is fused to a FokI nuclease domain to sequence 
specifically cleave DNA.  We validate the tool in vitro using purified protein and two 
sets of guide RNAs, showing specific cleavage activity. Unfortunately, we were not 
able to successfully apply the tool in vivo in eukaryotic cells.
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Abstract 
Small guide RNAs play important roles in cellular processes such as regulation of 
gene expression and host defense against invading nucleic acids. The mode of 
action of small RNAs relies on protein-assisted base pairing of the guide RNA with 
target mRNA or DNA to interfere with their transcription, translation or replication. 
Several unrelated classes of small non-coding RNAs have been identified including 
eukaryotic RNA silencing associated small RNAs, prokaryotic small regulatory RNAs 
and prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats) 
RNAs. All three groups identify their target sequence by base pairing after finding 
it in a pool of millions of other nucleotide sequences in the cell. In this complicated 
target search process, a region of 6 to 12 nucleotides of the small RNA termed 
the ‘seed’ plays a critical role. Here we review the concept of seed sequences and 
discuss its importance for initial target recognition and interference.
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Small guide RNAs and their versatile roles
Due to the ever growing capacity to sequence cellular RNAs, small guide RNAs and 
their functions continue to be discovered. It has become increasingly more evident 
that small RNAs are key players in fine-tuning gene expression and protecting hosts 
from mobile genetic elements such as viruses and transposons. To date, three main 
classes of small guide RNAs have been described: (i) RNA interference (RNAi) based 
small RNAs, (ii) prokaryotic small regulatory RNAs and (iii) immune-associated 
CRISPR (clustered regularly interspaced short palindromic repeat) RNAs (crRNAs).
 The first class of small RNAs is involved in regulating gene expression in 
eukaryotes through different RNAi pathways (reviewed in (Bartel, 2009; Juliano 
et al., 2011; Ketting, 2011; Siomi and Siomi, 2009)). RNA interference associated 
small RNAs are critical for cell development, adaptation to changing environmental 
conditions, resistance to viruses, repression of transposable elements, chromatin 
structuring and regulation of many other cellular processes. The second class of 
small RNAs consists of prokaryotic small regulatory RNAs (sRNA) and has been 
studied mostly in bacteria. This class also regulates gene expression, using distinct 
mechanisms (reviewed in (Storz et al., 2011; Waters and Storz, 2009)). sRNAs are 
involved in the response to changing environmental conditions. A third class of 
small RNAs, called CRISPR RNAs, guide an adaptive and heritable immune system 
in bacteria and archaea, which protects microbial cells from invading nucleic acids 
such as viral genomes and conjugative plasmids (Sorek et al., 2013b; Westra et al., 
2012b).
 Although these three classes of small guide RNAs are unrelated, they show 
similarities in the way their target nucleic acids are recognized. In all cases, the 
recognition of target nucleic acids occurs by Watson-Crick base pairing with the 
small RNA. Initial target recognition by these three small RNA classes is governed by 
only part of the small RNA guide, a 6-12 nucleotide (nt) segment referred to as the 
‘seed’. This functionally essential segment is involved in initial pairing between guide 
and targets, and allows rapid probing of different regions of cellular nucleic acids. 
Seed sequences have been identified by one of four different methods including 
(i) In vivo loss of function assays; seed-target mismatches are poorly tolerated and 
lead to loss of a silencing or resistance phenotype. (ii) In vitro biochemical assays; 
the seed sequence of guide RNAs exhibits a higher affinity than the remainder of 
the guide RNA for the target nucleic acids. (iii) Structural observations; the seed 
sequence is structurally more accessible and/or in a configuration optimal for base 
pairing with the target. (iv) Computational analysis; seed sequences are conserved 
regions in RNA guides. In this review, we will compare the characteristics of seed 
sequences from RNAi-based small RNAs, sRNAs and crRNAs, and discuss how class-
specific proteins assist in the target search process.
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Table 1. Comparison of small guide RNA properties
miRNA/siRNA sRNA crRNA
Type I Type II
Schematics of 
short guide RNAs 
(5’ to 3’)
6-7 nt seed
P OH
6-25 nt guide section
6-8 nt seed
7-12 nt guide section 32-44 nt guide section
(spacer)
7-9 nt seed
(PP)P UUUOH HO cP
20 nt guide section
(spacer)
12 nt seed
OH
Length of small 
RNA
20-25 nt >50 nt 58-70 nt 35-45 nt
Length of guide 
section
6-25 nt 7-12 nt 32-44 nt 20 nt
Length of seed 6-7 nt 6-8 nt 7-9 nt 12 nt
Type of seed
Contiguous Contiguous (with 
exceptions)
Non-contiguous Contiguous
Position of seed
Position 2-7 or 2-8 Near 5’ end or 
internal
Position 9-19 Position 9-20
RNA 5’ end P PPP or P OH Not described
RNA 3’ end OH, 2’-CH3 OH 2’,3’–cyclic P or P OH
Seed only pairing Translation inhibition, 
no mRNAcleavage
Translation inhibition Abolishes inter-
ference
Abolishes interfer-
ence
Seed helical 
pre-ordering
Yes No Possibly Possibly
Seed mismatch 
tolerance
Yes, via compensato-
ry pairing
No No No
Target nucleic 
acid
mRNA mRNA Invader DNA Invader DNA
Associated pro-
tein
Argonaute Hfq Cascade complex Cas9
Refs
(Bartel, 2009; Bren-
necke et al., 2005; 
Chorn et al., 2010; 
Doench and Sharp, 
2004; Elkayam et al., 
2012; Grimson et al., 
2007; Lewis et al., 
2003; Nakanishi et 
al., 2012; Schirle and 
MacRae, 2012) 
(Bandyra et al., 
2012; Sauer, 2013; 
Storz et al., 2011)
(Jore et al., 
2011a; Maier 
et al., 2013; 
Sinkunas et al., 
2013; Wieden-
heft et al., 2011a; 
Wiedenheft et 
al., 2011b)
(Deltcheva et al., 
2011; Gasiunas et 
al., 2012; Jiang et 
al., 2013; Jinek et 
al., 2012)
RNAi based small RNAs
RNAi uses small RNA guides of 20-25 nt to regulate gene expression in eukaryotes 
(Table 1) (reviewed in (Bartel, 2009; Juliano et al., 2011; Ketting, 2011; Siomi and 
Siomi, 2009)). Three major types of RNAi-based small RNAs have been described: (i) 
microRNAs (miRNAs), which are derived from small hairpin structured RNAs encoded 
on the genome; (ii) small interfering RNAs (siRNAs), which originate from duplex 
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RNAs or longer RNA hairpins; and (iii) PIWI-interacting RNAs (piRNAs), of which the 
biogenesis is poorly understood. These small RNAs form complexes with proteins from 
the Argonaute family (Ago or PIWI proteins), the key protein component of the RNA-
induced silencing complex (RISC). In these complexes, the RNA guides sequence specific 
binding of mRNA resulting in translational repression or mRNA cleavage. This review 
will focus on the seed of miRNA and siRNA, as no evidence exists for a seed in piRNAs 
(Vourekas et al., 2012).
Guide architecture
The term ‘seed’ was first used to describe nt 2-7 or 2-8 of miRNAs, as base pairing of only 
these nucleotides is sufficient to cause translational repression (Table 1) (Brennecke et 
al., 2005; Lewis et al., 2003). Furthermore, the guide consists of an anchor (nt 1), a 
central region (nt 9-12), a 3’ supplementary region (nt 13-17) and tail region (nt 18-21), 
each with its own functional importance as described below (Wee et al., 2012).
PIWI module PAZ module
Pre-ordered seed
Seed only base pairing
Translation inhibition
Seed and 3’ base pairing
Translation inhibition
miRNA/siRNA
5’
3’ 
anchored
5’
3’
5’
5’
3’
5’
3’
5’
5’
Full base pairing
Target mRNA cleavage
3’ released
II)
I) II)
III)
I) III)
mRNA
3’ 
anchored
3’ 
anchored
Figure 1 - Model of miRNA/siRNA-Argonaute complex and target binding. I) Guide RNA (red) is bound to 
Argonaute, stretching (5’- 3’) from the PIWI module (grey) to the PAZ module (yellow). Nt 2-8 (seed) of the 
RNA are pre-ordered in a helical conformation, nt 1 is flipped into a binding pocket and is not available for 
base pairing. The 3’ part of the guide is anchored to the PAZ domain. Recognition of the incoming mRNA 
(blue) is nucleated through pairing with seed nt 2-8. II) In case of extensive complementarity between 
guide and target, base pairing is extended starting from the seed. This leads to a conformational change of 
Argonaute. Progressive base pairing leads to the release of the 3’ part of the guide from the PAZ domain, 
allowing guide and target to intertwine, possibly forming a complete helix. Complete binding, allows an 
active Argonaute to cleave the target mRNA between position 10 and 11 (indicated by scissors). III) In case 
of partial 3’ complementarity, guide and target pair around nt 13-16, leaving a gap between seed and 3’ 
pairing. Despite 3’ pairing, the guide remains anchored to Argonaute. Figure adapted from (Bartel, 2009).
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Translational repression by mRNA binding
Translational repression usually requires only pairing of the guide’s seed with the 
target mRNA (Figure 1) (Brennecke et al., 2005; Chorn et al., 2010; Doench and 
Sharp, 2004; Grimson et al., 2007). Although the nucleotide composition of the 
seed affects binding affinity and the degree of translational repression (Ui-Tei et al., 
2008), seed–target mismatches, bulges and G:U wobbles typically decrease target 
binding affinities much more than can be explained by thermodynamics of the 
seed-target match alone (Brennecke et al., 2005; Doench and Sharp, 2004; Schwarz 
et al., 2006; Wee et al., 2012). This indicates that the structure of the seed plays an 
important role during target binding. During perfect seed–target pairing, additional 
pairing of the 3’ region of the guide called supplementary pairing can enhance 
translational repression (Figure 1) (Brennecke et al., 2005; Chorn et al., 2010; 
Doench and Sharp, 2004; Grimson et al., 2007; Wee et al., 2012). Supplementary 
pairing requires four contiguous Watson-Crick base pairs in the region of nt 13-16. If 
seed pairing is imperfect, 3’ compensatory pairing at a minimum of nine nt positions 
may compensate for a single bulge or mismatches in the seed region (Bartel, 2009; 
Brennecke et al., 2005; Doench and Sharp, 2004; Grimson et al., 2007; Lewis et al., 
2005; Ui-Tei et al., 2008; Wee et al., 2012; Yekta et al., 2004). Compensatory pairing 
can decrease the seed pairing requirement to as little as four base pairs (Brennecke 
et al., 2005). However, seed mismatches with compensatory sites are scarce and 
appear to be rarely conserved (Friedman et al., 2009; Lewis et al., 2005). 
Target mRNA cleavage
Upon perfect pairing of the seed, central and 3’ supplementary region target mRNA 
binding can lead to ATP-independent mRNA cleavage by the Argonaute protein 
when it has an RNase H –like PIWI domain with an intact active site (i.e. slicer 
Argonaute) (Ameres et al., 2007; Dahlgren et al., 2008; Elbashir et al., 2001; Haley 
and Zamore, 2004; Hutvágner and Zamore, 2002; Schwarz et al., 2006; Wee et al., 
2012; Yekta et al., 2004) (Figure 1). Base pairing between the guide and the target 
initiates at the seed and propagates to the 3’ end resulting in release of the 3’ end 
of the guide to enable full base pairing (Ameres et al., 2007; Haley and Zamore, 
2004). This induces a conformational change in Argonaute (Nakanishi et al., 2012) 
and results in cleavage of the target between nt 10 and 11 opposite of the guide 
(Elbashir et al., 2001).
Effect of mismatches on target cleavage
Single and double guide–target mismatches lower the activity of the slicer complex 
depending on their position (Ameres et al., 2007; Dahlgren et al., 2008; Haley and 
Zamore, 2004; Pusch et al., 2003; Schwarz et al., 2006). Mismatches in the seed and 
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3’ complementary region affect target cleavage efficiency, whereas mismatches in 
the central region result in a complete loss of cleavage (Elbashir et al., 2001; Pusch 
et al., 2003; Schwarz et al., 2006). Mismatches are only tolerated at positions 1 (the 
anchor) and 18-21 (the 3’ tail), as these nucleotides do not contribute to target 
binding (Wee et al., 2012) but instead are required for stable binding of the guide to 
Argonaute (Elkayam et al., 2012). The anchor is tightly bound in a pocket of the PIWI 
domain in which several amino acids strongly interact with the 5’-phosphate of the 
guide, preventing base pairing of the first nucleotide with the target (Elkayam et 
al., 2012; Nakanishi et al., 2012; Schirle and MacRae, 2012) (Table 1). Securing the 
anchor ensures proper guide binding while positioning the seed and cleavage site.
Structural basis for seed binding
The seed is bound in a narrow groove in which specific amino acids of the protein 
interact with backbone phosphates and 2’OH groups of the RNA (Elkayam et al., 
2012; Nakanishi et al., 2012; Schirle and MacRae, 2012). Binding takes place in 
such a way that nt 2 to 6-8 are pre-ordered in an A-form helix with Watson-Crick 
faces pointed towards the solvent to promote target binding. The pre-ordered helix 
lowers the entropic cost when the seed of the guide RNA forms a stable duplex with 
the target (Bartel, 2004).
Differential guide loading
In most RNAi pathways, short duplex RNA molecules of 21-25 nt with 2 nt 3’ overhangs 
are the precursors for guides (Elbashir et al., 2001; Siomi and Siomi, 2009). Which one 
of the two strands becomes the guide is determined by both nucleotide composition 
and the presence of mismatches at either end of the double-stranded RNA (dsRNA) 
precursor. This differential guide loading process has direct consequences for what 
becomes the seed (Khvorova et al., 2003; Schwarz et al., 2003), as Argonaute is 
loaded with the strand that has the least thermostable 5’-end (nt 1-5) and 3’-mid 
region (nt 12-15). Both mismatches and G:U wobbles in these regions enhance the 
dsRNA unwinding and promote strand selection (Hibio et al., 2012; Kawamata et al., 
2009; Khvorova et al., 2003; Schwarz et al., 2003; Ui-Tei et al., 2008; Yoda et al., 2009).
 To summarize, RNAi-based small RNAs are relatively uniform and carry a 6-8 
nt seed. The RNA is tightly associated with Argonaute and the seed is pre-ordered in 
an A-form helix. Target mRNA binding is sequential and starts at the seed. The extent 
of guide:target pairing and the type of Argonaute determines the fate of the target.
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Prokaryotic sRNA
sRNAs in bacteria and archaea are morphologically a highly diverse group of molecules 
ranging from 50 nt to several kilobases that regulate gene expression through a 
variety of mechanisms (Georg and Hess, 2011; Storz et al., 2011). Although seed 
sequences have only been described for trans-acting sRNAs (i.e. transcribed from a 
locus other than their target), cis-acting antisense sRNAs (asRNA) also nucleate with 
their targets in specific regions and are therefore briefly discussed below.
Hfq
sRNA
mRNA
Active cycling of 
competing RNAs
Seed binding, 
triphosphorylated sRNA
Translation inhibition leading 
to mRNA instability
RNase E mediated breakdown 
of both RNAs
3’
3’
5’
5’-PPP 3’
3’
5’
5’-PPP 3’
3’
5’
5’-P 3’
3’
5’
Monophosphorylated sRNA
(activated)
5’-P 3’
3’
5’
5’-P
5’-P
RNase E mediated 
breakdown of sRNA
6-8 nt seed
Seed binding
3’
3’
5’
3’
3’
5’
3’
3’
5’
No matchRelease from Hfq
A
B I) II) III)
II) III)
RNase E
RNase E
I) 
Monophosphorylated sRNA
(activated)
Figure 2 - Model of interactions between sRNA/mRNA and Hfq. A) sRNA (red/purple) and mRNA 
(blue/yellow) are bound on opposite sides of the Hfq protein (grey-blue) (Bandyra et al., 2012; Vogel 
and Luisi, 2011). The sRNA seed is presented to mRNA for potential base pairing. Competing RNAs are 
rapidly cycled on Hfq and this is hypothesised to facilitate pair-matching. BI) 6-8 nt seed of sRNA binds 
to mRNA in the vicinity of the RBS and might in some cases be extended to 7-12 base pairs (Balbontín 
et al., 2010; Gottesman and Storz, 2011; Kawamoto et al., 2006; Vogel and Luisi, 2011; Waters and 
Storz, 2009). After duplex formation, Hfq releases the bound RNAs which leads to a stable inhibition 
of translation and ultimately degradation of the naked mRNA (Fender et al., 2010; Moll et al., 2003; 
Møller et al., 2002). BII) 5’-PPP of the sRNA is converted to 5’-P (activated) by an unknown pathway, 
leading to recruitment and allosteric activation of RNase E (yellow). After seed binding, the two RNA 
species are separately degraded by RNase E. BIII) 5’-PPP of the sRNA is converted to 5’-P (activated) 
by an unknown pathway, leading to recruitment and allosteric activation of RNase E. If the RNAs do 
not match, only the sRNA will be degraded by RNase E, releasing Hfq. Figure adapted from (Bandyra 
et al., 2012).
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Trans-acting sRNA
Trans-acting sRNAs are typically 50-300 nt long (Table 1). Binding of the sRNA to 
an mRNA can lead to translational repression by occlusion of the ribosome binding 
site (RBS) or translation start site (Figure 2) (Bouvier et al., 2008; Gottesman, 2004). 
Alternatively, sRNA binding can cause mRNA instability by eliciting RNase E-mediated 
mRNA breakdown (Bandyra et al., 2012). In vitro studies with E. coli RNase E, Hfq 
and either MicC or an artificial sRNA suggest that RNase E-mediated breakdown of 
target mRNA depends on the conversion of the 5’-triphosphate of the sRNA into a 
5’-monophosphate (Bandyra et al., 2012) (Figure 2). Apart from the fate of the 
target, the phosphorylation state of sRNA also determines its own turnover, as 
monophosphorylated sRNAs are broken down by RNase E (Figure 2). Another recent 
study shows that the position of stem loops within the sRNA protects against RNase 
E-mediated degradation (Shao et al., 2013). Interestingly, recent studies show that 
sRNA can also activate mRNA through seed pairing interactions by shielding it from 
RNase E (Frohlich et al., 2013; Papenfort et al., 2013).
 Although there are examples of sRNAs with predicted pairing regions of 10-25 
nt, most trans-acting sRNAs base pair over a stretch of only 7-12 nt with their target 
mRNAs (Bandyra et al., 2012). For some sRNAs base pairing of just 6-8 nt is sufficient to 
repress gene expression (Balbontín et al., 2010; Gottesman and Storz, 2011; Kawamoto 
et al., 2006; Waters and Storz, 2009). The minimal stretch of sRNA nucleotides that 
needs to base pair with the target to induce repression, and which does not tolerate 
mismatches, is generally referred to as the seed for prokaryotic sRNAs.
sRNA structure and seed
Most sRNAs show a remarkable variability in length, sequence and structure. 
Enterobacterial sRNAs, however, have a more defined architecture comprising a 5’ 
seed, an A/U-rich binding site for the RNA chaperone Hfq (see below) and a structured 
3’ end containing a poly(U) stretch that binds Hfq. Both a poly(U) stretch and an 
occupied Hfq binding site help to confer resistance against exonucleases (Guillier 
and Gottesman, 2008; Papenfort et al., 2010; Storz et al., 2011) (Figure 2). The 
functional modularity of this type of sRNA has been demonstrated by showing that 
target recognition occurs when a seed is transplanted to an unrelated scaffold RNA 
(Papenfort et al., 2010; Pfeiffer et al., 2009). For most sRNAs the seed is predicted to be 
unstructured (Peer and Margalit, 2011) and it has been shown for the E. coli sRNA Spot 
42 that only unstructured parts contribute to regulation (Beisel et al., 2012). However, 
some studies have reported sRNAs that rely on stem loops for their activity. For the 
enterobacterial CyaR, Vibrio harveyi Qrr sRNAs and several staphylococcal sRNAs the 
seed has been predicted or shown to be located within a stem loop (Bohn et al., 2010; 
Geissmann et al., 2009; Johansen et al., 2008; Papenfort et al., 2008; Shao et al., 2013).
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Role of Hfq
Hfq is a hexameric ring-like protein required in vivo for the function of most sRNAs 
studied today (Hussein and Lim, 2011; Moon and Gottesman, 2011; Vogel and Luisi, 
2011). Although it has a promiscuous affinity for many cellular RNAs, it preferably 
binds sRNA and mRNA molecules (Chao et al., 2012; Christiansen et al., 2006). 
Three RNA binding surfaces with distinct specificities have been described for Hfq: 
a proximal face of the ring with a preference for U-rich sequences such as sRNAs 
containing a 3’ poly-U stretch, a distal face preferring A-rich sequences or ARN 
repeats found in mRNAs, and a lateral side (Sauer, 2013).
 Available data supports a model in which Hfq is important for the initial 
formation of an sRNA–mRNA duplex by binding both RNA molecules on either 
face of the ring, bringing the seed in close proximity of a potential target (Figure 
2). Although Hfq is an abundant protein, it has been proposed that both sRNAs 
and mRNAs are in constant competition for binding sites (Fender et al., 2010), 
causing active cycling of competing RNAs on Hfq (Figure 2). Moreover, Hfq creates 
free binding sites by releasing sRNA-mRNA duplexes, which then remain stable 
(Kawamoto et al., 2006; Moll et al., 2003; Møller et al., 2002). While the majority 
of studied sRNAs contain an Hfq binding site and are Hfq-dependent for their 
function, some sRNAs repress translation in the absence of Hfq. For example, the 
sRNA RyhB from Escherichia coli remains functional without an Hfq binding site 
in the absence of Hfq (Hao et al., 2011). Although most sRNAs carry a seed, there 
is no evidence for a direct structural association between the seed and Hfq that 
facilitates target binding, as is the case for RNA silencing based small RNAs with 
Argonaute. Instead, the seed of sRNAs seems to produce RNA duplexes based on 
predicted thermodynamic stability alone (Hao et al., 2011)i. The formation of these 
complexes is catalyzed by Hfq and is achieved by presenting the RNAs to each other, 
increasing the likelihood of pairing, reducing either the entropic penalty of duplex 
formation, or modifying sRNA structure for increased binding site exposure (Soper 
et al., 2011; Vogel and Luisi, 2011).
Cis-acting antisense sRNA
asRNA-mediated gene regulation employs a variety of mechanisms, many of 
which result in degradation of the asRNA–mRNA duplex by RNase III or RNase E 
(Brantl, 2007; Georg and Hess, 2011). Although asRNAs generally exhibit extensive 
complementarity to their targets, base pairing is often initiated in a ‘kissing complex’ 
in which transient pairing occurs between exposed loops of the asRNA and the 
mRNA (Brantl, 2007). Base pairing of these short stretches is subsequently extended 
to the flanking regions, but the extensive secondary structure of the asRNA often 
prevents complete duplex formation (Han et al., 2010). While asRNAs are generally 
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not associated with Hfq, they are sometimes associated with other chaperones, 
protecting the asRNA from RNase E degradation and/or stabilizing the kissing 
complex (Brantl, 2007). Although the short stretches of the asRNA are generally not 
referred to as seed, the nucleation-type pairing mechanism bears some similarity 
to seed-containing small RNAs. Since the sequences of asRNAs co-evolve directly 
with their targets, the seed is usually difficult to identify by sequence conservation.
 In summary, sRNAs are diverse in length and structure, but many employ a 
6-8 nt seed for target recognition. The seed is not directly associated to protein and 
is in most cases free of secondary structures. The pairing of the seed to target mRNA 
is often catalyzed by Hfq by bringing sRNAs and target mRNAs in close proximity.
CRISPR RNA 
crRNAs guide the prokaryotic CRISPR-Cas immune system that protects the cell 
from foreign nucleic acid invaders (Box 1). Mature crRNAs are 35-70 nt long and are 
only complementary to their target over 20-44 nt (Table 1). This segment is flanked, 
at the 5’ end, 3’ end or both, by ribonucleotides transcribed from the repeats 
(Box1). Similar to siRNA and miRNA which are bound by Argonaute, crRNAs are 
bound by Cas proteins to form ribonucleoprotein complexes. There is systematic 
evidence for a seed sequence in crRNAs from Type I and Type II CRISPR-Cas systems, 
while no evidence currently supports the existence of a seed in Type III systems 
(Gudbergsdottir et al., 2011; Millen et al., 2012). Therefore Type III systems are not 
further discussed.
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PAMdsDNA target
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after PAM recognition
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Figure 3 - Model of Cascade target binding. I) A Cascade complex (grey) with bound crRNA, consisting 
of repeat derived nucleotides (orange) and spacer derived nucleotides (red), containing the seed. The 
seed is potentially structurally pre-ordered in a helical conformation to promote base pairing. Cascade 
recognizes target site (protospacer, blue bases) in dsDNA (blue/grey) on the basis of a PAM sequence 
(red box) (Sashital et al., 2012). II) PAM recognition promotes strand invasion by Cascade. III) Base 
pairing nucleates at the seed (position 1-8), with the exception of position 6, which is unavailable for 
base pairing. The PAM is located directly next to the target site and is not involved in base-pairing with 
the crRNA (Westra et al., 2013). IV) Both ends of the crRNA remain bound to Cascade, so the target 
DNA strand cannot wrap around the crRNA and form a full duplex. Instead, the crRNA binds the target 
DNA in non-contiguous helical segments (interruptions are indicated by asterisks). The non-target 
strand of the dsDNA target is displaced, creating an R-loop. The steps involved in subsequent target 
cleavage are not included in this figure.
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Seed of Type I CRISPR-Cas systems
An interrupted seed of 7 nt positions has been found for Type I-E and Type I-F 
crRNAs in E. coli, Pseudomonas aeruginosa and Pectobacterium atrosepticum, 
comprising positions 1-5 and 7-8 of the spacer segment of the crRNA (Cady et al., 
2012; Semenova et al., 2011; Vercoe et al., 2013; Wiedenheft et al., 2011b) (Table 
1 and Figure 3). Generation of point mutations in the seed region allows viruses 
and plasmids to escape CRISPR immunity, because these mutations greatly reduce 
the binding affinity of crRNA-loaded Cascade-like complexes for their DNA targets. 
Furthermore, compared to the remainder of the guide, the seed sequence has a 
higher affinity for target oligonucleotides (Wiedenheft et al., 2011b)|. This effect 
was abrogated when the Cas proteins were removed, indicating that the higher 
affinity is not an inherent property of the crRNA. Type I-B crRNAs from Haloferax 
volcanii carry 9 nt seed sequences and, strikingly, position 6 was again found not 
to be part of the seed (Maier et al., 2013). This points at a common structural 
conformation of the seed sequences from these Type I CRISPR-Cas systems in which 
position 6 is not base pairing with the target (Jore et al., 2011a), most likely due to a 
disruption of the crRNA-target DNA helix at this position (Wiedenheft et al., 2011a). 
Above phenomena suggest a structural pre-ordering of the seed, favoring duplex 
formation, as seen in RNAi based small RNAs.
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Figure 4 - Model of Cas9 target binding. I) Streptococcus pyogenes and S. thermophilus Cas9 (Gasi-
unas et al., 2012; Jinek et al., 2012) protein (grey) with bound crRNA, consisting of repeat derived nu-
cleotides (orange) and spacer derived nucleotides (red) containing the seed. Cas9 furthermore carries 
a tracrRNA (dark red), which is paired to the repeat of the crRNA. The seed is potentially structurally 
pre-ordered in a helical conformation to facilitate base pairing. Cas9 likely recognizes the target site 
(protospacer, blue bases) in dsDNA (blue/grey) on the basis of a PAM sequence (red box). II) PAM 
recognition might promote strand invasion by Cas9. III) Base pairing nucleates at the seed (last 12 nt 
of spacer). The PAM is located on the DNA downstream of the seed and is not involved in base-pairing. 
IV) Base pairing is extended over the entire spacer region of the crRNA possibly through release of the 
5’ end of the crRNA, while the non-target strand of the dsDNA target is displaced, creating an R-loop. 
Target DNA cleavage then occurs in both strands by distinct nuclease domains of Cas9.
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Seed of Type II CRISPR-Cas systems
Cas9 is guided by Type II crRNAs containing an uninterrupted 12 nt seed sequence 
at the 3’ end of the spacer segment (Jiang et al., 2013) (Table 1 and Figure 4). Seed-
target DNA mismatches affect target DNA binding and result in loss of cleavage 
activity, which normally takes place within the seed, 3 nt from its 3’ end (Garneau et 
al., 2010; Gasiunas et al., 2012; Jinek et al., 2012). Especially mutations near the DNA 
cleavage site allow viruses and plasmids to escape from CRISPR immunity (Deveau 
et al., 2008; Jiang et al., 2013; Sapranauskas et al., 2011; Sun et al., 2013). Similar to 
Type I systems it was found that the affinity of the seed for target DNA is higher than 
other regions of the guide when associated with the Cas9 protein. Again, this might 
point to a structural pre-ordering of the seed. The RNA-directed DNA nuclease 
activity of Cas9 from a number of Bacterial species such as Streptococcus pyogenes 
has recently revolutionized genome editing in many eukaryotes (Cong et al., 2013; 
Mali et al., 2013; Ran et al., 2013b). The single nucleotide distinguishing feature 
of seed sequences could be harnessed in gene therapy strategies of dominant 
heterozygous mutations where cleavage of only the mutant chromosome is desired.
Protospacer adjacent motif and sequential target binding
Apart from the seed sequence, the protospacer adjacent motif (PAM) is another 
sequence element that typifies Type I and II CRISPR-Cas systems. The PAM is a 
conserved nucleotide sequence located near the seed-matching sequence in the 
target DNA, just outside the crRNA pairing region (Figure 3 and 4). During CRISPR 
interference, the PAM serves to differentiate target DNA from non-target DNA 
including the host CRISPR locus (Sashital et al., 2012; Westra et al., 2013). The short 
distance between the PAM and seed in Type I and II systems and the importance of 
the PAM for high affinity target DNA binding of Cascade and Cas9 (Gasiunas et al., 
2012; Jinek et al., 2012; Semenova et al., 2011; Sinkunas et al., 2013) has led to the 
idea that PAMs might be recognized by Cas9 and Cascade in the initial phase of target 
search (Figure 3 and 4) (Jinek et al., 2012; Sashital et al., 2012). This is then followed 
by local dsDNA unwinding at the PAM, allowing strand invasion and base pairing of 
the crRNA seed, and progressing into base pairing of the 3’ remainder of the guide 
to form a full R-loop. PAM sequences therefore seem to be a necessary adaptation to 
efficiently recognize dsDNA targets by reducing the complexity of the target search 
process from checking all nucleotide sequences to checking for seed-matches next 
to fixed nucleotide sequences. A strikingly similar target search strategy is employed 
by Group II introns during retrohoming. Group II introns are mobile catalytic RNAs 
that form a complex with intron-encoded proteins (Lambowitz and Zimmerly, 2011). 
The complex scans dsDNA until it recognizes a short nucleotide motif (e.g. TNGAN
23
T 
for Lactococcus lactis LtrA). These sites are then locally melted to allow two exposed 
RNA loops of the ribozyme to base pair over stretches of 4 to 9 nt with a target 
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DNA locus before the intron integrates. This mechanism resembles the target search 
strategy of Type I and II CRISPR systems and therefore represents an interesting case 
of convergent evolution of an RNA-guided dsDNA target search mechanism.
 To summarize, the crRNA is tightly associated with Cas proteins. The seed is 
7-12 nt long and possibly pre-ordered in a structure favoring duplex formation with 
target DNA. The PAM in the target DNA and seed cooperate in a sequential manner 
to maximize the efficiency of the target search process.
Role of seed in target search 
To protect cells from mobile genetic invaders, siRNAs and crRNAs need to identify 
and neutralize their targets before they replicate and proliferate, while miRNAs and 
sRNAs must facilitate rapid response to changing environmental conditions. To 
achieve effective recognition of target nucleic acids, small guide RNAs make use 
of seed sequences of approximately 6-12 nt. By pairing only short regions, small 
guide RNAs can rapidly associate with and dissociate from potential targets. Too 
short pairing regions, however, are actually detrimental for association rates. 
In fact, it has been shown in vitro that a minimum of 7 contiguous base pairs is 
required for the rapid annealing of short DNA and RNA oligonucleotides (Cisse et 
al., 2012). Furthermore, advantageous kinetics through shortening of the pairing 
region comes at the cost of sequence specificity. This is important because guide 
RNAs will encounter many non-targets with partial sequence identity. The length of 
the seed therefore seems to be a trade-off between optimal kinetics during initial 
target scanning and sufficient sequence specificity. The scanning process itself likely 
involves sensing base pairing of the seed with a potential target site and hopping, 
jumping, or sliding to the next potential target site (Gorman and Greene, 2008). 
Structurally, the length of the seed in RNA interference based RNAs and crRNAs 
may be determined by topological constraints that result from fixing both ends 
of the guide RNA to the protein complex as this restricts helical duplex formation 
between the guide and target. The length of the seed may therefore depend on the 
number of nucleotides available for interacting with the target in the span of part of 
a single helical turn (Wiedenheft et al., 2011b). Longer uninterrupted seed pairing 
interactions would require strand twisting to form a helical duplex, which is difficult 
to envisage without the release of one end of the guide from the complex, and 
moreover, would seem inefficient during target scanning. Cascade deals with these 
topological constraints in a different way by pairing its guide in interrupted segments 
to the target. These segments allow pairing without twisting the guide and target 
strands thereby avoiding topological complications (Figure 3) (Wiedenheft et al., 
2011a). sRNAs achieve a high efficiency of scanning in a completely different way 
by rapidly cycling sRNAs and mRNAs on the Hfq platform, bringing the seed in close 
proximity to many potential target RNAs.
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Tolerance to mismatches in the seed
All three small RNA systems are highly sensitive to mismatches within the seed. 
Whereas miRNAs and siRNAs may overcome seed mismatches using compensatory 
pairing, crRNAs and sRNAs lose their function when mismatched at seed positions 
(Balbontín et al., 2010; Cady et al., 2012; Kawamoto et al., 2006; Maier et al., 2013; 
Papenfort et al., 2010; Sapranauskas et al., 2011; Semenova et al., 2011; Vercoe et 
al., 2013). In CRISPR-Cas, instead of directly interfering with this class of mutated 
invaders, seed mutants trigger priming: a process in which new spacers against 
the same target are integrated in the CRISPR array to restore immunity of the host 
(Datsenko et al., 2012).
Target site evolution
Base pairing of only the seed causes very different downstream effects in the 
three RNA guided systems. Whereas crRNAs and siRNAs require pairing of nearly 
the complete guide sequence to support target interference, miRNAs and sRNAs 
require only seed pairing to interfere with their targets. Contrary to crRNAs which 
are meant to contain a perfect and maximum degree of complementarity, seed-
target interactions of miRNAs and sRNAs have co-evolved to form the desired 
degree of interaction. The seed is generally the most conserved part in miRNAs and 
in sRNAs. Moreover, the short length of the seed enables a single miRNA, siRNA, or 
sRNA to regulate a multitude of genes with conserved seed matching sites, reducing 
the number of small RNAs required to regulate a high number of genes (Beisel and 
Storz, 2010; Brennecke et al., 2005; Friedman et al., 2009; Guillier and Gottesman, 
2008; Papenfort and Vogel, 2009). Genes that are part of the same pathway or 
that carry out related cellular functions can therefore be regulated simultaneously. 
Furthermore, a short conserved seed facilitates the process in which mRNAs are 
added or removed from small RNA regulons by target site mutagenesis (Papenfort 
et al., 2012). As such, guide RNAs contribute to the evolution of gene regulatory 
networks, which is thought to be vital for the evolution of biological complexity 
(Carroll, 2008; De Robertis, 2008; Shubin et al., 2009).
Concluding remarks
Although referred to by the same word, seed sequences of the three classes of 
small guide RNAs discussed in this review differ substantially in many ways. They 
not only have a different sequence and structure, associate with different proteins, 
and tolerate mismatches to a different degree, they also target different nucleic 
acid types. Yet, their analogous role of probing potential target nucleic acids for 
complementarity must be the shared basis of an efficient target search process 
in the crowded environment of a cell, allowing finding a needle in a haystack by 
planting the seed.
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Glossary
Argonaute: Key protein in RNAi, utilizes small RNA guides to bind and/or cleave 
complementary RNA targets.
Bulge: Regions in which one strand of a helix has “extra” inserted bases with no 
counterparts in the opposite strand.
Cas9: crRNA-guided DNA endonuclease that occurs in Type II systems. It uses crRNA 
to find and bind double stranded target DNA to make a double stranded break.
Cascade: CRISPR associated complex for antiviral defense. These complexes in 
Type I CRISPR-Cas systems carry the crRNA and use it as a guide to find and bind 
complementary DNA. Base pairing of crRNA to DNA results in the formation of an 
R-loop.
CRISPR-Cas: Clustered regularly interspaced short palindromic repeats. Genomic 
array of conserved repeat sequences interspaced by unique, invader derived spacer 
sequences. Together with CRISPR-associated (cas) genes they form the CRISPR-Cas 
system, an adaptive immune system in prokaryotes against foreign nucleic acid 
invaders.
crRNA (CRISPR RNA): Small guide RNA transcribed from the CRISPR array which 
mediate target nucleic acid recognition and destruction.
Group II introns: Class of self-catalytic ribozymes encoded by mobile genetic 
elements that can splice in or out of the genomes.
Guide RNA: Small RNA that recognizes cognate target molecules by Watson-Crick 
base pairing and directs associated proteins to their target.
Hfq: RNA chaperone in bacteria with a preference for binding sRNA and mRNA.
Kissing complex: Unstable loop-loop interaction between sRNA and mRNA where 
base pairing between the two RNAs initiates.
miRNA (microRNA): Guides Argonaute proteins, derived from small hairpin 
structured RNAs.
PAM (Protospacer adjacent motif): Conserved nucleotide motif that is found next 
to target DNA sequences (protospacers) in Type I and II CRISPR-Cas systems.
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piRNA (PIWI-interacting RNA): Interacts with PIWI proteins, biogenesis poorly 
understood.
R-loop: Formed upon base pairing of crRNA guided complexes with double stranded 
target DNA. The crRNA forms Watson-Crick base pairs with complementary strand 
of DNA, while the non-complementary DNA strand is displaced and remains single 
stranded.
RNAi (RNA Interference): Eukaryotic pathway in which small RNA molecules guide 
Argonaute family proteins to mediate mRNA binding and/or cleavage.
RNase E: Bacterial endoribonuclease that cleaves single stranded RNA in A- and 
U-rich regions.
RNase III: Ribonuclease family that cleaves dsRNA.
siRNA (small interfering RNA): Guides Argonaute proteins, derived from duplex 
RNAs or long RNA hairpins.
sRNA (Small regulatory RNA): Small RNA regulating gene expression by interacting 
with mRNA. The RNA can be cis- (same genetic locus as target) or trans-encoded 
(derived from another locus than the target).
Wobble base pair: Non-Watson-Crick base pairing in RNA-RNA or RNA-DNA 
duplexes (e.g. G-U pairing).
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Box 1. Classification and mechanism of CRISPR-Cas systems
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Figure I (in Box 1): Mechanism of CRISPR-Cas immunity depicted for Type I. In the adaptation stage 
the microbial host encounters a new virus or conjugative plasmid. Genetic material of the invader is 
recognized as foreign, processed, and somehow integrated into the CRISPR locus to form an additional 
memory unit. The expression stage involves transcription of the CRISPR locus into a long precursor 
CRISPR RNA (pre-crRNA), which is cleaved in the repeats by the dedicated endoribonucleases Cas6e. 
The mature crRNA ends up bound to Cascade to serve as a guide to recognize invader nucleic acids in 
the interference stage. When invader nucleic acids are identified through base pairing of the crRNA, 
they are cleaved by Cas3 preventing further virus or plasmid proliferation.
Clustered regularly interspaced short palindromic repeats (CRISPR) refers to genomic 
loci consisting of DNA repeats, interspaced by invader derived DNA sequences 
(termed spacers) which serve as a memory of an adaptive immune system. A leader 
sequence, containing promoter elements, is located upstream of the CRISPR array. 
CRISPR loci are often flanked by a set of CRISPR-associated (cas) genes, which 
encode the protein machinery of the immune system. Three substantially different 
types of CRISPR-Cas systems exist: Type I systems encode a Cascade-like multi-
protein complex, which uses a small crRNA to specifically recognize target DNA by 
base pairing the crRNA to one of its strands (R-loop). After binding the target DNA 
is degraded by a recruited effector nuclease Cas3 (Westra et al., 2012c) (Figure I). 
Type II systems encode Cas9 which can bind and cleave target DNA molecules using 
a crRNA guide and a second small RNA called tracrRNA (Deltcheva et al., 2011; 
Gasiunas et al., 2012; Jinek et al., 2012). Type III systems encode a multi-Cas protein 
complex which utilizes crRNA to target DNA (Type IIIA) (Marraffini and Sontheimer, 
2008) or RNA (Type IIIB) (Hale et al., 2009).
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 The molecular mechanism of CRISPR-Cas is divided into three functional 
stages (Figure I): adaptation of immune specificity, expression and maturation of 
crRNAs, and target interference. During the adaptation stage, pieces of invader DNA 
are incorporated at one end of the CRISPR locus (Barrangou et al., 2007). Although 
it is known that cas1 and cas2 are essential for adaptation (Datsenko et al., 2012; 
Yosef et al., 2012), the mechanism of spacer acquisition remains largely unknown. 
During the expression stage, the CRISPR array is transcribed into one long precursor 
crRNA, subsequently cleaved in the repeats by dedicated Cas proteins or RNase 
III and sometimes further trimmed to yield mature crRNAs (Brouns et al., 2008a; 
Deltcheva et al., 2011; Haurwitz et al., 2010; Sashital et al., 2011). These small guide 
RNAs are then loaded into Cas protein complexes to guide detection of memorized 
invaders through crRNA complementarity, resulting in target inactivation (Jinek et 
al., 2012; Westra et al., 2012c).
Box. Outstanding questions
• Differences in effectiveness of individual small RNAs can often be poorly 
explained. Could these differences be due to regions flanking target sites, and/
or by differences in non-base pairing parts of guide RNAs?
• How do sRNAs regulate gene expression in prokaryotes lacking Hfq, including 
archaea?
• Is the seed pre-ordered in a helical conformation in crRNA-Cas complexes such 
as Cascade and Cas9?
• How do Type III CRISPR-Cas systems find their DNA or RNA targets in the absence 
of a PAM and/or seed?

Chapter 3
Electrophoretic mobility shift assay of DNA and 
CRISPR-Cas ribonucleoprotein complexes
Tim Künne1, Edze R. Westra2 and Stan J.J. Brouns1
1Laboratory of Microbiology, Department of Agrotechnology and Food Sciences,
Wageningen University, Dreijenplein 10, 6703 HB Wageningen, The Netherlands.
2Biosciences, University of Exeter, Penryn, TR10 9EZ, UK
This chapter has been published as:
Künne T, Westra ER, Brouns SJ 2015. Electrophoretic Mobility Shift Assay of DNA 
and CRISPR-Cas Ribonucleoprotein Complexes. Methods Mol Biol, 1311:171-84
Chapter 3
52
3
Abstract
The Electrophoretic Mobility Shift Assay is a straightforward and inexpensive method 
for the determination and quantification of protein-nucleic acid interactions. 
It relies on the different mobility of free and protein-bound nucleic acid in a gel 
matrix during electrophoresis. Nucleic acid affinities of crRNA-Cas complexes can be 
quantified by calculating the dissociation constant (Kd). Here we describe how two 
types of EMSA assays are performed using the Cascade complex from Escherichia 
coli as an example.
Keywords
Electrophoretic mobility shift assay, EMSA, gel shift, binding assay, CRISPR, RNA 
guide, affinity, Cascade, protein-DNA interaction
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Introduction
All CRISPR systems share the common feature of encoding a crRNA-guided 
ribonucleoprotein complex targeting complementary nucleic acids. Type I systems 
encode Cascade/crRNA complexes, Type II systems Cas9/crRNA complexes and 
Type III systems Cmr/crRNA or Csm/crRNA complexes (reviewed in (Westra et al., 
2012b)). Invader detection by these complexes is a key step of the CRISPR-dependent 
immune response. The binding behaviour of these complexes is a key determinant 
of the activity and specificity of the respective systems and can reveal mechanistic 
features, such as the seed sequence (Hale et al., 2009; Jinek et al., 2012; Semenova 
et al., 2011). Examining the binding behaviour of proteins with nucleic acids can be 
done using various techniques, such as Surface Plasmon Resonance (Biacore), single 
molecule TIRF (total internal reflection microscopy), Microscale Thermophoresis or 
Electrophoretic Mobility Shift Assay (EMSA) (Helwa and Hoheisel, 2010; Jerabek-
Willemsen et al., 2011; Monico et al., 2013).
 Usually EMSA is the method of choice, as it is a relatively straightforward 
and inexpensive method that generally provides robust and easy to interpret 
data. EMSAs can be used for simple qualitative analysis, such as identifying target 
and non-target nucleic acids. Importantly, it can also be used for quantitative 
analysis, which can reveal binding stoichiometry and affinity (Fried, 1989). To this 
end, protein and target are brought to binding equilibrium over a range of molar 
ratios and separated by gel electrophoresis. Free nucleic acid generally migrates 
faster through the gel than protein bound nucleic acid. This shift in migration is 
dependent on the bulkiness of the protein and the combination of protein pI and 
electrophoresis conditions. 
 EMSAs are easy to perform and do not require specialized equipment. 
A wide range of conditions can be used, as long as they are compatible with 
electrophoresis. Furthermore, any nucleic acid can be used as substrate as long 
as it can be visualized after electrophoresis; the nucleic acid size range spans from 
single stranded short oligonucleotides to plasmids of several thousand nucleotides. 
Furthermore, EMSA can be combined with footprinting analyses or competition 
binding experiments (Fried and Daugherty, 1998; Jore et al., 2011a; Westra et al., 
2010; Westra et al., 2012c). 
 Despite these advantages of EMSA over more specialized techniques, 
EMSA also has some disadvantages. The main drawback of EMSAs is the fact 
that the chemical environment of electrophoresis differs from the environment 
of equilibration. Hence, the binding equilibrium can change at electrophoresis 
conditions. However, when the sample enters the gel matrix, interactions are 
usually stabilized by a caging effect, preventing or slowing down further changes 
(Cann, 1989; Fried and Bromberg, 1997). Still, low-affinity interactions can be lost 
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during electrophoresis while they are maintained in solution. This could lead to 
underestimation of binding affinity.
 Here, we provide two different protocols for EMSA: Plasmid EMSA using 
agarose gel electrophoresis and short oligonucleotide EMSA using poly acrylamide 
gel electrophoresis (PAGE). The choice between these two protocols is determined 
mainly by the nature of the target nucleic acid. The use of plasmids better mimics 
biologically relevant conditions and allows one to address the influence of DNA 
topology on binding affinity. However, synthetic probes offer more experimental 
flexibility. Plasmids are best separated on agarose gels, while shorter nucleic acids 
are better separated on PAGE gels. When using intermediate sized nucleic acids, 
PAGE gels are preferred as they offer better resolution. Short probes usually need to 
be radio-labelled, since they cannot be sufficiently visualized by intercalating dyes. 
Here, 32P 5’ end labelling is the most used technique, but internal or 3’ labelling is 
also possible. When using larger target molecules isotope labelling is generally not 
required, instead standard intercalating dyes are used, which are compatible with 
both agarose and PAGE gels. 
Materials
Agarose EMSA
1. 37 ˚C incubator or water bath and microcentrifuge
2. 11-14 horizontal gel electrophoresis system (Biometra Horizon 11-14) or 
comparable
3. Electrophoresis power supply
4. UV imager (Syngene GBox or comparable) 
5. Purified protein (1-10 mg/ml) (see Note 1)
6. Plasmid DNA (60 ng/µl)
7. 5x Equilibration buffer (100 mM HEPES pH 7.5, 375 mM NaCl, 5 mM DTT) (see 
Note 3)
8. Optional: 100 µM stabilizing probe (see Note 4)
9. Optional: Competitor nucleic acid (see Note 5)
10. 1x sodium boric acid (SB) buffer pH 8.3 (8.6 mM sodium borate, 45 mM boric 
acid) (see Note 6)
11. Agarose, molecular biology grade (Sigma)
12. 6x DNA loading dye (Thermo Scientific) and DNA size marker (Gene ruler 1kb, 
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Thermo Scientific)
13. SYBR safe (Thermo Scientific) or Ethidium bromide (Sigma)
14. Reagent grade water
PAGE EMSA
1. Isotope facilities
2. Programmable heat block or incubator and microcentrifuge
3. Vertical PAGE apparatus and casting setup, including glass plates, spacers, 
combs, clamps, casting stand and running unit (Bio-Rad or comparable)
4. Electrophoresis power supply
5. Phosphor screen (GE  Healthcare) or autoradiography film (Kodak) or comparable
6. Phosphor Imager (Bio-Rad PMI)
7. Purified protein (1-10 mg/ml) (see Note 1)
8. DNA oligonucleotides (100 µM)
9. 5x Equilibration buffer (100 mM HEPES pH 7.5, 375 mM NaCl, 5 mM DTT) (see 
Note 3)
10. Optional: 100 µM stabilizing probe (see Note 4)
11. Optional: Competitor nucleic acid (see Note 5)
12. Polynucleotide kinase (PNK) (Thermo scientific). This comes with buffer A 
(forward reaction) and buffer B (exchange reaction) 
13. Phenol, chloroform, isoamyl alcohol mix (25:24:1) (Roth)
14. Nucleotide removal kit (Qiagen) or Sephadex G50 columns (GE Healthcare)
15. ExoI enzyme (Thermo Scientific), supplied with 10x ExoI buffer
16. 5x Tris-borate-EDTA (TBE) buffer (445 mM Tris, 445 mM boric acid, 10 mM 
EDTA) (see Note 6)
17. 30% w/v acrylamide-bisacrylamide (29:1) stock solution (Sigma)
18. 10% Ammonium persulfate solution (APS), made by dissolving APS powder 
(Sigma) in reagent grade water
19. TEMED (N,N,N′,N′-Tetramethylethylenediamine) (Bio-Rad)
20. Optional: Gel dryer (Model 583 gel dryer, Bio-Rad or comparable)
21. Blotting paper (Whatman) or comparable
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22. Plastic food wrap (Saran Wrap®)
23. Reagent grade water
Methods
Agarose EMSA
Protein-DNA equilibration
1. Set up a pipetting scheme as in Table 1. The amounts shown are based on 
Cascade (Mw = 405 kDa) and pUC-λ (Mw = 1739 kDa). The amount of DNA per 
reaction is fixed, while protein is titrated (see Note 2). For good visualization of 
the DNA, use 360 ng plasmid per reaction. The amount of protein is calculated 
based on the desired molar ratio. As a negative control, include a no-protein 
sample. Amounts can be modified according to the molecular weight of the 
ribonucleoprotein complex or the target plasmid, in order to keep the same 
molar ratio. Optional: Include a competitor nucleic acid by pre-mixing this with 
your target plasmid (see Note 5). The amount of 5x equilibration buffer in the 
final reaction is calculated to yield a final 1x concentration (taking into account 
the salts present in the protein solution). Reactions are brought to a total 
volume of 30 µl with reagent grade water. 
2. Make fresh working stock dilutions of your protein (see Note 1) in 1x equilibration 
buffer to fit your requirements. 
3. Pipette everything on ice, add water and buffer first, then add protein solution, 
and last add plasmid solution. Vortex the reaction mixture for 10 seconds and 
spin down in a microcentrifuge.
4. Incubate at 37 ˚C for 30 min to allow the reaction to equilibrate (see Note 2). In 
the meanwhile start preparing the gels.
5. Optional: Add 1 µl of a 100 µM stabilizing probe to the reaction after equilibration 
(see Note 4). Incubate for another 20 minutes at 37 ˚C.
6. Optional: At this point, additional procedures, such as enzymatic footprinting 
can be carried out (see Note 7).
7. Add 6 µl 6x DNA loading dye to each sample and store on ice until loading on 
gel (see below).
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Preparing and running the gel
1. Prepare a 0.8% (see Note 8) SB buffer agarose gel by mixing 0.88g agarose with 
110 ml 1x SB buffer (see Note 6). Dissolve the agarose by heating the solution in 
a microwave. Make sure the agarose is completely dissolved. Do not include an 
intercalating dye. Cast the gel in an 11-14 gel tray or comparable system. Use a 
comb for 20 µl slots.
2. Assemble the electrophoresis unit and fill the container with 1x SB buffer (see 
Note 6) until it covers the gel.
3. Load half of each sample (18 µl) in the slots and add the DNA size marker in the 
first and the last lane of the gel (this allows to check if the gel ran uniformly). 
Store the other half of the samples in the freezer (-20 ˚C) as backup.
4. Run the gel at 20 mA for 18 hours (based on Cascade binding to a ~3kb plasmid; 
less time is needed to separate smaller protein-DNA complexes).
5. Remove the gel from the electrophoresis chamber and put it in a plastic tray.
6. Stain the gel by covering it with 1x SB buffer containing 1:10000 SYBR safe or 
Ethidium Bromide for 30 min (important: mix the 1x SB buffer and SybR safe or 
Ethidium Bromide well before applying it on the gel. Poorly mixed solutions can 
yield stains on the gel).
7. Rinse the gel and destain it in dH2O for 15 min
8. Visualize the DNA using a UV imager (see Table 2 for troubleshooting). Make 
sure not to saturate the signal anywhere in the gel. In case of quantification, 
safe the file in an appropriate format for your image analysis software (.sgd file 
for GBox or .tif file for cross platform analysis). Figure 1 is a typical example of a 
plasmid EMSA on agarose.
9. Continue to image analysis
B
A
 1:1    2:1    4:1    8:1    16:1  32:1   48:1  64:1   96:1    0
Figure 1. Agarose EMSA of Cascade with plasmid DNA. Cascade and plasmid have been incubated 
at indicated molar ratios to equilibrium and free plasmid (upper band (A)) has been separated from 
Cascade bound plasmid (lower band (B)) on a 0.8% sodium borate agarose gel. Each lane contains a total 
of 180 ng plasmid DNA and Cascade protein according to indicated molar ratios of Cascade:plasmid. 
Gel was run at 8 mA for 18h and post-stained with SYBR Safe for 30 min
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PAGE EMSA
5’ 32P Labelling of short oligonucleotide substrate
(Note: You can perform this protocol using cold ATP in parallel to conveniently 
measure DNA concentrations afterwards)
1. To prepare dsDNA oligonucleotides mix the following in a microcentrifuge tube 
(annealing mix):
1 µl 10 µM forward oligonucleotide
1 µl 10 µM reverse oligonucleotide
2 µl 10x PNK buffer (use either Buffer A, for non-phosphorylated oligonu-
cleotides or buffer B, for phosphorylated oligonucleotide)
16 µl H2O
2. If you are using single stranded DNA, replace the reverse oligonucleotide 
volume with reagent grade water and Skip to step 5.
3. Heat to 95 °C for 5 min
4. Slowly cool down to 37 °C (>30min).
5. Add 1 µl PNK and 2 µl y-32P ATP (Caution: Exposure to radiation is hazardous, 
follow safety procedures of your institution).
6. Incubate 1 h at 37 °C.
7. Clean up using nucleotide removal kit or a sephadex G-50 column (preferred 
method).
8. Elute in 44 µl reagent grade water.
9. Add 5 µl 10x ExoI buffer and 1 µl ExoI (Important: Skip this step when using a 
single stranded DNA substrate)
10. Incubate 30 min at 37 °C
11. Add 50 µl phenol-chloroform-isoamyl alcohol mix.
12. Vortex thoroughly, spin 3 min at maximum (>13000rpm) speed in a 
microcentrifuge 
13. Recover the aqueous phase (usually the upper phase)
14. Optional: Determine DNA concentration of cold sample (if available), or hot 
sample (Caution: Only use specified equipment for the use with radiolabelled 
samples)
15. Store at -20 °C.
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Protein-DNA equilibration
1. Set up a pipetting scheme as indicated in Table 1: The amounts shown are based 
on Cascade (Mw = 405 kDa) and a short dsDNA oligonucleotide. The amount of 
DNA per reaction is fixed, and protein is titrated. Use 1 µl of 4x diluted labelled 
oligonucleotide per reaction (The amount depends on the activity of the sample). 
The amount of protein is calculated based on the desired molar ratio (see Note 
2). As a negative control include a no-protein sample. Amounts can be modified 
according to the molecular weight of the ribonucleoprotein complex or the target 
oligonucleotide, in order to keep the same molar ratio. Optional: Include an 
unlabelled competitor nucleic acid by pre-mixing this with your oligonucleotide (see 
Note 5). The amount of 5x equilibration buffer in the final reaction is calculated to 
yield a final 1x concentration (taking into account the salts in the protein solution). 
Reactions are brought to a total of 30 µl with reagent grade water. 
2. Make fresh stock dilutions of your protein (see Note 1) in 1x reaction buffer to 
fit your requirements.
3. Pipette everything on ice, add water and buffer first, then add protein and add the 
oligonucleotide last. Vortex for 10 seconds and spin down in a microcentrifuge.
4. Incubate at 37 ˚C for 30 min to allow the reaction to equilibrate (see Note 2). In 
the meanwhile start preparing the gels. 
5. Optional: Add 1 µl of a 100 µM stabilizing probe to the reaction after equilibration 
(see Note 4). Incubate for another 20 minutes at 37 ˚C.
6. Optional: At this point, additional procedures, such as enzymatic footprinting 
can be carried out (see Note 7).
7. Add 6 µl 6x DNA loading dye to each sample and store on ice until loading on 
gel (see below).
Preparing and running the gel
1. Prepare a 5% (see Note 8) TBE PAGE gel, preferably in a large format (e.g. 20x15):
8.3 ml 30% w/v acrylamide-bisacrylamide (29:1) stock solution
10 ml 5x TBE
31 ml H2O
0.8 ml APS
Assemble the glass plates in a casting setup. Fill with water, to check for leakage. 
Remove water.
2. Add 50 µl TEMED to the gel solution and pour the gel. Insert the appropriate 
comb for 20 µl samples
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3. Assemble the gel tray and wash the slots with running buffer (0.5x TBE)
4. Pre-run the gel for 20 min at 40mA
5. Load the samples and run for 15 min at 30 mA until the tracking dye has 
migrated into the gel
6. Run the gels for 3-4h at 20 mA or until the cyan blue dye reaches ¼ of the gel. 
Carefully rinse and dry the assembly, separate the glass plates and carefully 
transfer the gel to a blotting paper, wrap the gel and paper in plastic food wrap. 
Prevent air bubbles and wrinkles.
7. Optional: Dry the gel on a paper membrane using a gel-dryer (gives better 
resolution but there is a risk of breaking the gel)
8. Expose the gel to a phosphor screen or autoradiography film in an exposure 
cassette. Short time exposure (~2h) can be done at room temperature or 4 
°C. Longer exposures of un-dried gels can be performed at -20 ˚C to prevent 
diffusion. Make sure not to saturate the signal anywhere on the phosphor 
screen or autoradiography film. Scan the image using a phosphor imager (see 
Table 2 for troubleshooting). Proceed to image analysis.
Image analysis and quantification
In many cases, EMSA results will need to be analysed quantitatively to obtain the 
affinity values (Kd) associated with a protein-DNA interaction. Such quantitative 
analysis requires that the intensities of the bands as well as the background intensity 
are quantified. To this end, import the picture in an image analysis software (e.g. 
Genetools for GBox .sgd files). Use the program to automatically or manually 
quantify the intensity of unshifted and shifted bands in the gel. Apply appropriate 
background correction for each lane to correct for uneven exposure of the gel. Once 
the intensities of shifted and unshifted bands have been obtained, the affinity of the 
interaction can be calculated as described below. Analysis of more complex binding 
behaviour can be done as described in (Fried and Daugherty, 1998). However, in the 
case of Cas ribonucleoprotein complexes binding to protospacer sequences, we can 
assume that each protein (complex) binds only one specific binding site per target 
molecule, which greatly simplifies the analysis. To obtain binding affinities using 
this assumption, calculate the fraction of bound substrate (y) and the free protein 
concentration (x) for each sample. ‘y’ is calculated by dividing the shifted band 
intensity by the total intensity present in that lane. ‘x’ is calculated by multiplying 
the total protein concentration (as added in the reaction) with the fraction of 
unbound DNA (1-y). Perform non-linear regression using the formula y = x/(Kd+x) to 
determine the dissociation constant Kd.
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Table 2: Troubleshooting
Problem Possible cause Potential solutions
No bands visible 
on gel
Too little or no nucleic 
acid in reaction
Check nucleic acid concentration,  test sensitivity 
of applied visualization method
Nucleic acid is de-
graded
Check substrate integrity on gel. Replace rea-
gents when suspecting nuclease contamination. 
If possible exclude metal cations and include 
chelating agent (e.g. EDTA). If working with RNA, 
work RNase free or include commercial RNase 
inhibitors.
Labelling failed or 
insufficient exposure 
time
Check functionality of labelling method. If neces-
sary, adapt protocol. Increase exposure time.
No shifted band 
present
Protein concentration 
too low
Verify protein concentration, check protein for 
purity. Increase protein concentration in EMSA.
Protein is inactive or 
co-factor missing
Check protein on SDS-PAGE for integrity. Re-purify 
protein, possibly adapt protocol to get more active 
preparation. Test co-factors, e.g. divalent metal 
ions.
Protein bound nucleic 
acid migrates at same 
speed as free nucleic 
acid
Check migration of protein alone in gel. Use differ-
ent pH in equilibration and electrophoresis buffer 
or use a different electrophoresis buffer. If protein 
is very small compared to nucleic acid, use smaller 
nucleic acid.
Bands are generally 
smeared
Gel overheating Check gel concentration and running buffer con-
ductivity. Lower the above or use lower voltage 
during electrophoresis.
High sample conduc-
tivity
Reduce salt content in samples
Bad gel quality Check even polymerization/solidification. Use 
fresh, clean components.
Degas PAGE gels before polymerization.
Only protein bound 
band is smeared
Too high conductivity 
in protein solution
Reduce salt concentration in protein stock solu-
tion, or concentrate protein and add less volume 
to reactions.
Complex dissociates 
during electrophoresis
Minimize time of sample in loading well. Start 
with higher voltage to run samples into the gel. 
Minimize overall electrophoresis time.
Notes
1. Protein: Use purified Cas ribonucleoprotein complexes. Make sure to accurately 
determine the protein concentration. If additives are required for protein 
storage that are undesired in the EMSA equilibration, exchange the buffer 
beforehand by dialysis or a buffer exchange column. Alternatively, keep additive 
concentration low and protein concentration high to minimize the volume that 
is added in the reactions. Ideally the protein is dissolved in a buffer very similar 
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to the equilibration buffer. Make working stock dilutions of the protein in 1x 
Equilibration buffer.
2. Equilibration: Test a range of molar ratios of protein:DNA (e.g. 0.5:1 up to 
400:1). In later experiments, choose ratios that cover the whole dynamic range 
of binding (i.e. ranging from all DNA in the unbound state to all DNA protein-
bound). Test the incubation time needed to reach equilibrium for each protein 
and each different type of substrate (plasmid, short oligonucleotides etc.). Do 
this by testing several time points (e.g. 5 min, 30 min, 60 min); when there is no 
change in the bound fraction between two time points, equilibrium is reached. 
Typically an incubation time of 30 min at 37 ˚C is used.
3. Equilibration buffer: Choose a buffer for protein-DNA complex equilibration that 
gives efficient complex formation, is relatively close to physiological conditions 
and is compatible with the buffer of your protein solution. Do not use salt 
concentrations that are considerably higher than in your electrophoresis buffer, 
as this leads to a higher conductivity of the sample compared to the gel and 
electrophoresis buffer, which will lead to distorted bands. If additives are 
required for the function of the protein (e.g. metal ions), these should be added 
to the equilibration buffer. Most common buffers can be used (e.g. Tris, MOPS, 
HEPES, Phosphate) and total salt concentration is typically around 100 mM.
4. Stabilizing probe:  When working with an R-loop forming complex (i.e. the 
situation where the crRNA base pairs with the target DNA strand, while the 
non-target strand is displaced and remains single stranded), stabilizing DNA 
oligonucleotides can be added after equilibration to prevent changes during 
subsequent steps (Westra et al., 2012a). These probes are complementary to 
the crRNA as well as to the displaced strand. By binding to the displaced strand 
these probes prevent re-annealing of the target and non-target strands and 
thereby inhibit complex dissociation. Furthermore free complex is inactivated 
by binding of the probe to the crRNA. This step is advisable when additional 
steps, such as enzymatic footprinting, are performed, or when the interaction 
of the complex and the target is unstable and tends to dissociate during 
electrophoresis (e.g. Cascade binding to relaxed plasmid DNA (Westra et al., 
2012c)). Choose to add an amount of probe resulting in a 10-fold excess of 
probe, compared to  target- or protein molecules.
5. Competitor nucleic acid:  In case of a high nonspecific nucleic acid binding 
affinity of the protein (independent of crRNA sequence), which might obscure 
specific binding, it is advisable to add unlabelled competitor nucleic acid. It 
should have the same nonspecific binding affinity to the protein as the target, 
while the target should have a higher specific binding affinity to the protein. 
Concentrations of competitor have to be optimized empirically to find a ratio 
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that allows clear discrimination of specific and nonspecific binding. If the gel is 
non-selectively stained by an intercalating dye, make sure the competitor has a 
different size than the target, to distinguish the target and the competitor.
6. Electrophoresis conditions: Do not leave samples in loading slots over a longer 
period of time, as complexes might dissociate. The choice of electrophoresis 
buffer can have an effect on the relative mobility of the protein-DNA complex 
and the free nucleic acid. Especially with large nucleic acid targets in agarose 
EMSAs it is possible that the mobility of free- and protein-bound nucleic acid 
is very similar, yielding poor resolution. In this case it is important to choose 
electrophoresis conditions such that the protein is not negatively charged. 
Negative protein charges lead to a co-migration of protein with nucleic acid 
to the anode, decreasing resolution. Hence, the resolution can be improved 
by changing to a running buffer with a lower pH. Commonly used buffers are 
TAE and TBE, while we successfully applied sodium borate buffer (Brody and 
Kern, 2004), improving the resolution of the shift. Make sure to use the same 
buffer in all involved steps. Although long electrophoresis times increase the 
risk of complex dissociation, we got the best results with overnight runs at low 
currents. We have not seen differences in bound fractions between short or 
long electrophoresis, while longer runs produced sharper bands.
7. Footprinting is generally an independent alternative to EMSA, but can be used 
in concert with it. Particularly useful, in the case of crRNA-Cas complexes, is 
the use of ssDNA specific Nuclease P1 (Jore et al., 2011a) or an endonuclease 
cleaving in the known binding site (protospacer) on the target DNA (Westra 
et al., 2012c). Footprinting allows detection and quantification of protein-
DNA interactions in solution, without relying on their stability in subsequent 
electrophoresis
8. An agarose gel percentage of 0.8% is typically used and will give satisfactory 
results with most large nucleic acid targets. A PAGE gel percentage of 5% is 
typically used, this can be adjusted to yield the best resolution with the chosen 
nucleic acid target. Be aware that higher gel percentages might not allow large 
proteins to enter the gel matrix, trapping protein-DNA complexes in the loading 
slots or leading to dissociation.
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Table 3: DNA size separation by gel percentage
DNA Size Range  
(Base Pairs)
Acrylamide  
(%)
100 - 1,000 3.5
80 - 500 5.0
60 - 400 8.0
40 - 200 12.0
10 - 100 20.0
DNA Size Range  
(Base Pairs)
Agarose  
(%)
1,000 - 30,000 0.5
800 - 12,000 0.7
500 - 10,000 1.0
400 - 7,000 1.2
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Abstract
Prokaryotes encode adaptive immune systems called CRISPR-Cas to provide 
resistance against mobile invaders such as viruses and plasmids. Host immunity is 
based on incorporation of invader DNA sequences in a memory locus (CRISPR), the 
formation of guide RNAs from this locus and the degradation of cognate invader DNA 
(protospacer). Invaders can escape Type I-E CRISPR-Cas immunity in Escherichia coli 
K12 by making point mutations in the seed region of the protospacer or its adjacent 
motif (PAM), but hosts quickly restore immunity by integrating new spacers in a 
positive feedback process termed priming. Here, by using a randomized protospacer 
and PAM library and high-throughput plasmid loss assays we provide a systematic 
analysis of the constraints of both direct interference and subsequent priming in 
E. coli. We have defined a high-resolution genetic map of direct interference by 
Cascade and Cas3, which includes five positions of the protospacer at 6 nt intervals 
that readily tolerate mutations. Importantly, we show that priming is an extremely 
robust process capable of utilizing degenerate target regions with up to thirteen 
mutations throughout the PAM and protospacer region. Priming is influenced by 
the number of mismatches, their position and is nucleotide dependent. Our findings 
imply that even out-dated spacers containing many mismatches can induce a rapid 
primed CRISPR response against diversified or related invaders, giving microbes an 
advantage in the co-evolutionary arms race with their invaders. 
Significance Statement
Bacteria are constantly exposed to foreign elements, such as bacteriophages and 
plasmids. The CRISPR-Cas adaptive immune systems provide heritable sequence-
specific protection against these invaders. To develop immunity, bacteria add 
segments of foreign nucleic acid to their CRISPR memory. However, phage and 
plasmid mutants can evade CRISPR-Cas recognition by altering their targeted 
sequence. CRISPR-Cas responds to evasion by quickly generating immunity by 
acquiring new pieces of invader genome. We determined that this rapid generation 
of resistance is promiscuous, with recognition of highly diverged or related elements 
eliciting new immunity. Our results demonstrate that CRISPR-Cas systems are more 
robust than previously thought and, not only have a highly-specific resistance 
memory, but also have a broad ability to identify divergent genetic elements.
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Introduction
Bacteria and Archaea are regularly exposed to bacteriophages and other mobile 
genetic elements, such as plasmids. To control the competing effects of horizontal 
gene transfer, a spectrum of resistance strategies have evolved in prokaryotes 
(Samson et al., 2013). One of the most widespread and well-characterised are the 
CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-
associated) systems, which provide bacterial ‘adaptive immunity’ (Barrangou, 
2013; Marraffini and Sontheimer, 2010a; Richter et al., 2012a; Samson et al., 2013; 
Sorek et al., 2013b; Terns and Terns, 2011; Westra et al., 2012b; Wiedenheft et 
al., 2012). Simply, CRISPR-Cas functions in three major steps. Firstly, in a process 
termed adaptation, short sequences are derived from the invading element and 
incorporated into a CRISPR array (Fineran and Charpentier, 2012). CRISPR arrays are 
composed of short repeats that are separated by the foreign-derived sequences, 
termed spacers. Secondly, CRISPRs are transcribed into a pre-crRNA, which is then 
processed into short crRNAs, which encompass portions of the repeat(s) and most, 
or all of the spacer. Finally, as part of a Cas ribonucleoprotein complex, the crRNAs 
guide a sequence-specific targeting of complementary nucleic acids (for recent 
reviews see (Barrangou, 2013; Marraffini and Sontheimer, 2010a; Richter et al., 
2012a; Samson et al., 2013; Sorek et al., 2013a; Westra et al., 2012b; Wiedenheft 
et al., 2012)). 
 CRISPR-Cas systems are divided into three major Types (I-III) and further 
categorized into subtypes (e.g. I-A to I-F) (Makarova et al., 2011). The mechanisms 
of both crRNA generation and interference differ between the types and there 
are even significant differences between closely related subtypes. However, Cas1 
and Cas2 are the only two Cas proteins completely conserved across all CRISPR-
Cas systems and they are crucial for adaptation in E. coli (Datsenko et al., 2012; 
Makarova et al., 2011; Yosef et al., 2012). The acquisition of new spacers is the 
most poorly understood stage in CRISPR-Cas immunity, mainly hindered by the 
paucity of robust laboratory assays to monitor this process (reviewed in (Fineran 
and Charpentier, 2012)). Streptococcus thermophilus is highly proficient at spacer 
acquisition and provided much of the early insight into adaptation, showing that 
new spacers are typically acquired at one end of the CRISPR array from either 
phages (Barrangou et al., 2007; Deveau et al., 2008; Horvath et al., 2008a) or 
plasmids (Garneau et al., 2010). Recently, spacer acquisition has been detected in 
a variety of other systems (Cady et al., 2012; Datsenko et al., 2012; Erdmann and 
Garrett, 2012; Li et al., 2014; Swarts et al., 2012; Yosef et al., 2012). Adjacent to 
the expanding end of the array is the leader region, which harbours the promoter 
for pre-crRNA expression and sequences important for spacer acquisition (Diez-
Villasenor et al., 2013b; Yosef et al., 2012). Recent studies in E. coli in the Type I-E 
system have shown that spacer acquisition can occur from phages and plasmids 
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when either the Cas1 and Cas2 proteins are overexpressed or if the native cas genes 
are upregulated, due to deletion of hns (Datsenko et al., 2012; Diez-Villasenor 
et al., 2013b; Savitskaya et al., 2013; Swarts et al., 2012; Yosef et al., 2012). The 
DNA targets (termed protospacers) of newly acquired spacers are consistently 
flanked by protospacer adjacent motifs (PAMs), with the E. coli Type I-E consensus 
5’-protospacer-CTT-3’. PAMs were originally identified computationally (Mojica et 
al., 2009b) and were shown to play a role in interference in an early study (Deveau 
et al., 2008). The importance of PAMs in the recognition and selection of precursor-
spacers (pre-spacers) during adaptation was demonstrated unequivocally using 
assays that were independent of interference (Diez-Villasenor et al., 2013b; Yosef 
et al., 2012). The simple overexpression of Cas1 and Cas2, in the absence of other 
cas genes, demonstrated these are the only Cas proteins essential for adaptation 
and are likely to recognize PAMs (Yosef et al., 2012).
 Adaptation consists of two related stages, termed naïve and primed (Fineran 
and Charpentier, 2012). Naïve adaptation occurs when a bacterium harbouring a 
CRISPR is infected by a new foreign element that it has not previously encountered. 
Although the acquisition of a new spacer can result in effective protection from 
the element, point mutations within the protospacer or PAM allow the element to 
‘escape’ CRISPR-Cas targeting (Deveau et al., 2008; Semenova et al., 2011; Vercoe 
et al., 2013). This had been viewed as a weakness of CRISPR-Cas interference, but 
recent studies show that a positive feedback loop called priming occurs, which 
enables one or more new spacers to be acquired (Datsenko et al., 2012; Savitskaya 
et al., 2013; Swarts et al., 2012). Specifically, single mutations within either the PAM 
or the seed region of the protospacer, although inactive for interference, promote 
the rapid acquisition of new spacers from the same target (Datsenko et al., 2012). 
Priming is proposed to allow an effective response against viral or plasmid escapees, 
through the incorporation of new spacers. Unlike naïve adaptation, priming is more 
complex, and in Type I-E systems requires Cas1, Cas2, crRNA, the targeting complex 
termed Cascade (CRISPR associated complex for antiviral defence – composed of 
Cse1, Cse2, Cas7, Cas5 and Cas6e (Brouns et al., 2008a; Jore et al., 2011a)) and the 
Cas3 nuclease/helicase (Datsenko et al., 2012). Interestingly, the vast majority of 
spacers acquired through priming are derived from the same DNA strand as the 
original priming spacer (Datsenko et al., 2012; Savitskaya et al., 2013; Swarts et 
al., 2012). In addition, priming in E. coli was abolished by two mutations in the 
protospacer and PAM region (Datsenko et al., 2012).
 In this study, we generated a mutagenic variant library of a protospacer 
and PAM region and used both individual high-throughput plasmid loss assays and 
next generation sequencing to determine the limits of both direct interference 
and indirect interference through priming. Our results demonstrate that direct 
interference tolerates mutations mostly at very specific positions in the protospacer, 
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whereas priming tolerates extensive mutation of the PAM and protospacer region. 
The results have wide evolutionary consequences for primed acquisition and could 
explain the retention of multiple ‘older’ spacers in CRISPR arrays.
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Figure 1 - Preexisting spacers with up to 7 mismatches promote priming. (A) Loss of plasmid pGFPuv 
from Δhns and various pRSF-1b PIM derivatives (Swarts et al., 2012). (B) Plasmid loss in Δhns, PIM25 
and PIM2 backgrounds for plasmids pGFPuv and pACYC184. The percentage of plasmid-free clones 
containing no spacers (white) or at least one new spacer (grey) is shown. (C) Percentage of spacers 
derived from forward (priming) or reverse strands of the plasmids from B. (D) Match of PIM25 S26 
crRNA to the protospacer in pGFPuv. (E) Mapping of new spacers acquired by PIM25 following loss of 
pGFPuv. (F) Match of PIM25 S26 crRNA to the protospacer in pACYC184. (G) Mapping of new spacers 
acquired by PIM25 following loss of pACYC184. (H) Match of PIM2 S22 crRNA to the protospacer 
in pGFPuv. (I) Mapping of new spacers acquired by PIM2 following loss of pGFPuv. In D, F and H 
the spacer (red), protospacer (blue), PAM (green) and mismatches (bold) are indicated. In E, G and 
I the protospacer (PS) region is indicated in purple, new forward (primed) spacers in pale green, 
new reverse spacers in red and all the respective consensus PAMs are shown in green (forward) and 
orange (reverse). 
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Results
Plasmid insensitive mutants lose unrelated plasmids via priming
Previously, E. coli strain Δhns was shown to acquire spacers from plasmid pRSF-1b 
when cultured over ~1-2 weeks in the absence of antibiotic selection for plasmid 
maintenance (Swarts et al., 2012). Naïve spacer acquisition and plasmid loss were 
not robustly reproducible and the requirement for prolonged cultivation was 
unclear. Therefore, we tested the ability of the Δhns strains that had acquired new 
pRSF-1b-derived spacers to lose an alternative plasmid. Eight plasmid insensitive 
mutants (PIMs) previously isolated after acquiring spacers against pRSF-1b (Swarts 
et al., 2012) were transformed with pGFPuv, an unrelated plasmid with a different 
antibiotic resistance marker and origin of replication. Plasmid retention was 
consistent with previous observations that Δhns did not lose plasmids over two 
days (Swarts et al., 2012). However, PIM2 and PIM25, displayed different levels of 
plasmid loss (Fig. 1A). PIM2 had 20% plasmid loss, whereas PIM25 had almost 100% 
plasmid loss by two days. 
 We were interested why E. coli PIM25 displayed heightened plasmid loss. 
PIM25 previously acquired five new spacers from pRSF-1b, three in CRISPR2.1 
and two in CRISPR2.3 (Swarts et al., 2012). Potential targets for these five spacers 
were assessed against pGFPuv and surprisingly, spacer 26 (spacer two from the 
CRISPR2.3 leader) matched 31 of 32 bases in pGFPuv and a consensus PAM was 
present (5’-protospacer-CTT-3’). The mismatch was at +1 in the seed sequence 
of the protospacer (Fig. 1D), a mutation previously shown to enable priming 
(Datsenko et al., 2012). Most plasmid loss in PIM25 (~60%) was associated with 
spacer acquisition in CRISPR2.1 and/or CRISPR2.3 and the remaining plasmid-free 
clones had not acquired spacers (Fig. 1B). For 40 PIMs, 54 newly-acquired spacers 
were sequenced and the protospacer locations in pGFPuv, their orientation relative 
to the original spacer (S26), and the presence of PAM sequences were determined 
(Table S1). The vast majority of spacers (52/54; 96%) mapped to the same DNA 
strand as the S26 spacer, indicative of priming (Fig. 1C and 1E) (Datsenko et al., 
2012; Swarts et al., 2012). Therefore, strains that have acquired spacers targeting a 
plasmid may have increased loss of an unrelated plasmid. This data was consistent 
with a priming model, where the single mismatch between S26 (derived from pRSF-
1b) and the protospacer in pGFPuv promoted the accelerated acquisition of spacers 
in a strand-specific manner (Datsenko et al., 2012; Swarts et al., 2012). 
At least seven mismatches are tolerated for priming
Datsenko et al. demonstrated that a single mutation in the PAM (-1 position) or in the 
seed (+1 position) resulted in primed spacer incorporation, but a double mutation 
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(-1 PAM and +1 seed) abolished priming in the E. coli Type I-E system (Datsenko et 
al., 2012). To examine if the results observed using PIM25 were due to priming, we 
tested the ability of PIM25 to lose pACYC184 (Rose, 1988). S26 from PIM25 matches 
pACYC184 but has three mismatches (-1 PAM, +1, +5 in seed; Fig. 1F), whereas S29 
has 6 mismatches. Since the S26 spacer:protospacer match contained the exact 
two mutations previously observed to abolish priming (Datsenko et al., 2012), we 
expected no priming. Surprisingly, ~55% of the PIM25 strains had lost pACYC184, 
80% of which showed CRISPR expansion (Fig. 1B). In contrast, ~25% of Δhns clones 
had lost pACYC184, yet none had acquired new spacers (Fig. 1B). Of 44 new PIM25-
derived strains, the new spacers were strand-specific (43/47; 91%) indicative of 
priming (Fig. 1C, 1G and Table S2). We cannot conclude which original PIM25 spacer 
caused priming since they both are predicted to pair with the same DNA strand. 
However, it is clear that a minimum of three spacer:protospacer mutations within 
the PAM and seed region enable primed spacer acquisition. 
 The question arose why PIM2 showed increased loss of pGFPuv (Fig. 1A). 
Compared with Δhns, PIM2 contains two spacers derived from pRSF-1b, one in 
each CRISPR (Swarts et al., 2012). The closest spacer:protospacer match to pGFPuv 
is S22 (the first spacer in CRISPR2.1), which has seven mutated positions (-2 PAM, 
+2 seed and 5 positions outside of seed; Fig. 1H). PIM2 had increased CRISPR-
dependent pGFPuv loss compared with Δhns (Fig. 1B). Spacers acquired by 37 
PIM2 derivatives showed strand-specific features of priming (46/62; 74%; Fig. 1C, 
1I and Table S3), albeit less pronounced than for PIM25. Since PIM2 differs from 
Δhns by two spacers, it was possible that either spacer was promoting the priming 
phenotype. To test if S22 was responsible for priming, CRISPR2.1 was replaced by an 
array with three spacers bearing no homology to pGFPuv. This strain, which lacked 
S22 but still contained S11 in CRISPR2.3, showed no acquisition during multiple 
plasmid loss assays, demonstrating that S22 in CRISPR2.1 was required for priming. 
Therefore, spacers with up to seven mismatches to a protospacer and PAM region 
enable priming. 
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Figure 2 - Experimental design for high-throughput individual and pooled plasmid loss experiments. 
A test system of E. coli PIM5 containing protospacer (PS) 8 was selected that would target a pGFPuv-
Km plasmid containing a consensus PAM and PS8. A degenerate PAM-protospacer 8 library of variants 
was generated in pGFPuv-Km with an average distribution of 5 mutations per insert (histogram). For 
the individual experiment, the plasmid library was transformed into PIM5, individual colonies were 
sequenced, plasmid loss experiments without selection performed and a subset of variants checked 
for spacer acquisition by PCR and sequencing. In the pooled experiment, plasmid DNA was prepared 
for the original library (T0), which was then transformed into PIM5 (T1) and then passaged for plasmid 
loss without selection for 24 h (T2) and 48 h (T3). For T0-T3, samples were amplified with barcoded 
primers, pooled and sequenced.
Individual high-throughput assay reveals that up to 11 mutations support 
priming
The observation that up to 7 mismatches between a crRNA and protospacer-
PAM target region promoted priming, led us to develop a randomized screen to 
test the limits of priming (Fig. 2). A strain that contained an additional spacer in 
CRISPR2.1 compared with Δhns was selected (i.e. PIM5) and a library of variant 
PAM-protospacers (PS8; protospacer 8) with 85% WT nt and 5% alternative nt 
at each position was generated in pGFPuv (pGFPuv-Km-mPS8). This yielded on 
average 5 mutations per PAM-protospacer (Fig. 2). Control plasmids were generated 
that contained either no protospacer (pGFPuv-Km; negative control) or PS8 with 
a +1 seed mutation (pGFPuv-Km-PS8; priming positive control). Approximately 
210,000 transformants of E. coli DH5α were grown and a plasmid library prepared. 
Transformation bias was avoided by using E. coli DH5α which lacks any spacers 
targeting the PAM-protospacer plasmid. The library and control plasmids were 
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introduced into E. coli PIM5 and those directly targeted were expected to be 
eliminated. After 48 h of culturing in non-selective media, the positive priming 
control showed 82%  (±25%) average plasmid loss and the negative control 0.3% 
(±1.2%) loss.
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Figure 3 - Up to 11 mutations within the 
protospacer and/or PAM region promote 
priming. (A) Plasmid loss at 48 h for 366 individual 
loss experiments relative to the number of 
mutations in each protospacer and PAM (lines 
represent average loss for variants with that 
number of mutations). (B) Twenty variants with 
between 1-11 mutations that displayed plasmid 
loss via priming. The spacers acquired by these 
variants are shown in (C) and details are in 
Datasets S1, S2 and Table S4.
 A total of 366 individual PAM-
protospacer variants were sequenced 
and each tested for stability upon growth 
for 48 h without antibiotic selection (Fig. 
2 and Dataset S1). Up to 12 mutations 
were detected and plasmid loss ranged 
from 0-100% (Fig. 3A). On average, 
the percentage loss decreased with 
increasing mutations (Fig. 3A). Analysis 
of 20 PIMs from the positive control 
demonstrated priming (20/24; 83% 
of spacers analyzed). Colonies (n=4 to 
16) from 43 variants exhibiting >10% 
plasmid loss were checked by PCR for 
spacer acquisition, which revealed that 
88% (38/43) of the variants had acquired 
new spacers. Twenty eight variants with 
a range of 1-11 mutations were selected 
(Fig. 3B) and the new spacers sequenced 
(Table S4 and Dataset S2). The resulting 
spacers were mapped to pGFPuvKm-
PS8 and demonstrated the expected 
strand bias of priming (175/193; 91%; 
Fig. 3C and Table S4). Remarkably, one 
of these protospacers deviated from the 
original PAM and protospacer region by 
11 mutations, yet still provoked priming. 
In the various mutants the locations of 
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these mismatches were throughout the protospacer and PAM region, including the 
seed sequence (Fig. 3B). In conclusion, extensive protospacer mutations, even in 
the PAM and seed, enable the acquisition of new spacers through priming. 
High-throughput overview of the entire dataset
The individual high-throughput assay demonstrated that up to 11 mutations 
promoted priming (Fig. 3B). This screen also enabled us to follow the loss, spacer 
acquisition, target strand and location for individual mutants (n=366). However, this 
only represented a small proportion of the mutant library generated. Therefore, 
we transformed the entire library into E. coli PIM5 and performed high-throughput 
pooled plasmid loss experiments and followed plasmid abundance by deep 
sequencing (Fig. 2). Plasmids were prepared from i) the initial non-targeting E. 
coli DH5α strain (total library; denoted T0), ii) E. coli PIM5 immediately following 
growth of transformants (i.e. variants surviving direct interference; denoted T1), iii) 
E. coli PIM5 after 24 h of non-selective growth (T2) and iv) E. coli PIM5 after 48 h of 
non-selective growth (T3). Following plasmid preparation, the variant protospacers 
were amplified by barcoded PCR, the different samples (T0-T3) were pooled and 
sequenced. In the total library, the distribution of mutations was close to the 
theoretical prediction with an average of 5 mutations (Fig. 2).
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Figure 4 - Classification of functional behavior of individual PAM-protospacer variants in the pooled 
loss experiment. (A) Contour map of the number of variants. The depletion ratio of the number of 
reads at T1 and T0 (revealing direct interference) is plotted on a double log2 scale vs the ratio of reads 
at T3 and T1 (revealing priming). Variants were binned in 0.1 by 0.1 bins and the number of sequences 
per bin is shown in a color range of blue to red (1-100 variants). Black boxes indicate the boundaries 
of the three different functional categories (Direct interference (X<-2, n=8,792), Priming (X>0, Y<-0.5, 
n=26,842), and Stable (X>0, Y>0.5, n=12,066)) and a group of Unclassified (n=86,395) variants. (B) 
Contour map as in (A) showing the average number of mutations of each bin in a color range of purple 
to red (0-12 mutations). (C) Percentage distribution of the functional categories at increasing numbers 
of mutations (D, Direction interference; P, Priming; S, Stable and U, Unclassified).
 The protospacer-PAM plasmids were analyzed based on changes in 
abundance over the total time course of the experiment using plots depicting the 
ratio of reads at T3/T1 versus T1/T0 (Fig. 4A). This allowed us to classify the behavior 
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of the sequences into three functional categories termed Direct interference, 
Priming and Stable. The Direct interference group was defined as protospacers that 
decreased in abundance between the initial library and following transformation 
into PIM5 (T0 to T1); the Priming group was defined as protospacers that did not 
decrease in abundance after transformation into PIM5, and only decreased in 
abundance following 48 h of culturing (T1 to T3) and the Stable group showed no 
decrease in abundance after transformation and prolonged culturing (T0 to T1, 
and T1 to T3). A number of other protospacers were not classified (Unclassified) 
due to the stringent criteria we applied to define the groups (Fig. 4 legend). When 
the average number of mutations was plotted of each local region of the graph, a 
clear link became apparent between the functional categories and the number of 
mutations (Fig. 4B). As expected, the number of mutations increased going from 
Direct interference to Priming to Stable. Although this was the general trend, some 
clusters were also evident of priming variants with high numbers of mutations. 
Plotting the percentage of each of the different groups at increasing numbers of 
mutations revealed that Direct interference drops rapidly with more mutations (Fig. 
4C). Priming is the most dominant behavior at five mutations and still occurs at 13 
mutations (Fig. 4C). The Stable group steadily increases in abundance (Fig. 4C). Each 
category is addressed in detail in the following sections.
Direct interference
Previously in E. coli, cases were shown of protospacers carrying 4 or 5 mutations 
within the protospacer that would still lead to interference (Semenova et al., 2011). 
In the same study, Semenova and colleagues demonstrated, using single point 
mutations, that perfect pairing in the seed (position 1-5, 7-8) was essential for 
interference. The importance of the PAM sequence in interference has also been 
demonstrated for Type I-E (Semenova et al., 2011; Sinkunas et al., 2013; Westra 
et al., 2013). However, a detailed understanding of the “rules of interference” are 
not available for any Type I system. Our high-throughput approach allowed us to 
directly assess which protospacer and PAM mutations abolish interference. Firstly, 
we noted that the distribution of the number of mutations in the Direct interference 
group (n=8,792 variants) was maximal at 3 mutations per protospacer (Fig. 5A). 
This means that of the initial library, plasmids with fewer mutations were likely to 
be targets of direct interference. Secondly, by plotting the percentage of mutations 
at each PAM or protospacer position we observe which positions tolerate mutation 
(high abundance after introduction into PIM5) and those that do not (low abundance 
after introduction into PIM5) (Fig. 5B). As expected, mutations within the PAM (-3 
to -1) and within the seed (1-5, 7-8) do not readily tolerate mutation and therefore 
inhibit direct interference. In addition, our analysis reveals that seed positions 5 and 
8 tolerate mutations better than position 1, 2, 3, 4 and 7.
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Figure 5 - Analysis of variants displaying direct interference. (A) Distribution of the number of 
mutations per variant. (B) Percentage mutation per substitution type per position. For example, ~10% 
of all G to A mutations at position 6 end up in the Direct interference class. (C) Analysis of the mutation 
position of all double mutants (n=2,791 sequences) found in the Direct interference class. Protospacer 
mutations were scored regardless of the identity of the nucleotide, whereas PAM nucleotides were 
scored taking the nucleotide identity into account. Bubble size is indicative of the fraction of variants 
with mutations at a certain combination of positions displaying Direct interference behavior. The 
absence of a bubble indicates that a certain combination of mutations leads to escape from direct 
interference. (D) Schematic representation of five PAM sequences on the target strand from 5’ to 3’ 
supporting Direct interference (see also Table S7). The five pinch point positions of Cas7 where 
mutations are readily tolerated for direct interference (red base pairs numbered 6, 12, 18, 24 and 30), 
as well as the five helical segments within the Cascade R-loop (grey lines, numbered 1-5) are indicated.
 To interrogate the data in an alternative manner, we plotted the percentage 
of different nucleotide variants with two mutations at different positions in the entire 
PAM and protospacer region (Fig. 5C). This clearly high lights the significance of the 
PAM and seed, and shows seed discontinuity at position 6. The greater importance 
of seed positions 1, 2 and 7 becomes evident as well as they rarely co-occur in the 
Direct interference group together with mutations elsewhere in the protospacer. 
Particular double mutant variants are synergistic, and escape direct interference 
(i.e. they have decreased black circles in Fig 5C) This synergy for evasion of direct 
interference is observed between position 28 with 19-23, 25-27, 31 and 32 (Fig. 5C 
and 5D segments 4 and 5; see below). Likewise, a similar synergy is detected with 
position 25 with 19-23, 26-27, 29 and 31 (Fig. 5C and 5D segments 4 and 5). Other 
clusters of low abundance double mutants occur, in particular at positions 19-23 
and also in positions 9 and 10 with positions 13-16 (Fig. 5C and 5D segments 2 and 
3). It is probable that two mismatches in close proximity in certain locations are 
more likely to disrupt the required crRNA:DNA base pairing.
 Most striking from the data in Figure 5B is the six nt periodicity in which 
mutations are allowed (i.e. position 6, 12, 18, 24 and 30). Variants with up to 
seven mutations may still display direct interference, while carrying typically half 
of their mutations at these positions. The positions where mutations are tolerated 
accurately map five pinch points of the backbone subunit Cas7 in the cryo-TEM 
structure of Cascade (Wiedenheft et al., 2011a), where the crRNA:target DNA 
heteroduplex is not base paired (Fig. 5D). These interruptions are key in avoiding 
topological complications associated with base pairing Cascade-bound crRNA to a 
double stranded target DNA, and create five segments of five nt and a final two nt 
region in which the crRNA can base pair to the target DNA (Fig. 5D).
 To determine the influence of the PAM on direct interference, we focused 
on sequences which only contained mutations in the PAM. Out of the 64 possible 
PAMs (with no mutations in the protospacer), 40 were present in our dataset. Of 
these, only 5 PAMs allowed direct interference, indicating that the PAM requirement 
for this particular behavior is rather strict (Fig. 5D). In summary, analysis of the 
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transformation efficiency of a large protospacer and PAM library has reinforced the 
importance of the PAM and seed regions in direct interference and revealed with 
high-accuracy the 5 pinch point mutations permitted with a periodicity of 6 nt.
Priming
In the Priming group (n=26,842 variants), the distribution of the number of mutations 
peaks at 5 mutations per PAM-protospacer region (Fig. 6A), which is more than for 
the Direct interference group, and is consistent with the individual priming data 
(Fig. 3). Based on the published data (Datsenko et al., 2012), we predicted that 
protospacers that enable priming might have a preference for mutations within 
the PAM or seed that allow escape from direct interference. Indeed, analysis of 
the position of mutations of Priming protospacers revealed a subtle increase in 
mutations within the PAM and seed that promoted priming (Fig. 6B). This was very 
pronounced when protospacers with three mutations were examined (Fig. 6C). The 
analysis revealed that mutants with two mutations in the PAM-seed region (position 
-2 to 5, 7, 8) displayed significant Priming behavior regardless of the position of 
a third mutation (Fig. 6C). Also a mutation at position 9 which is adjacent to the 
seed, shows enhanced priming (Fig. 6C). Strikingly, almost 35% of all mutations at 
position 28 ends up in the Priming category (Fig. 6B). Even in combination with two 
other mutations, a mutation at position 28 significantly leads to priming (Fig. 6C). 
Further inspection of the plot showed that position 16 also contributes significantly 
to priming in a number of triple mutants. Apart from a number of positions that 
stimulate priming, a decreased abundance of mutations in positions 11, 12, 22, 24 
and 30 were associated with Priming (Fig. 6B and 6C, also see below).
 With regard to the influence of PAM mutations, the number of PAMs that 
allow Priming is much greater compared with Direct interference (Fig. 6D). We 
observed that 22 out of the 40 PAM mutants in the dataset resulted in priming, 
suggesting that the majority of PAMs promote either Direct interference of an 
invader (5 out 40), or indirect interference by Priming (22 out of 40). Especially 
a CGT PAM, which is obtained by point mutation of the -2 position of the PAM, 
appeared to have a dominant priming effect on the behavior of many triple mutants 
(Fig. 6C and 6D). Overall, priming is a robust host response that can deal with a 
myriad and large number of mutations in protospacer and PAM regions. 
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Figure 6 - Analysis of variants displaying priming. (A) Distribution of the number of mutations 
per variant. (B) Percentage mutation per substitution type per position. For example, ~40% of all 
C to A mutations at position 28 end up in the Priming class. (C) Analysis of pairs of mutations in 
triple mutants that significantly (p < 0.05) contribute to priming behavior (n=17,109 triple mutants 
sequences). Protospacer mutations were scored regardless of the identity of the nucleotide, 
whereas PAM nucleotides were scored taking the nucleotide identity into account. The absence of 
a point indicates that a certain combination of mutations does not significantly lead to priming. (D) 
Schematic representation of the Cascade R-loop indicating PAM sequences on the target strand from 
5’ to 3’ supporting priming (see also Table S7). PAM sequences indicated with an asterisk (*) were 
computationally inferred from the analysis of the behavior of the sequences containing the given PAM 
and either one or two additional mutations (see Table S7). Protospacer position 28, which is highly 
associated with priming, is shown in red.
Stable
The Stable group had the highest number of mutations of all the groups, with on 
average 6 substitutions per PAM-protospacer region (Fig. 7A). This was expected, 
since this group avoids both Direct interference and subsequent Priming. Mutations 
at position 10, 11, 12, 18, 22, 24 and 25 are all overrepresented in the Stable group 
(Fig. 7B), and surprisingly, these positions are all guanosines. This suggests that 
rG-dC (i.e. riboG-deoxyriboC) base pairing between the crRNA and the target DNA 
should not be disrupted for priming to occur, which is consistent with the fact that 
rG-dC basepairs are the strongest basepair known (Hall and McLaughlin, 1991; 
Roberts and Crothers, 1992). The importance of rG is again reflected in the analysis 
of triple mutants (Fig. 7C) where mutations of guanosines at position 11, 24 and 25 
mutations are frequently found in Stable triple mutants. A mutation from T to C is 
strongly overrepresented in the Stable group at position 29, 30 and 31, and to some 
degree also position 15 and 32 (Fig. 7B). These mutations all result in rU-dG wobble 
basepairs between the crRNA and target DNA (Sugimoto et al., 2000), which appear 
to disrupt the priming process and result in stable plasmids. Mutations in the PAM 
alone are not sufficient to promote Stable behavior. However in triple mutants, 
some PAMs significantly lead to Stable variants (i.e. CCC, ATC, ACT, AAT), while ATT 
PAMs yield a dominant stable behavior in combination with mutations at eight 
different positions of the protospacer (i.e. 10, 11, 14, 24, 25, 29, 30 and 31) (Fig. 7C 
and D, also see below).
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Figure 7 - Analysis of stable variants. (A) Distribution of the number of mutations per variant. (B) 
Percentage mutation per substitution type per position. For example, ~20% of all T to C mutations at 
positions 29, 30 and 31 end up in the Stable class. (C) Analysis of pairs of mutations in triple mutants that 
significantly (p < 0.05) contribute to stable behavior (n=17,109 triple mutants sequences). Protospacer 
mutations were scored regardless of the identity of the nucleotide, whereas PAM nucleotides were 
scored taking the nucleotide identity into account. The absence of a point indicates that a certain 
combination of mutations does not significantly lead to priming. (D) Schematic representation of the 
Cascade R-loop indicating that no PAM sequences are sufficient to cause stable behavior. Positions 
of variants overrepresented in the Stable class are shown in red (10-12, 18, 22, 24, 25) and orange 
(29-31). 
Nucleotide dependent effects
To investigate nucleotide specific effects in more detail, we analyzed the behavior of 
variants containing increasing numbers of specific mismatches in the protospacer 
(Fig. 8). Mutations in the protospacer DNA resulting in all types of mismatches 
with specific RNA nucleotides (rA, rC, rG, or rU) reduce direct interference (Fig. 
8A). However, priming is very differently affected by each type of mismatched 
ribonucleotide. While mismatched rG nucleotides are detrimental to priming and 
lead to more Stable behavior as was observed for mutations at position 10, 11, 
12, 18, 22, 24 and 25 (Fig 7B and 8A), mismatched rC nucleotides on the contrary 
strongly promote priming (Fig. 8A and 7B). In addition, mismatched rA and rU 
nucleotides do not strongly effect the behavior.
0 1 2 3 4
rA
 # of mismatched rAs 
%
 o
f t
ot
al
 p
op
ul
at
io
n
0
20
40
60
80
10
0
D
P
S
U
0 1 2 3 4 5
rC
# of mismatched rCs 
%
 o
f t
ot
al
 p
op
ul
at
io
n
0
20
40
60
80
10
0
D
P
S
U
0 1 2 3 4 5 6
rG
# of mismatched rGs 
%
 o
f t
ot
al
 p
op
ul
at
io
n
0
20
40
60
80
10
0
D
P
S
U
0 1 2 3 4 5
rU
#of mismatched rUs 
%
 o
f t
ot
al
 p
op
ul
at
io
n
0
20
40
60
80
10
0
D
P
S
U
0 1 2 3 4 5 6
dA
# of mismatched dAs 
%
 o
f t
ot
al
 p
op
ul
at
io
n
0
20
40
60
80
10
0
D
P
S
U
0 1 2 3 4
dC
# of mismatched dCs 
%
 o
f t
ot
al
 p
op
ul
at
io
n
0
20
40
60
80
10
0
D
P
S
U
0 1 2 3 4 5
dG
# of mismatched dGs 
%
 o
f t
ot
al
 p
op
ul
at
io
n
0
20
40
60
80
10
0
D
P
S
U
0 1 2 3 4 5 6
dT
# of mismatched dTs 
%
 o
f t
ot
al
 p
op
ul
at
io
n
0
20
40
60
80
10
0
rA rC rG rU
dA dC dG dT
Number of mismatches
1 2 3 4 5 6 7 1 2 3 4 5 1 2 3 4 5 6 1 2 3 4 5 6 7
1 2 3 4 5 1 2 3 4 5 6 1 2 3 4 5 6 7 1 2 3 4 5 6
100
0
50
100
0
50
100
0
50
100
0
50
100
50
100
50
100
50
10
50
A
B
D
P
S
U
rU
%
 o
f t
ot
al
 p
op
ul
at
io
n
20
40
60
80
10
0
D
P
S
U
%
 o
f t
ot
al
 p
op
.
%
 o
f t
ot
al
 p
op
.
Figure 8 - Effect of mismatches between the crRNA spacer sequence and the targeted strand of the 
protospacer. Variants with mutations in the PAM were excluded in this analysis (remaining group 
n=83,655). (A) Mismatched ribonucleotides in the crRNA spacer. (B) Mismatched deoxyribonucleotides 
in the targeted strand of the protospacer DNA.
 We next repeated the analysis from a target point of view by looking at 
mismatched DNA nucleotides (dA, dC, dG and dT) in the targeted strand of the 
protospacer (Fig. 8B). Although this analysis is very different from the one described 
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above (i.e. analysis of mutation to a particular nucleotide (Fig. 8B; e.g. dA, dG, or dT 
to dC) compared with mutations of specific nucleotides to any nucleotide (Fig. 8A; 
e.g. dG to dA, dC, or dT)), the results were strikingly similar. Again, the increased 
numbers of mismatched dC and to some extent also dT nucleotides promoted 
priming, whereas increased numbers of dG abolished priming. Mismatched dA 
nucleotides in the targeted strand of the protospacer appeared to have no strong 
effect on priming behavior. Analysis of 10 priming variants with 12 mutations in the 
protospacer indeed revealed that on average each these highly mutated variants 
carry mostly mutations promoting priming. 
 The opposing effects of rC and rG mismatches argue against a role for the 
thermostability of the protospacer DNA duplex in affecting priming, as the decrease 
in stability of double stranded DNA on average is similar when introducing mutations 
causing an rC mismatch (dG to dA, dC, or dT) or rG mismatch (dC to dA, dG, dT). 
The same is true for dC mismatches (dA, dG, or dT to dC), and dG mismatches (dA, 
dC, or dT to dG) both of which on average increase the duplex stability. Instead, the 
reason for the unequal effects of particular mutations might reside in differences 
in stabilities or conformation between individual mismatched RNA:DNA nucleotide 
pairs (Sugimoto et al., 2000) in the context of the Cascade R-loop. 
 All in all the rules for priming appear to be a complex combination of the 
number of mutations (Fig. 6A and 7A), position dependent effects, such as in the 
PAM and seed (Fig. 6C and 7C), and nucleotide dependent effects (Fig. 8). As a rule 
of thumb, however, mismatched rG or dG nucleotides lower the chances of priming, 
while mismatched rC and dC promote priming.
Discussion
A perceived Achilles heel of the CRISPR-Cas adaptive immune systems, which was 
detected in early studies (Deveau et al., 2008), is the ability of phages and plasmids 
to escape immunity through mutation of their PAM or protospacer (Sapranauskas 
et al., 2011; Sun et al., 2013). Recently, it was shown that despite these mutations 
allowing avoidance of direct interference, they led to an enhanced positive feedback 
process of new spacer acquisition, termed priming (Datsenko et al., 2012; Swarts 
et al., 2012). This suggests a further evolved function of the CRISPR-Cas systems in 
the arms race between bacteria and their invading mobile genetic elements. In the 
current study, we have investigated the requirements of both direct interference 
and priming by the Type I-E system of E. coli. We have revealed that direct 
interference readily tolerates mutations at specific positions in the protospacer (6, 
12, 18, 24, 30), and can cope with 2 or 3 more mutations in the non-seed region 
of the protospacer. Protospacer sequences that are not directly targeted, including 
sequences with mutations in the PAM and seed, enhance the acquisition of new 
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spacers even when the existing spacer has many mismatches. Therefore, priming is 
an incredibly flexible and promiscuous process that may provide a major, if not the 
main, route to adaptation in CRISPR-Cas systems.
 We observed that up to 5 mutations in the PAM and seed (of 11 total 
mutations) still facilitated primed spacer acquisition, in contrast to Datsenko et al. 
(Datsenko et al., 2012), who reported that a double mutant of the PAM and seed 
abolished the process. The difference between these findings may be due to the 
use of either phages or plasmids, and/or the time to allow priming to occur (0-8 h vs 
24-48 h). Our finding that high numbers of mismatches in the PAM and protospacer 
region stimulate primed spacer acquisition, challenges and expands the concept of 
adaptation in CRISPR-Cas systems. Further, we show that the number, position and 
kind of mutation greatly influence the priming process. For example, mismatched 
cytosine ribonucleotides in the crRNA promote priming, whereas mismatched 
guanine ribonucleotides abolish priming. It would therefore seem advantageous 
for a host to select and retain C-rich spacers in their CRISPR arrays to be capable of 
a better primed response, while discarding outdated G-rich spacers.
 During the preparation of this manuscript, priming was demonstrated in 
the Type I-B system of Haloarcula hispanica against an archaeal virus (Li et al., 2014). 
Interestingly, the pre-existing spacer responsible for priming contained incomplete 
complementarity (Li et al., 2014). Analysis of a number of other reports suggests that 
priming might occur in other CRISPR-Cas systems. Firstly, the most active CRISPR-Cas 
system for adaptation is the Type II in S. thermophilus (Barrangou et al., 2007; Deveau 
et al., 2008; Garneau et al., 2010; Horvath et al., 2008a; Magadan et al., 2012; Paez-
Espino et al., 2013). Previously, upon testing the CRISPRTarget protospacer finding tool, 
we identified partial matches between existing spacers and phage used in challenge 
experiments and proposed that this might have resulted in priming if such a process 
would exist in S. thermophilus (Biswas et al., 2013). In another report, gfp mRNA and 
plasmid DNA were reduced in E. coli with a Type I-E system by a spacer that only had 
an ~10 bp stretch of complementarity (Perez-Rodriguez et al., 2011). Although this 
degree of complementarity falls well outside the limits we observed, all Cas proteins, 
including Cas1 and Cas2, and the CRISPR locus were required for gfp loss, which might 
indicate that priming was involved. More recently, Sulfolobus solfataricus was shown 
to have remarkable flexibility for protospacer recognition. Up to 15 mismatches still 
enabled interference, albeit at roughly 50% efficiency (Manica et al., 2013). Again, 
the interesting possibility arises that these divergent protospacers might be able to 
trigger priming and subsequent interference. Whether these, and other, studies are 
attributable to priming will require further research. It is clear however, that when 
looking for targets of crRNA, those with partial matches, or lacking PAMs, can no longer 
be discarded as non-functional. Tools such as CRISPRTarget enable easy detection of 
these degenerate crRNA targets and their flanking sequences (Biswas et al., 2013).
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 It was proposed that priming enables a rapid response to genetic elements 
that have acquired a point mutation to escape CRISPR-Cas direct interference 
(Datsenko et al., 2012). Our data supports this concept, since mutations that 
led to escape from direct interference promoted priming. The ability of highly-
variant PAM-protospacer regions to be recognized as foreign, suggests that even 
diverse sequences can elicit immunity. This might enable CRISPR-Cas to remember 
invasions that occurred more distantly in evolutionary time and still mount a 
response. Likewise, this promiscuous immunity may provide a broad spectrum 
resistance to a range of mobile genetic elements possessing that protospacer (i.e. a 
family of related phages or plasmids). By virtue of this loose selectivity, CRISPR-Cas 
can apparently detect unrelated elements that share only weak sequence identity. 
Therefore, it is conceivable that priming might be the favored route to resistance, 
which is in agreement with the robustness of this process relative to the apparent 
intractable nature of naïve acquisition (Fineran and Charpentier, 2012; Li et al., 
2014). In theory, longer CRISPR arrays that contain a greater number of spacers 
would have an improved chance of expressing a crRNA that facilitates priming. 
Therefore, the evolutionary selection acting on spacers, in particular, the older 
ones, might function at two levels; immediate protection and primed protection. 
This might provide a rationale for the maintenance of spacers in long CRISPRs, for 
which the immediate invader is no longer a threat, and fits with the low turnover 
of spacers in some CRISPR-Cas systems (Diez-Villasenor et al., 2010; Touchon et al., 
2011; Touchon and Rocha, 2010).
 Various models have been proposed to explain priming. In the E. coli Type 
I-E system, all cas genes and crRNA are required and new spacers are integrated 
in a strand-specific manner (Datsenko et al., 2012; Swarts et al., 2012). A sliding 
model was proposed in which Cascade-crRNA weakly binds protospacers with 
mismatches, then slides along the DNA until a PAM is reached. Spacers are then 
acquired from the strand of the original priming protospacer in a process requiring 
Cas1, Cas2 and Cas3 (Datsenko et al., 2012). The sliding model requires a bias of 
new spacers acquired from nearby the priming protospacer; however, new spacers 
do not reveal this distribution (Savitskaya et al., 2013). Since short sequence motifs 
other than PAMs can influence spacer acquisition efficiency (Yosef et al., 2013), 
the interpretation of spacer distribution becomes more challenging. Indeed, we 
observed that four different spacers accounted for a quarter of all newly acquired 
spacers and contained the recently identified AA nt motif (Yosef et al., 2013) at 
the 3’ end of the spacer (Table S4). This suggests that this AA nt motif influences 
acquisition efficiency during both primed and naïve adaptation. As an alternative 
model to ‘sliding’, Cascade-crRNA was proposed to cause the exposure of extended 
regions of ssDNA, potentially mediated by Cas3, and that Cas1 and Cas2 might have a 
preference for single-stranded DNA substrates (Savitskaya et al., 2013). This is similar 
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to the original priming model, where we proposed that single-stranded substrates, 
possibly preferred by Cas1 and Cas2, are generated due to Cascade-crRNA and 
Cas3-dependent targeting or weak targeting, resulting in spacer acquisition (Swarts 
et al., 2012). Which of these models proves to be correct remains subject of future 
studies.
 To date, the PAM has been well characterized in a number of Type I and Type 
II systems and the effect of mutations in the protospacer has been documented 
(Deveau et al., 2008; Künne et al., 2014; Mojica et al., 2009b; Shah et al., 2013; 
Sorek et al., 2013a). However, only few high-throughput random-mutagenesis 
studies of the effects of PAM and protospacer mutations have been reported. 
Recently, studies of the Type II/Cas9 system have used high-throughput approaches 
to investigate PAM and protospacer requirements for direct interference. Jiang et al. 
generated a variant 5 nt PAM library in Streptococcus pneumoniae which revealed 
that NGG PAMs support interference (Jiang et al., 2013). Investigation of the effects 
of protospacer mutations on direct interference revealed a seed region of nt 1 to 
12 (Jiang et al., 2013), in line with previous studies (Jinek et al., 2012). In another 
study, different PAM specificities of three different Cas9s were demonstrated 
(Esvelt et al., 2013). Our approach allowed an in depth assessment of the Type I-E 
sequence requirements for both direct interference and priming. We revealed five 
PAMs for direct interference and 22 PAMs for priming. These direct interference 
PAMs included a new CTA PAM and the remaining ones were consistent with the 
four previously observed PAMs for interference (Westra et al., 2013; Westra et 
al., 2012c). There were no PAM mutants which resulted in the stable phenotype, 
indicating that mutating the PAM alone does not allow complete escape from Type 
I-E CRISPR-Cas systems. The results demonstrated the critical role of the PAM and 
the seed sequence, in agreement with previous work (Semenova et al., 2011; Westra 
et al., 2013), and revealed that base pairing at position 1, 2 and 7 within the seed 
is of greater importance than base pairing at other seed positions. Semenova et al. 
showed cases where interference tolerated up to 4 or 5 mutations outside the seed 
or PAM and that additional single non PAM/seed mutations could lead to escape 
(Semenova et al., 2011). Similarly, in the Type I-F system, in the presence of four 
mismatches, further mutations inside or outside of the seed or PAM were shown to 
disrupt interference (Cady et al., 2012). The Cryo-EM structure of Cascade revealed 
that the pinch points of the backbone subunit Cas7 disrupted 1-2 nt of base pairing 
that were separated by 4-5 nt helical segments (Wiedenheft et al., 2011a). Here, the 
pinch points of Cas7 were mapped with nucleotide precision, resulting in five helical 
segments of 5 nt. The importance of position 1, 2 and 7 fits with the hypothesis 
that crRNA:target DNA base pairing starts from the PAM end of the protospacer 
(Sashital et al., 2012; Semenova et al., 2011) as position 1 is the first nucleotide of 
the first segment to be involved in base pairing with the target DNA (Westra et al., 
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2013), and 7 is the first nucleotide of the second segment. Remarkably, the distance 
of 6 nucleotides between pinch points is identical to the interval at which Type 
III-B CRISPR-Cas systems cleave their target (Hale et al., 2009; Staals et al., 2013), 
suggesting that the backbone subunits of Type I and III complexes bind their crRNA 
and target nucleic acid with the same periodicity.
 An apparent paradox also emerged from the data. Apart from being 
overrepresented in the Direct interference dataset, mutations at some pinch point 
positions (i.e. 12, 18, and 24) were also overrepresented in the Stable group. This 
would suggest that although these positions are not engaged in base pairing with 
the target during direct interference, they do base pair with the target during 
priming. This finding raises the possibility that there is a conformational change in 
Cascade:crRNA during priming that alters the position of the crRNA, freeing these 
positions for base pairing thereby allowing the detection of weak targets. 
 We are only beginning to understand the intricate interaction between 
the CRISPR-Cas systems and their invaders. This study highlights the incredible 
flexibility of these systems to respond to a rapidly evolving, or diverse mobile genetic 
elements and generate new resistance. We propose that promiscuous priming is an 
extremely important feature of the CRISPR-Cas mechanism and is not restricted to 
the Type I-E system, but is a feature of other CRISPR-Cas Types.
Materials and Methods 
Bacterial strains and growth conditions. The E. coli K12 W3110 derivative, Δhns 
was generated previously by removal of the kanamycin resistance cassette from 
JW1225 (Westra et al., 2010). E. coli strains were grown at 37°C in Luria Broth (LB; 
5 g L-1 NaCl, 5 g L-1 yeast extract and 10 g L-1 tryptone) at 180 rpm or on LB-agar 
plates containing 1.5% (w v-1) agar. When required, medium was supplemented 
with the following: ampicillin (Ap; 100 µg ml-1), chloramphenicol (Cm; 25 µg ml-1) 
or kanamycin (Km; 50 µg ml-1). Bacterial growth was measured at 600 nm (OD
600
). 
Molecular biology and DNA sequencing. Oligonucleotides used in this study are 
listed in Table S5, Table S6 contains read counts, barcodes and scaling factors of the 
large scale sequencing experiment and the PAM sequence analysis is shown in Table 
S7. All strains and plasmids were confirmed by PCR and sequencing (GATC-Biotech, 
Konstanz, Germany). Plasmids were prepared using GeneJET Plasmid Miniprep 
Kits (Thermo Scientific) and DNA from PCR and agarose gels was purified using the 
Thermo Scientific GeneJET PCR Purification and Gel Extraction Kits. 
Replacement of the PIM2 CRISPR2.1 locus. Previously, a synthetic recombination 
cassette was generated that corresponded to 400 bp flanking regions on each side of 
the CRISPR 2.1 locus separated by a kanamycin resistance gene flanked by FRT sites 
Chapter 4
90
4
(Westra et al., 2010). This construct includes a synthetic CRISPR sequence with the 
leader, eight repeats and seven spacers, the first of which (J3) targets bacteriophage 
lambda (Westra et al., 2010). These spacers were compared with pGFPuv using 
CRISPRTarget (Biswas et al., 2013) with the cut off score lowered to 0 and only 
spacer 3 ‘matched’ (score 7, 14/35 mismatches and 7 bp longest continuous match). 
Therefore, this CRISPR 2.1 replacement cassette should not promote priming. 
Recombineering was performed using a protocol described elsewhere (Datsenko 
and Wanner, 2000), with minor modifications. E. coli PIM2 was transformed with 
the recombineering functions on plasmid pKD46 and grown at 30°C (plasmid pKD46 
is unstable at temperatures > 37°C). The CRISPR 2.1 J3 replacement sequence was 
amplified by PCR using primers BG3113 and BG3114 with Pfu polymerase (Thermo 
Scientific). The PCR product was purified, digested with DpnI to remove any 
remaining plasmid template DNA, re-purified and transformed by electroporation 
into E. coli PIM2 containing pKD46. Note that electrocompetent PIM2 pKD46 were 
prepared with 0.2% (w v-1) L-arabinose for expression of the lambda red proteins. 
Transformants were recovered for 2.5 h in LB at 30°C, plated out onto LBA with 
kanamycin (50 µg ml-1) and incubated at 30°C. Plasmid pKD46 was cured by growth 
at 37°C and recombination was validated by PCR and sequencing.
Plasmid loss experiments. Plasmids were introduced into E. coli by either 
electroporation or via heat shock and were pGFPuv (Clontech; pUC origin, ~500/
cell, ApR, gfp, 3337 bp), pACYC184 ((Rose, 1988), p15A origin, 20-30/cell, CmR, TcR, 
4245 bp) and pACYCDuetTM-1 (Novagen; p15A origin, 20-30/cell, CmR, lacI, 4008 bp). 
E. coli with plasmids of interest were grown for 24 h in 10 ml LB in 50 ml tubes 
(Greiner) at 37°C with shaking at 180 rpm. For further passaging, 100 µl of culture 
was subcultured into 10 ml LB in 50 ml tubes for a further 24 h at 37°C at 180 
rpm. When indicated, further periods of incubation were performed using the same 
conditions. Dilutions were plated on LBA and pGFPuv loss detected under UV and 
GFP +/- colonies identified. For plasmids pACYC184 and pACYCDuetTM-1, individual 
colonies were patched onto LBA with or without the appropriate antibiotics to 
identify colonies that had lost the plasmid.
Colony PCR and spacer sequencing. Plasmid-free colonies were screened for spacer 
integration by colony PCR using DreamTaq Green DNA polymerase (Fermentas) 
(Swarts et al., 2012). Briefly, acquisition of spacers in CRISPR2.1 was detected by 
PCR using primers BG3474, which binds in the leader and primer BG3475, which 
anneals in spacer 4. New spacers in CRISPR2.3 were detected using BG3414, which 
anneals in the leader and BG3415, which binds in spacer 3. PCR products were 
visualized on 2% agarose gels and stained with SYBR-safe (Invitrogen). CRISPR2.1 
and 2.3 were sequenced with BG3474 and BG3414, respectively and analyzed as 
follows. Firstly, the sequence was uploaded into CRISPRFinder (Grissa et al., 2007)
and spacers and repeats were manually extracted. Spacer lists were generated in 
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FASTA format and then aligned with the target plasmids by using Geneious (v6.0.5) 
(Kearse et al., 2012) and CRISPRTarget (Biswas et al., 2013). 
Generation of control plasmids for priming experiments. Plasmids were generated 
that either lacked a protospacer target (pGFPKm; negative control) or contained a 
single protospacer with a +1 seed mutation (pGFPKm-PS8; positive priming control). 
The KmR gene was amplified by PCR from pRSF-1b with BG4225 as the forward 
primer and either BG4226 (no protospacer) or BG4227 (protospacer 8 and PAM 
with +1 seed mutation) as reverse primers. The products were digested with EcoRI 
and NcoI and ligated to pGFPuv, previously cut with EcoRI and PagI (BspHI), which 
removed the bla gene. This strategy enabled positive selection with Km for plasmids 
containing the inserts into the 1.8 kb EcoRI/PagI backbone of pGFPuv. 
Generation of a library of protospacer and PAM variants. To generate a pool of 
plasmids with variant protospacer and PAM sequences, KmR gene was amplified by 
PCR from pRSF-1b with BG4225 as the forward primer and BG4228 (protospacer 8 
and PAM with 85% WT nt and 5% chance of each alternative nt at each position) as 
the reverse primer. This ratio provided variants with an average of 5 mutations in 
the 35 nt PAM and protospacer sequence. Products were digested with EcoRI and 
NcoI and ligated to pGFPuv, previously cut with EcoRI and PagI. Five libraries were 
produced from independent PCRs and used to transform chemically-competent 
E. coli NEB5a. A total of ~210,000 transformants were isolated after plating on 
LBA containing Km. For each library, colonies were pooled into LB by scraping the 
bacteria from the plates and plasmids were extracted. 
Individual high-throughput priming assays of protospacer and PAM variants. 
Libraries of pGFPKm-mPS8 were transformed into E. coli PIM5 by electroporation 
and plated onto LBA with Km. Single colonies were picked into 200 µl of LB in 2 
ml 96-well culture plates (Greiner), in addition to positive and negative controls, 
and the plates were incubated for 24 h with shaking at 750 rpm at 37°C. Five µl 
was subcultured into 195 µl of LB in a further 96-well plate as above and cultures 
were grown for 24 h. At 24 h and 48 h, samples were plated on LBA. Total colonies 
were counted, GFP +/- colonies were assessed under UV and spacer acquisition 
determined by PCR. 
High-throughput plasmid loss assays and Illumina sequencing. Plasmid DNA 
was pooled for the 5 libraries (~210,000 protospacer 8 and PAM transformants; 
T0), transformed in triplicate into E. coli PIM5 by electroporation. Positive (PIM5 
pGFPKm-PS8) and negative (pGFPKm) controls were included to enable tracking 
of priming and plasmid stability, respectively. Approximately 2 × 107 colonies were 
pooled for each transformation (~100-fold excess over the estimated library size 
of 2 × 105) and resuspended in 10 ml LB. The OD
600
 was measured and adjusted to 
an OD
600
=4 and 100 µl was used to inoculate 10 ml LB without antibiotics, divided 
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equally over 3 replicates of 16 wells of a 2 ml 96-well microtiter plate. Plates were 
incubated at 37°C with shaking at 750 rpm and every 24 h, each replicate of 16 wells 
was pooled and subcultured 1:40 into 200 µl fresh LB. This was performed for 48 h. 
After transformation (T1), 24 h (T2) and 48 h (T3) growth, plasmids were prepared 
from the pooled 10 ml culture. Positive (pGFPKm-PS8) and negative (pGFPKm) 
controls were also analysed for plasmid loss as described earlier. Plasmid loss of the 
total library was monitored by the agar plate method as described for the individual 
high-throughput assay. Spacer integration during these assays was verified by PCR 
as described earlier.
 These DNA pools from pre-PIM5 transformation (T0, replicate A,B,C), 
post-PIM5 transformation (T1, replicate A, B, C), 24 h (T2, replicate A, B, C) and 
48 h (T3, replicate A, B, C) subculturing were amplified by PCR using Phusion DNA 
polymerase (Thermo Scientific) and a primer pair selected from BG4325 to BG4356 
flanking the protospacer and PAM. Each primer contained a unique 6-nucleotide 
barcode differing in at least two positions from another barcode, which enabled 
sorting of the different samples (Table S5). The 125 base pair PCR amplicons were 
separated by agarose gel electrophoresis, excised from gel and purified using the 
Zymoclean DNA recovery kit (Zymo Research) and eluted in 30 µl H2O. The purified 
fragments were quantitated by Qubit fluorometic quantitation (Invitrogen) and 
equal quantities were pooled. Purity of the sample was analyzed on a Bioanalyzer 
using the High Sensitivity DNA Assay Kit (Agilent). PCR amplicons were prepared 
for Illumina sequencing using the TruSeq SBS Kit (v3), 2 × 100 bp (Paired-End) and 
sequenced on a Hi-Seq (FC-401-3001, Illumina) at the Imagif, Centre for Molecular 
Genetics, CNRS, France.
Analysis of plasmid loss next generation sequence data. A total of 82,221,629 
read pairs were obtained. Data analysis consisted of the following steps. As the 
100 bp paired end reads of the 125 bp amplicon fully overlapped in the 35 bp 
PAM-protospacer region, we first assembled both paired end reads into a single 
consensus sequence (CS) with the merger application from the EMBOSS package 
(Rice et al., 2000):. Only those CSs where there was complete agreement between 
both paired reads of the 35 bp PAM-protospacer sequences were taken for further 
analysis. CSs were categorized based on the barcodes introduced at either end. A 
total of 49,198,699 sequences were accepted with a full hit of both the 5’ and 3’ 
barcodes (Table S6) and without insertions or deletions in the consensus sequence. 
Next, the 35 bp fragments were extracted from the 49,198,699 contigs by using 
the PAM-protospacer flanking sequences. A text file was created specifying the 
nucleotide sequence of the region of interest of the CS (i.e. the PAM-protospacer) 
and its counts across all replicates of all time points (12 replicate in total). As the 
sequence reaction contained equal amounts of DNA from all samples, the sequence 
counts were scaled and rounded by using scaling factors based on the sample with 
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the highest number of sequences (i.e. T2B) (Table S6). Next, a filtering step was 
applied to select only PAM-protospacer sequences that had at least 20 reads in 
any three sequenced samples. This resulted in 134,095 unique PAM-protospacer 
sequences which were selected for further analysis.
 Computational analysis of PAM sequences and combinatorial mutants 
leading to stable or priming classes. Significance scores (p-values) for the 
frequencies of the categorizations were computed by comparing the obtained 
frequencies with the frequencies in a randomly selected subset of a background 
set. The background set was selected in each case to have the same characteristics 
(number of mutations) as the set under study. The randomizations were performed 
1000 times to estimate the p-values. The p-values are given in Table S7. 
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Table S4. pGFPuvKm-mPS8 PIMs derived from PIM5 in high-throughput individual plasmid loss 
experiments
spacer 
variant
spacer (5’-3’) Length 
(nt)
target nt F/Ra PAMb #spacers 
found
S400 AAATGCATAAACTTTTGCCATTCTCACCGGAT 32 1660-1691 F CTT 5
S401 AACAGTATTTGGTATCTGCGCTCTGCTGAAGC 32 2193-2162 R CTT 1
S402 AACTCTGTAGCACCGCCTACATACCTCGCTCT 32 2230-2261 F CTT 1
S403 AACTTTTCACTGGAGTTGTCCCAATTCTTGTT 32 0305-0336 F CTT 6
S404 AATATCCTGATTCAGGTGAAAATATTGTTGAT 32 1453-1484 F CTT 9
S405 AATGGAATCAAAGCTAACTTCAAAATTCGCCA 32 0763-0794 F CTT 2
S406 ACACGACTTATCGCCACTGGCAGCAGC-
CACTG
32 2307-2276 R CTT 2
S407 ACGATAGTTACCGGATAAGGCGCAGCG-
GTCGG
32 2328-2359 F CTT 1
S408 ACGCGTGCTGAAGTCAAGTTTGAAGGTGA-
TAC
32 0610-0641 F CTT 1
S409 AGCGCCCAATACGCAAACCGCCTCTCCCCG-
CG
32 0001-0032 F CTT 1
S410 AGTATGAGCCATATTCAACGGGAAACGTCTTG 32 1116-1147 F CTT 9
S411 AGTGCCATGCCCGAAGGTTATGTACAG-
GAACG
32 0544-0575 F CTT 3
S412 AGTTGGTAGCTCTTGATCCGGCAAACAAAC-
CA
32 2142-2111 R CTT 3
S413 ATCCTTTGATCTTTTCTACGGGGTCTGACGCT 32 2041-2010 R CTT 1
S414 ATGACGGGAACTACAAGACGCGTGCTGAA-
GTC
32 0593-0624 F CTT 2
S415 ATGGAAACATTCTCGGACACAAACTCGAG-
TAC
32 0686-0717 F CTT 5
S416 ATGGATCCGTTCAACTAGCAGACCATTATCAA 32 0806-0837 F CTT 16
S417 CATTTTATCCGTACTCCTGATGATGCATGGTT 32 1374-1405 F CTT 3
S418 CCCGATGCGCCAGAGTTGTTTCTGAAACAT-
GG
32 1257-1288 F CTT 5
S419 CCGTTTCTGTAATGAAGGAGAAAACTCAC-
CGA
32 1856-1825 R CTT 1
S420 CGAGTGATTTTGATGACGAGCGTAATGGCT-
GG
32 1606-1637 F CAT 1
S421 CGGAAGAGCGCCCAATACGCAAAC-
CGCCTCTC
32 2810-0026 F CTT 2
S422 CGGCAGGGTCGGAACAGGAGAGCGCAC-
GAGGG
32 2493-2524 F CTT 2
S423 CGGGCAGTGAGCGCAACGCAATTAATGT-
GAGT
32 0085-0116 F CTT 9
S424 CGTGACCACATGGTCCTTCTTGAGTTTGTAAC 32 0931-0962 F CTT 8
S425 CGTTGCCAATGATGTTACAGATGAGATGGTCA 32 1298-1329 F CTA 1
S426 CTAACTTCAAAATTCGCCACAACATTGAAGAT 32 0776-0807 F CTT 8
S427 CTCACATTAATTGCGTTGCGCTCACTGCCCGC 32 0115-0084 R TTA 1
S428 CTGTTGAACAAGTCTGGAAAGAAATG-
CATAAA
32 1639-1670 F GCC 1
S429 CTTGCATGCCTGCAGGTCGACTCTAGAGGATC 32 0237-0268 F CTT 13
S430 GAAGAGTATGAGCCATATTCAACGG-
GAAACGT
32 1112-1143 F CTT 3
S431 GAGTGCCATGCCCGAAGGTTATGTACAG-
GAACG
33 0543-0575 F CTT 1
S432 GCGCAGCGGTCGGGCTGAACGGGGGGT-
TCGTG
32 2347-2378 F CTT 1
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S433 GCGGACAGGTATCCGGTAAGCGGCAGG-
GTCGG
32 2473-2504 F CTT 3
S434 GGCAGATTGTGTCGACAGGTAATG-
GTTGTCTG
32 0906-0875 R CTT 2
S435 GGTAAGTTTTCCGTATGTTGCATCACCTTCAC 32 0417-0386 R CTT 1
S436 GGTATCACCTTCAAACTTGACTTCAGCACGCG 32 0642-0611 R CTT 1
S437 GTAACTGGCTTCAGCAGAGCGCAGATAC-
CAAA
32 2155-2186 F CTT 12
S438 GTAGCGTTGCCAATGATGTTACAGATGAGATG 32 1294-1325 F CTT 8
S439 GTAGCGTTGCCAATGATGTTACAGATGAGAT-
GG
33 1294-1326 F CTT 1
S440 GTATTGATTTTAAAGAAGATGGAAACATTCTC 32 0668-0699 F CTT 1
S441 GTGATACCCTTGTTAATCGTATCGAGTTAAAA 32 0635-0666 F CTT 10
S442 GTGATGCAACATACGGAAAACTTACCCTTAAA 32 0392-0423 F CTT 14
S443 TCATGCCGTTTCATGTGATCCGGATAACGGGA 32 0533-0502 R CTT 1
S444 TCGTGTCTTACCGGGTTGGACTCAAGACGATA 32 2302-2333 F CTT 3
S445 TCTGGAAAGAAATGCATAAACTTTTGCCATTC 32 1651-1682 F CTT 1
S446 TGGTGGCCTAACTACGGCTACACTAGAA-
GAAC
32 2222-2191 R CTT 1
S447 TTTGAAGGTGATACCCTTGTTAATCGTATCGA 32 0628-0659 F CTT 4
S448 TTTTCCGTATGTTGCATCACCTTCACCCTCTC 32 0411-0380 R CTT 2
aF/R refers to the direction of the new spacer relative to the original ‘priming’ spacer, where F is the 
same (or primed) direction and R is the reverse direction.
bPAM is defined as 5’-protospacer-PAM-3’ on the targeted strand.
Table S5. Oligonucleotides used in this study
Name Sequence (5’-3’)a Description Restric-
tion site
BG3113 GCTGGAGAAATACAACCGC-
CGGCCCCACCT
F CRISPR2.1 J3 replacement
BG3114 CTGAGGCAGTAAGGAAATTAACGCG-
CGACA
F CRISPR2.1 J3 replacement
BG3414 GGTAGATTTTAGTTTGTATAGAG F CRISPR2.3 leader
BG3415 CAACAGCAGCACCCATGAC R CRISPR2.3 spacer 3
BG3474 AAATGTTACATTAAGGTTGGTG F CRISPR2.1 leader
BG3475 GAAATTCCAGACCCGATCC R CRISPR2.1 spacer 4
BG4225 TTTGAATTCGCGCTGCATGCCTATTTG F KmR in pRSF-1b EcoRI
BG4226 TTTTCCATGGTTAGAAAAACTCATC-
GAGCATC
R KmR in pRSF-1b with PIM5 PS8 NcoI
BG4227 TTTTCCATGGAAAAGTGCCACTTG-
CGGAGACCCGGTCGTCAACT-
TTTAGAAAAACTCATCGAGCATC
R KmR in pRSF-1b with PIM5 primed PS8 NcoI
BG4228 TTTTCCATGGAAAAGTGCCACTTG-
CGGAGACCCGGTCGTCAGCT-
TTTAGAAAAACTCATCGAGCATC
R KmR in pRSF-1b with PIM5 mutant PS8 
(85% WT nt 5% each other nt in PS + PAM)
NcoI
BG4325 aactaaTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T0A 
BG4326 acacttTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T0B
BG4327 acgcatTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T0C
BG4328 acgttcTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T1A
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BG4329 actaacTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T1B
BG4330 actctcTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T1C
BG4331 agactcTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T1D
BG4332 agcaacTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T2A
BG4333 agcagaTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T2B
BG4334 agtcagTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T2C
BG4335 agtgcgTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T3A
BG4336 atcacgTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T3B
BG4337 atcgttTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 T3C
BG4340 caccgcTAAATTGCAGTTTCATTTGATG Barcoded F primer for pGFPKm-mPS8 
+Cntr
BG4341 cactgtGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T0A
BG4342 cagtagGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T0B
BG4343 catgatGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T0C
BG4344 catgccGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T1A
BG4345 ccagttGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T1B
BG4346 ccggaaGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T1C
BG4347 cctaccGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T2A
BG4348 cctagaGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T2B
BG4349 cctgtaGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T2C
BG4350 taatagGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T3A
BG4351 tactctGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T3B
BG4352 tcacagGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 T3C
BG4356 ttgataGTGGAACGAAAACTCACG Barcoded R primer for pGFPKm-mPS8 
+Cntr
aRestriction sites are in bold, protospacers are in italics, PAMs are in bold italics and barcodes are in 
lowercase
Table S6. Read counts, barcodes and scaling factors of the large scale sequencing experiment
Sample Barcode 5’-3’ Primer Read count Total reads Scaling factor
T0A AACTAA forward 1,455,741 4,425,417 0.642264
CACTGT reverse 2,970,335
T0B ACACTT forward 1,195,931 3,866,736 0.561182
CAGTAG reverse 2,671,231
T0C ACGCAT forward 1,043,464 2,618,215 0.379984
CATGAT reverse 1,575,124
T1A ACGTTC forward 845,894 2,260,308 0.32804
CATGCC reverse 1,414,824
T1B ACTAAC forward 1,284,315 3,504,841 0.50866
CCAGTT reverse 2,220,967
T1C ACTCTC forward 953,688 3,004,487 0.436043
CCGGAA reverse 2,051,229
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T2A AGACTC forward 1,812,468 5,718,939 0.829994
CCTACC reverse 3,907,707
T2B AGCAAC forward 2,478,705 6,890,338 1
CCTAGA reverse 4,412,609
T2C AGCAGA forward 1,902,481 4,761,649 0.691062
CCTGTA reverse 2,859,905
T3A AGTCAG forward 1,981,100 5,249,299 0.761835
TAATAG reverse 3,269,185
T3B AGTGCG forward 1,138,619 3,067,987 0.445259
TACTCT reverse 1,929,819
T3C ATCACG forward 1,558,125 3,830,483 0.555921
TCACAG reverse 2,273,260
Total 49,198,699
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Abstract
Prokaryotes use a mechanism called priming to update their CRISPR immunological 
memory to rapidly counter revisiting, mutated viruses and plasmids. Here we have 
determined how new spacers are produced and selected for integration into the 
CRISPR array during priming. We show that Cas3 couples CRISPR interference to 
adaptation by producing DNA breakdown products that fuel the spacer integration 
process in a two-step, PAM-associated manner. The helicase-nuclease Cas3 pre-
processes target DNA into fragments of around 30-100 nt enriched for thymine-
stretches in their 3’ ends. The Cas1-2 complex further processes these fragments 
and integrates them sequence specifically into CRISPR repeats by coupling of a 3’ 
cytosine of the fragment. Our results highlight that the selection of PAM-compliant 
spacers during priming is enhanced by the combined sequence specificities of Cas3 
and the Cas1-2 complex leading to an increased propensity of integrating functional 
CTT-containing spacers. 
Keywords
CRISPR-Cas; Priming; Interference; adaptive immunity; Phage resistance; Cascade; 
Cas1; Cas2; Cas3; Spacer acquisition 
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Introduction
Priming is a mechanism by which immune systems provide an improved immune 
response to parasite exposure. In vertebrates, priming of adaptive immunity can 
occur upon first contact of a T or B cell with a specific antigen and causes epigenetic 
changes as well as cell differentiation into effector T or B cells, producing high levels 
of antibodies (Bevington et al., 2016). More recently, immune priming has been 
observed in invertebrates, where it provides increased resistance to previously 
encountered pathogens (Kurtz and Franz, 2003; Schmid-Hempel, 2005). In plants, 
priming refers to a state in which the plant can activate its defense responses 
more rapidly and strongly when challenged by pathogenic microbes, insects, or 
environmental stress (Conrath et al., 2015). In microbes, priming is a mechanism 
in which cells can update their immunological memory to provide protection 
against previously encountered but slightly changed viruses or conjugative plasmids 
(Datsenko et al., 2012; Li et al., 2014; Richter et al., 2014; Swarts et al., 2012; 
Vorontsova et al., 2015). Microbial adaptive immune systems do this by integrating 
short fragments of invader DNA sequences (called spacers) into Clusters of Regularly 
Interspaced Short Palindromic Repeats (CRISPR). These spacers are transcribed and 
processed into small CRISPR RNAs and guide Cas (CRISPR-associated) surveillance 
complexes such as Cascade, Cas9, Cpf1, Csm and Cmr to their DNA or RNA target 
sequences, resulting in target cleavage and neutralization of the invading threat 
(Carter and Wiedenheft, 2015; Charpentier et al., 2015; Makarova et al., 2015; 
Marraffini, 2015; Reeks et al., 2013).
 For many years, the acquisition of new spacers was the least understood 
process in CRISPR-Cas defense, but recent advances have begun to change this 
(Amitai and Sorek, 2016; Fineran and Charpentier, 2012; Heler et al., 2014; Sternberg 
et al., 2016). In the Type I-E system of E. coli, Cas1 and Cas2 form a complex that 
binds, processes and integrates DNA fragments into the CRISPR array to form spacers 
(Arslan et al., 2014; Nunez et al., 2014; Nunez et al., 2015b; Rollie et al., 2015; Wang 
et al., 2015). Apart from priming, spacers can also be acquired in a naïve manner. 
During naïve acquisition the host acquires spacers from an invading DNA element 
that has not been catalogued in the CRISPR array yet. This process is dependent 
on DNA replication of the invading DNA element (Levy et al., 2015) and requires 
only cas1 and cas2 genes (Yosef et al., 2012). In type I CRISPR-Cas systems, primed 
acquisition makes use of pre-existing spacers that partially match an invading DNA 
element. Therefore, primed acquisition of spacers is important to rapidly counter 
invaders that escape immunity by mutating their target site (Cady et al., 2012; 
Datsenko et al., 2012; Fineran et al., 2014; Semenova et al., 2011; Xue et al., 2015). 
Priming allows new spacers from such an ‘escaper’ to be rapidly acquired, leading 
to renewed immunity. Priming is especially advantageous for a host because the 
process quickly generates a population of bacteria with different spacers against the 
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same virus, efficiently driving the virus extinct (van Houte et al., 2016). In addition 
to Cas1-2, all remaining Cas proteins are required for priming, including the crRNA 
effector complex Cascade and the nuclease-helicase Cas3 (Datsenko et al., 2012; 
Richter et al., 2014). Despite knowing the genetic requirements for priming, the 
exact role of these proteins during priming remains unknown. Several models that 
explain parts of the priming process have been proposed. 
 In the Cascade-sliding model, Cascade moves along the DNA until a PAM is 
encountered, which marks the DNA for acquisition of a new spacer (Datsenko et al., 
2012). A second model was proposed in which a Cas1:Cas2-3 complex translocates 
away from the primed protospacer marked by the crRNA-effector complex until a 
new PAM is encountered (Richter et al., 2014). This new site is then used to acquire 
a new spacer from. Recently, supporting evidence for this hypothesis has been 
obtained. Single molecule studies have suggested that Cascade bound to a priming 
protospacer recruits Cas1-2, which in turn recruit a nuclease inactive Cas3 (Redding 
et al., 2015). A complex of Cas1-3 may then translocate along the DNA to select 
new spacers. While these models describe the biochemistry and movement of the 
proteins involved in priming, it has remained unknown how actual DNA fragments 
from an invading element are obtained to drive the priming process. We have 
previously put forward a model in which we propose that DNA breakdown products 
of Cas3 provide the positive feedback needed to fuel the priming process (Swarts 
et al., 2012). Similar models were proposed for priming in I-B and I-F systems (Li et 
al., 2014; Vorontsova et al., 2015). In line with that hypothesis, it has recently been 
suggested that during naïve acquisition spacer precursors are generated during DNA 
repair at double stranded breaks (Levy et al., 2015). These breaks are frequently 
formed at stalled replication forks during DNA replication and are repaired by the 
RecBCD complex. RecBCD unwinds the DNA strands with its helicase activity, while 
degrading the subsequent single stranded stretches using exonuclease activity. 
The resulting DNA oligomers have been proposed to form precursors for Cas1-2 
to produce new spacers. Similar to RecBCD, Cas3 is also a nuclease-helicase that 
degrades dsDNA by unwinding, with the difference that Cas3 has been shown to 
degrade one strand at a time (Gong et al., 2014; Huo et al., 2014; Mulepati and 
Bailey, 2013; Sinkunas et al., 2013; Westra et al., 2012c). This leads to the hypothesis 
that Cas3 also produces substrates for Cas1-2 mediated spacer acquisition during 
priming. 
 Here we have tested that hypothesis and prove that plasmid degradation 
products produced by Cas3 are bound by the Cas1-2 complex, processed into new 
spacers and integrated into the CRISPR array. The cleavage frequency and cleavage 
specificity of Cas3 facilitate the production of functional spacer precursor molecules 
that meet all requirements of new spacers. To achieve this, Cas3 produces fragments 
that are in the range of the length of a spacer (30-100 nt). Furthermore the cleavage 
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specificity of Cas3 leads to an enrichment of PAM sequences in the 3’ end of these 
fragments, which enhances the selection of productive spacer precursors by Cas1-2. 
Our results demonstrate that the DNA degradation fragments produced by Cas3 are 
the direct link between CRISPR interference and adaptation that make the priming 
mechanism so robust.
Results
Previous studies have shown that direct interference in Type I CRISPR-Cas systems 
(i.e. the breakdown of Cascade-flagged invading DNA by Cas3) is relatively sensitive 
to mutations in the PAM and seed sequence of the protospacer (Künne et al., 2014; 
Semenova et al., 2011; Wiedenheft et al., 2011b; Xue et al., 2015). Priming on the 
other hand is an extremely robust process capable of dealing with highly mutated 
targets with up to 13 mutations. Priming is influenced by a complex combination 
of the number of mutations in a target, the position of these mutations, and the 
nucleotide identity of the mutation. Furthermore, the degree of tolerance of 
mutations in a protospacer during interference and priming depends on the spacer 
choice (Xue et al., 2015). 
Timing of plasmid loss and spacer acquisition reveals distinct underlying 
processes
In order to find the molecular explanation for why some mutants with equal 
numbers of mutations show priming while others do not, we performed detailed 
analysis of a selected set of target mutants obtained previously (Fineran et al., 
2014). From the available list we chose the bona fide target (WT) and 30 mutants 
carrying an interference permissive PAM (i.e. 5’-CTT-3’). The mutants had between 
2 and 5 effective mutations (i.e. mutations outside the kinked positions, 6, 12, 18, 
24, 30 (Fineran et al., 2014; Jackson et al., 2014; Mulepati et al., 2014; Zhao et al., 
2014)) (Figure S1). We used E. coli strain KD263 with inducible expression of cas3 
and cascade-cas1-2 genes (Shmakov et al., 2014) to test both direct interference and 
priming in a plasmid loss setup. Plasmid loss curves of individual mutants (Figure 
S2) showed four distinct behaviors that led us to classify these target mutants into 
four groups: mutants capable of only direct interference (D+P-), mutants capable of 
direct interference and priming (D+P+), mutants capable of only priming (D-P+), and 
mutants incapable of both direct interference and priming (D-P-) (Figure 1A, B).
Chapter 5
112
5
0h 1h 2h 3h 4h 5h 24
h
0
50
100
D+P-
D+P+
D-P+
D-P-
Hours post induction
Pl
as
m
id
 re
te
nt
io
n 
[%
]
D+P- D+P+
D-P+ D-P-
Spacer acquisition
0     1     2      3     4     5    24       0    1     2     3      4     5    24
A B
No
 sp
ac
er 1h 2h 3h 4h 5h 24
h
0
1
2
3
4
5
24
No loss
New Spacers after:
St
ar
t o
f p
la
sm
id
 lo
ss
 [h
]
D+P-
D+P+
D-P+
D-P-
M1, M2, M3 
M8
WT, M5
M4, M7, M9
M10, M12
M6
M13, M18, M19, M20
M22, M26, M29, M30
M14, M16
 M17, M21 
M23, M25
M27, M28
M11 M24
M15
WT NT M
1 M2 M3 M4 M5 M6 M7 M8 M9 M1
0
M1
1
M1
2
M1
3
M1
4
M1
5
M1
6
M1
7
M1
8
M1
9
M2
0
M2
1
M2
2
M2
3
M2
4
M2
5
M2
6
M2
7
M2
8
M2
9
M3
0
1/1024
1/512
1/256
1/128
1/64
1/32
1/16
1/8
1/4
1/2
1
2
4
R
el
at
iv
e 
tra
ns
fo
rm
at
io
n 
ef
fic
ie
nc
y 
(fo
ld
 c
ha
ng
e)
D+P-
D+P+
D-P+
D-P-
C
1
32
1
32
3 2 2 2 3 2 3 3 2 3 34 5 2 4
3 3 5 5 5 4 5 3 3 4 3 3 4 5 3
Figure 1: Plasmid loss and transformation assay. Plasmid loss was assessed by plating cells and 
scoring for the GFP signal at various time points after induction of cas genes. Individual assays can 
be seen in Figure S2. The bona fide target is abbreviated as WT. A) Example curves and CRISPR PCR 
of four different types of plasmid behaviors that were observed: Rapid plasmid loss without spacer 
integration (D+P-), delayed plasmid loss and spacer integration (D+P+), strongly delayed plasmid loss 
and spacer integration (D-P+), and no plasmid loss with no spacer integration (D-P-). B) Summary of 
plasmid behavior of all mutants, showing timing of first plasmid loss and time of first observable spacer 
integration. C) The relative transformation efficiency is plotted for all mutant plasmids (fold change 
compared to co-transformed non-target plasmid, log2 scale). Bars are color coded based on plasmid 
behavior classification. Error bars represent the standard error of the mean of triplicate experiments. 
The positions of mutations are indicated schematically for each mutant (Pos1: Bottom, Pos32: Top). 
Open ovals represent mutations on positions 6, 12, 18, 24, 30. Closed ovals represent mutations 
outside of those positions (effective mutations). The amount of effective mutations is indicated above 
or below the schematic. For a more detailed overview of the mutations, see Figure S1.
 As expected, rapid plasmid loss was observed for the bona fide target, but 
also for five mutant targets. These target variants (D+P-) showed plasmid loss within 
2 hours post induction (hpi), reaching complete loss after 3 hpi (Figure 1B bottom left 
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cluster), and did not incorporate new spacers. The D+P+ group of mutants showed 
a slower decrease in plasmid abundance (starting ~3 hpi) and this decrease was 
accompanied by incorporation of new spacers 4 hpi (Figure 1B bottom right cluster). 
The D-P+ group of mutants showed more strongly delayed plasmid loss (>5 hpi), and 
this loss was preceded or directly accompanied by spacer acquisition (Figure 1B top 
right cluster). Therefore, these mutants could not be cleared from the cells by direct 
interference initially, but after primed spacer acquisition the plasmid was rapidly 
lost. No spacer incorporation was observed for D-P- targets and these variants did 
not show any plasmid loss within 48 hpi, similar to a non-target plasmid (Figure 1B 
top left cluster). This group exemplifies that no naïve acquisition had occurred within 
48 h in our experimental setup and that all spacer integration events observed in 
P+ groups were due to priming. To validate that spacer acquisition occurred by 
priming, we sequenced the newly incorporated spacers for a representative set of 
clones, especially including mutants with late acquisition. We did indeed observe 
the 9:1 strand bias of new spacers that is typical for priming (Datsenko et al., 2012; 
Savitskaya et al., 2013; Swarts et al., 2012). Taken together, we found that priming is 
facilitated by slow or delayed direct interference (D+P+), but that it does not strictly 
require direct interference as exemplified by the D-P+ group.
Moderate direct interference activity facilitates the priming process
To verify that rapid plasmid loss indeed results from direct interference, we 
performed plasmid transformation assays of the target plasmid set into E. coli 
KD263 and compared the transformation efficiency to a co-transformed control 
plasmid (Almendros and Mojica, 2015). While the bona fide target plasmid exhibited 
a relative transformation efficiency that was 512x lower than the control plasmid 
(1/512), also mutants with up to two effective mutations gave rise to strongly 
decreased transformation efficiencies (1/16 to 1/512) (Figure 1C). This means that 
these target variants still triggered an efficient direct interference response. Triple 
mutants showed a range of relative transformation efficiencies from full direct 
interference (i.e. 1/512) to no direct interference (~1), suggesting a dominant role 
for the position of the mutations in the protospacer. Mutants with 4 or 5 effective 
mutations transformed as efficient as the reference plasmid and displayed no 
direct interference. When we mapped the classification of all the mutants onto 
the relative transformation efficiency data, the same trend was observed that 
target variants with the highest direct interference showed no priming. Instead, 
intermediate levels of direct interference lead to rapid spacer acquisition, while low 
levels or the absence of direct interference lead to delayed spacer acquisition. This 
also confirms that late plasmid loss in the D-P+ group is indeed not caused by direct 
interference with the original spacer, but by primed spacer acquisition followed by 
direct interference.
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Pairing at the middle position of each segment is important for direct 
interference
The average number of effective mutations in a protospacer increases gradually 
over the groups D+P-, D+P+, D-P+, and D-P- (Figure S1). While D+P- and D+P+ had either 
2 or 3 effective mutations, the D-P+ mutants had 3 or 4 mutations and the D-P- 
mutants carried 3 or 5 effective mutations in the protospacer. In order to quantify 
how significant the shifts in the average number of mutations are, we used empirical 
bootstrapping to test against the hypothesis that the classification does not depend 
on the number of mutations. Our analysis showed that the D+P- and D+P+ groups 
have significantly fewer mutations than would be expected if the classification 
did not correlate with the number of mutations (>95% and >68% confidence 
respectively), while D-P- has significantly more mutations (>95% confidence) (Figure 
S3A).  We next looked in detail at the number of mutations in each segment, and 
the position of mutations in each five-nucleotide segment. As has been observed for 
the seed sequence (Semenova et al., 2011; Wiedenheft et al., 2011b), this showed a 
significantly lower than average number of mutations in segment 1 for D+P- and D+P+ 
groups (both 95% confidence, Figure S3B). Surprisingly, the analysis also revealed 
that groups showing direct interference (D+P-, D+P+) had no mutations at the third 
position of each segment (significantly lower than expected, 95% confidence), 
whereas D-P+ and D-P- groups were enriched for mutations at this position (>68% 
and >95% confidence respectively, Figure S3C). This observation therefore suggests 
that pairing of the middle nucleotide of the segment is somehow important for 
direct interference. The third nucleotide of each segment could represent a tipping 
point in the directional pairing of the crRNA to the DNA. This may occur during 
canonical, PAM-dependent target DNA binding, which leads to R-loop locking, 
efficient Cas3 recruitment and target DNA degradation (Blosser et al., 2015; Huo et 
al., 2014; Rutkauskas et al., 2015).
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Figure 2: EMSA and Cas3 activity assay. A) Electrophoretic mobility shift assay (EMSA) of the mutant 
plasmid set. The affinity ratio (Amplitude/Kd) is plotted for each mutant (see Table S3 for more 
details). Mutants are separated by the previously made plasmid behavior classification. The mean and 
standard deviation for each group are indicated. The bona fide target is abbreviated as WT. B) Cas3 
DNA degradation activity assay of mutant plasmid set. The initial Cas3 DNA cleavage rate [%/min] is 
plotted for each mutant. Mutants are classified according to previously identified plasmid behavior. 
The mean and standard deviation for each group are indicated. Individual gels for all activity assays 
can be found in Figure S4.
Cascade-plasmid binding is required for interference and priming
To determine the biochemical basis of priming, we first asked what determines if a 
mutant target can prime or not, and we hypothesized that the affinity of Cascade for 
a target plasmid would determine its fate. To test this, we performed plasmid based 
mobility shift assays with purified Cascade complexes (Künne et al., 2015). While the 
bona fide target and most of the mutant targets were bound to completion at increasing 
Cascade concentrations, some mutant target plasmids were only partially bound (Table 
S3), as has been observed before (Hochstrasser et al., 2014). By calculating an affinity 
ratio (Amplitude/Kd) and using it as an index for the binding strength, we were able to 
directly compare the binding properties of all target mutants (Figure 2A). The results 
show that the bona fide target plasmid had the highest affinity ratio (0.31 nM-1), while 
the mutants cover a range of ratios ranging from very weak binding (>0.008 nM-1) to 
almost the same levels as the bona fide target (<0.1 nM-1). D-P- mutants all cluster 
together with low ratios (<0.02 nM-1), and 5 out of 8 show no measurable Cascade 
binding. This suggests that a minimal level of target plasmid binding by Cascade is 
required for both direct interference and priming. However, the affinity ratio alone 
does not predict direct interference and/or priming behavior of a target plasmid.
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Cas3 DNA cleavage activity determines plasmid fate
Next, we analyzed if the catalytic rate of target DNA degradation by Cas3 would be 
related to direct interference and priming. Target DNA degradation is required for 
direct interference and might be required for priming as well, since all cas genes 
are required for priming in E. coli (Datsenko et al., 2012). To test this, we performed 
Cas3 activity assays with the same panel of target plasmids (Figure 2B, Figure S4). 
This showed that there is a strong dependence between plasmid fate and Cas3 
activity. Mutants capable of only direct interference (D+P-) display 5 to 10 times 
higher activity than priming mutant classes (D+P+, D-P+), while stable mutants (D-P-) 
show the lowest Cas3 activity. Furthermore, D+P+ mutants show a higher average 
activity than D-P+ mutants, although there is overlap between the two groups. The 
difference between the Cascade affinity and the Cas3 activity plots shows that Cas3 
activity is not a simple reflection of Cascade affinity, but is likely influenced by other 
factors such as conformational differences or the dynamics of Cascade binding. 
Taken together, there is a link between the Cas3 activity on a target, and target 
plasmid fate. Direct interference requires the highest Cas3 activity, while priming 
requires a level of target degradation and occurs at a broad range of intermediate 
or low Cas3 activities. Finally, it is striking that higher Cas3 activities seem to result 
in faster priming (D+P+ vs D-P+), while very high Cas3 activities (D+P-) do not lead to 
priming. 
Cas3 produces degradation fragments of near-spacer length
After establishing a connection between plasmid degradation (direct interference) 
and primed spacer acquisition, we sought to analyze whether the degradation 
fragments created by Cas3 could serve as spacer precursors. To this end, we 
performed Cascade-mediated plasmid degradation assays with Cas3 and plasmids 
containing the bona fide target or M4 target. Agarose gel electrophoresis showed 
that both target plasmids were degraded into similar sized products smaller than 
300 nt. Further biochemical analysis of the products revealed that the products 
were of double stranded nature and contained phosphates at their 5’ end (Figure 
S5A, B). Based on the unidirectional unwinding and single stranded DNA cleavage 
mechanism of Cas3 (Gong et al., 2014; Huo et al., 2014; Mulepati and Bailey, 2013; 
Sinkunas et al., 2013; Westra et al., 2012c), we had expected to find single stranded 
DNA. However, it appeared that complementary fragments had re-annealed to form 
duplexes, most likely generating annealed products with both 3’ and 5’ overhangs. 
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Figure 3: Next generation sequencing analysis of Cas3 DNA degradation products. A) Left: Schematic 
of R-loop formed by binding of Cascade to dsDNA target. Right: Schematic showing the four distinct 
Cas3 cleavage sites in dsDNA target. B) Length distribution of Cas3 DNA degradation fragments of M4 
target. C) Heat map of nucleotide frequencies around cleavage sites. The cleavage site is between 
position -1 and 1. Positions indicated in black are on the fragments, positions indicated in grey are 
outside of fragments. D) Heat map of dinucleotide frequencies around cleavage sites. Abundance of 
dinucleotides was measured in a shifting frame within 4 nucleotides around the cleavage sites.
 In order to determine the exact cleavage patterns of target plasmids by Cas3, 
we isolated DNA cleavage products from gel and sequenced them using the Illumina 
MiSeq platform. Analysis of the length of the DNA degradation products from the 
bona fide and M4 target revealed that the majority of fragments from the target 
strand had a size of around 30-70 nt (Figure 3B, Figure S6A). The non-target strand 
displayed a shifted distribution with most fragments being 60-100 nt long. Instead 
of cleaving the target DNA randomly, Cas3 produces fragments with a distinct length 
profile. Furthermore, the length of the main fraction, especially in the target strand, 
is close to the length of a spacer molecule (i.e. 32/33 nucleotides), supporting the 
idea that these fragments might be used as spacer precursor molecules.
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Cas3 cleavage is sequence specific for thymine stretches
In order to see if Cas3 cleaves the target DNA in a sequence specific manner, we 
analyzed the region encompassing the cleavage site. This revealed a preference for 
Cas3 to cleave in thymine-rich sequences for both the bona fide and the M4 target, 
preferably cleaving 3’ of a T nucleotide (Figure 3C,D and Figure S6B). The same 
pattern was also observed for single stranded m13mp8 DNA cleaved in the absence 
of Cascade, indicating that T-dependent cleavage specificity is an inherent feature 
of the HD domain of Cas3. The cleavage specificity of Cas3 leaves one or multiple T 
nucleotides on the 3’ ends of DNA degradation products. This enriches the 3’ ends of 
the fragments for NTT sequences, including the PAM sequence CTT. A considerable 
proportion of degradation fragments therefore satisfies the requirement of Cas1-2 
for having CTT sequences in the 3’ ends of spacer precursors in order for these to be 
correctly integrated into the CRISPR array (Shipman et al., 2016; Wang et al., 2015). 
Interestingly, C/T-associated cleavage has previously been shown for Streptococcus 
thermophilus Cas3 cleaving oligo nucleotides (Sinkunas et al., 2013), suggesting 
that this cleavage specificity may be common for HD-domains of Cas3 proteins.
Cas1-2 integrate Cas3-derived degradation fragments
To find out if Cas3 degradation products can indeed serve as spacer precursors, 
we reconstituted spacer integration in vitro using purified Cas proteins. Two types 
of spacer integration assays were performed (Figure 4A): the first assay used all 
Cas proteins simultaneously (Cascade, Cas3, Cas1-2) to degrade a target plasmid 
and integrate the resulting fragments into a plasmid carrying a leader and single 
CRISPR repeat (pCRISPR). The second assay used DNA degradation products from 
a separate Cascade-Cas3 reaction. These products were incubated with Cas1-2 and 
pCRISPR, as described (Nunez et al., 2015b). We noticed a pronounced Cas1-2-
dependent shift of the degradation fragments in the gel, suggesting the fragments 
are bound by Cas1-2 (Figure 4B, left panel). Interestingly, when Cas1-2 was present 
in the reaction we observed twice as much nicking of plasmid pCRISPR, suggesting 
half site integration of DNA fragments into pCRISPR had occurred (Figure 4B, right 
panel) (Nunez et al., 2015b). The same pCRISPR nicking activity was observed using 
purified Cas3 degradation products (integration assay 2) indicating the integration 
reaction was not dependent on Cascade or Cas3.
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Figure 4: In vitro spacer acquisition assays. A) Illustration of the three types of assays performed. 
In the oligo assay, pCRISPR is incubated with Cas1-2 and a spacer oligo (BG7415/6), leading to half 
site integration. In assay 1, pTarget and pCRISPR are incubated with Cascade, Cas3 and Cas1-2 for 
simultaneous degradation of pTarget and half site integration into pCRISPR. In assay 2, pTarget is 
incubated with Cascade and Cas3 and the resulting DNA degradation products are then separately 
incubated with pCRISPR and Cas1-2. B) Gel electrophoresis of integration assay 1. The bona fide target 
is abbreviated as WT. Left gel, untreated; right gel, Proteinase K treated. Cas1-2 presence causes 
upwards shift of DNA. Original plasmids are supercoiled (SC), half site integration causes nicking of 
pCRISPR, resulting in the open circular conformation (OC).
Chapter 5
120
5
 
B
Substrate       Integration assay 2            
Integration site         1                2 
Integr strand  NT   T   NT     T 
Integration
products
     Oligo assay           
     1           2 
NT T     NT     T 
Primer dimer
Primers
2000
1500
1000
700
500
400
300
200
75
La
dd
er
(n
t)
Half site integration PCR
Leader
5’
3’ 5’
3’
Repeat
A
T
NT5’ AAG
3’ TTC
3’
5’
PAM-Protospacer
5’
3’ 5’
3’
5’
5’
5’
3’ 5’
3’
5’
5’
5’
3’ 5’
3’
5’
5’
5’
3’ 5’
3’
5’
5’
Site 1 integration
Site 2 integration
Target strand 
integration
Non-Target 
strand integration
pCRISPR
pTarget
Figure 5: Half site integration PCR. A) Illustration of the half site integration PCR. Primer sets are chosen 
to show integration into site 1 (leader-proximal repeat end) and site 2 (leader distal repeat end), 
and to see both possible orientations of the integrated spacer. Primer sequences were chosen based 
on frequently incorporated spacers (hotspots) in vivo (Fineran et al., 2014). B) Gel electrophoresis 
of half site integration PCR based on integration assay 2 (left) and oligo assay (right). PCR products 
representing integrations are indicated with an arrow. PCR products were specific to reactions 
containing all components. Lower running PCR products are primer dimers (verified by sequencing). 
 To verify that spacer half-site integration had taken place and not just 
pCRISPR nicking, we gel-isolated the nicked pCRISPR band for PCR analysis. Since we 
did not know the sequence of the integrated fragments, we selected three primer 
pairs that would amplify frequently incorporated spacers from the plasmid in vivo 
(Fineran et al., 2014). Two of the three tested primers gave a PCR product of the 
expected size and we chose one of the primers for more detailed analysis. It has 
previously been shown that the first half-site integration may occur at the boundary 
of the leader and repeat in the sense strand (i.e. site 1), or at the penultimate base 
of the repeat in the antisense strand (i.e. site 2) (Nunez et al., 2015b; Rollie et al., 
2015). Furthermore, fragments can be integrated in two different orientations. We 
performed PCR amplification reactions to test for all four different situations (Figure 
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5A). This showed that integration of Cas3-derived degradation products occurs 
sequence specifically at both site 1 and site 2, and in both orientations (Figure 5B). 
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Figure 6: Sequencing analysis of spacer integration. A) Frequencies of exact integration locations 
for integration at site 1 (grey bars) and site 2 (black bars) as determined by sequencing. X-axis gives 
the backbone nucleotide to which the spacer is coupled. Frequencies of coupled spacer nucleotides 
are indicated for the 2 canonical insertion locations. B) Top: Schematic of integrated fragment and 
method of length determination. Bottom: Length of the integration amplicon for site 1 and site 2. 
Integration of fragments in the repeat is nucleotide and position specific
In order to obtain more insight into the accuracy of integration, we sequenced 48 
clones for each of the four primer sets. The results confirm that fragments from 
the target and non-target strands are integrated at both site 1 and site 2 of the 
repeat. Integration is very specific to the correct positions in the repeat. At site 1, 
94% of the integrated fragments were coupled correctly to the first nucleotide of 
the sense strand of the repeat, while at site 2, 73% of integrated fragments were 
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coupled correctly to the penultimate nucleotide of the antisense strand of the 
repeat, replacing the last nucleotide of the repeat in the process (Figure 6A). In line 
with previous findings (Nunez et al., 2015b; Rollie et al., 2015), both integration 
sites show a preference for coupling incoming C nucleotides; 49% and 55% for 
site 1 and site 2 respectively (Figure 6A). Considering that Cas3 DNA degradation 
fragments have T nucleotides on their 3’ ends, this suggests that precursors have 
been pre-processed by Cas1-2 before integration, as has been demonstrated for 
artificial substrates (Wang et al., 2015). The majority of the integration amplicons 
had a length of only 20 to 40 nucleotides (Figure 6B), indicating that the integration 
reaction prefers short to long substrates. Altogether, we show that the integration of 
PAM-containing spacers in the repeat during priming is enhanced by the combined 
sequence specificities of two Cas enzymes: (1) Cas3 which leaves thymines in the 
3’-end of DNA fragments, enriching the fragment ends for CTT, and (2) Cas1-2 which 
prefer CTT carrying substrates and process and couple the 3’ cytosine specifically to 
both integration sites of the repeat.
Discussion
A remaining gap in our understanding of Type I CRISPR-Cas mechanisms is how 
new spacers are selected and processed before being incorporated into the 
CRISPR array. In this work we demonstrate that Cas3 produces spacer precursors 
for primed adaptation of the CRISPR array. These spacer precursors are 30-100 
nt long partially double stranded DNA molecules formed by fragmentation of the 
target DNA. Cas3 DNA degradation fragments fulfill all criteria for spacer precursors 
that can be deduced from recent studies of the Cas1-2 complex (Figure 7). Ideal 
spacer precursors in E. coli are partially double stranded duplexes of at least 35 
nucleotides containing splayed single stranded 3’ ends with a CTT PAM sequence 
on one of the 3’ overhangs (Nunez et al., 2015a; Rollie et al., 2015; Shipman et al., 
2016; Wang et al., 2015). We have shown that Cas3 DNA degradation products are 
mainly double stranded in vitro. This is most likely due to re-annealing of the single 
stranded products that are produced by the nuclease-helicase activity of Cas3. It 
is possible that in vivo other proteins are involved in the formation of duplexes 
after degradation. In fact, it has been shown that Cas1 from Sulfolobus solfataricus 
can facilitate the annealing of oligonucleotides (Han and Krauss, 2009). These re-
annealed duplexes likely contain a mix of 3’ and 5’ overhangs, because the two 
DNA strands of the target are degraded independently. This also results in slightly 
shorter fragments for the target strand. Despite these differences in fragment size, 
both strands are cleaved by Cas3 with the same specificity, enriching the 3’ ends 
of the fragments for stretches of thymines. Contrary to the CTT requirements for 
spacer integration, it is known that Cascade tolerates five different PAM sequences 
(i.e. CTT, CTA, CCT, CTC, CAT) for direct interference (Fineran et al., 2014; Leenay et 
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al., 2016). However, the vast majority of new spacers (97%) resulting from primed 
acquisition carry CTT PAM sequences (Shmakov et al., 2014). This further supports 
the idea that spacer precursors with CTT-ends are selected non-randomly by the 
Cas1-2 complex from pools of Cas3 breakdown fragments and further trimmed to 
a 3’ C (Wang et al., 2015). These are then coupled to the repeat by nucleophilic 
attack of the 3’-OH (Nunez et al., 2014; Rollie et al., 2015). The T-dependent target 
DNA cleavage specificity of Cas3 further enhances the production of precursors 
that fit the requirements of new spacers by creating a pool of DNA fragments with 
the correct size and correct 3’ ends. The interference phase of CRISPR immunity is 
therefore effectively coupled to the adaptation phase, providing positive feedback 
about the presence of an invader. 
 It was previously reported that a dinucleotide motif (AA) at the 3’ end of 
a spacer increases the efficiency of naïve spacer acquisition (Yosef et al., 2013). 
We did not observe this motif at the expected distance from the end in the Cas3 
DNA degradation fragments, suggesting that Cas3 does not take the AA motif into 
account when generating spacer precursors. 
 We found that the integration reaction is very precise for the two correct 
integration sites in the repeat (site 1 and site 2), and we observed that the 
integrated fragments most often were the result of a 3’ cytosine coupling reaction. 
In vivo, however, only the integration of a CTT-containing fragment at site 2 would 
lead to a functional spacer targeting a protospacer with PAM (Figure 7), while half 
site integrations initiating at site 1 would result in ‘flipped’ spacers (Shmakov et 
al., 2014). Using a selective PCR strategy, we detected primed spacer acquisition 
events at both integration sites, and we identified that DNA fragments from both 
the target and non-target strand of the plasmid could be used for integration. In 
Type I-E CRISPR-Cas systems, primed spacer acquisitions display a typical 9:1 strand 
bias for the acquisition of spacers targeting the same strand of DNA as the spacer 
causing priming (Datsenko et al., 2012; Swarts et al., 2012). This suggests that in 
vivo, other factors might be involved in further increasing the accuracy of functional 
spacer integration. This includes the formation of supercomplexes between various 
Cas proteins (i.e. Cascade, Cas3, Cas1-2) (Plagens et al., 2012; Redding et al., 2015; 
Richter et al., 2014), and the involvement of non-Cas host proteins such as PriA, 
RecG and IHF (Ivancic-Bace et al., 2015; Nunez et al., 2016). IHF ensures that the 
first integration event takes place at the leader-proximal end of the repeat (site 1) 
and would be involved in ensuring that the PAM cytosine gets integrated at the 
leader-distal end (site 2). Supercomplex formation during precursor generation 
may lead to the selection of fragments from the target strand containing a CTT 
PAM at the 3’ end. Although the length of the observed integration amplicons is 
centered around 20-40 nt, we also find amplicons of up to 100 nt. In vivo, E. coli 
integrates fragments of 33 nt length. We speculate that trimming of the precursor 
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to 33 nt length occurs after half-site integration and before formation of the stable 
integration intermediate (Figure 7). Despite the mechanisms that lower erroneous 
integration of new spacers, it is likely that natural selection of functional spacers in 
vivo also plays a role in the spacers that end up being part of the first population of 
bacteria following a priming event. 
 It was surprising that that the bona fide target and several D+P- mutants did 
not show priming despite providing Cas3 degradation products. Furthermore, the 
degradation fragments of the bona fide target were very similar to the fragments of 
the M4 target (D+P+), which cannot explain the difference in priming behavior.  We 
propose that these targets are degraded and cured from the cell too rapidly, giving 
the acquisition machinery insufficient time to generate new spacers. However, a 
low level of spacer integration might be taking place at undetectable levels even for 
the bona fide target, as has been observed previously (Swarts et al., 2012; Xue et 
al., 2015). In this case, cells with additional spacers do not have a selective growth 
advantage over cells without new spacers as the plasmid is already effectively 
cleared from cells without new spacers. Mutant targets with intermediate levels of 
direct interference however, are replicated and subject to interference over a longer 
time period, thereby providing more precursors, more time for spacer acquisition 
to occur, and therefore a greater selective growth advantage. Low levels of direct 
interference lead to a slow priming response due to the scarcity of spacer precursor 
molecules. While this paper was under review, another study showed that perfectly 
matching protospacers with canonical PAMs can indeed stimulate priming and that 
plasmid targeting is the stimulating factor (Semenova et al., 2016). In line with our 
findings, the authors further propose that priming is usually not observed with fully 
matching protospacers because these targets are degraded too rapidly.
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Cut-paste spacer acquisition
We have shown that priming reuses target DNA breakdown products as precursors 
for new spacers, providing support for a cut and paste mechanism of spacer 
selection (Wang et al., 2015). Compatible models have recently been proposed for 
naïve spacer acquisition (Levy et al., 2015). It was shown that CRISPR adaptation is 
linked to double stranded DNA breaks that form at stalled DNA replication forks. 
Invading genetic elements often go through a phase of active DNA replication when 
they enter a host cell, and a replication dependent mechanism therefore helps the 
host to primarily select spacers from the invading element. The RecBCD complex 
is key in this process as it repairs double stranded breaks by first chewing back the 
ends of the DNA creating fragments of tens to thousands of nucleotides (Amitai and 
Sorek, 2016). These fragments are thought to reanneal and serve as precursors for 
new spacers. Other studies have shown the direct involvement of crRNA-effector 
complexes in spacer selection. In the Type I-F CRISPR-Cas system of Pseudomonas 
aeruginosa the Csy complex is required for naïve spacer acquisition (Vorontsova et 
al., 2015). Also Cas9 in Type II systems has a direct role in spacer acquisition (Heler 
et al., 2015; Wei et al., 2015b). Both systems incorporate spacers very specifically 
from canonical PAM sites, suggesting that the Csy complex and Cas9 are directly 
involved in PAM recognition during spacer sampling.
Mutations in the protospacer
In this study we have focused on the effect of mutations in the protospacer on direct 
interference and priming, while maintaining the dominant interference permissive 
PAM CTT. Apart from underscoring the importance of the number of mutations 
and existence of a seed sequence (Semenova et al., 2011; Künne et al., 2014; 
Wiedenheft et al., 2011b; Xue et al., 2015), we uncover that for direct interference 
pairing of the middle nucleotide in each 5-nucleotide segment of the protospacer 
is disproportionately important, and may represent a tipping point in the binding 
of a target. None of the 30 mutants showing direct interference carried mutations 
at these middle positions. Also in a previously obtained list of approximately 3,300 
triple mutants showing direct interference (Fineran et al., 2014), mutations at 
this position were underrepresented (Figure S3D). This suggests that pairing at 
the middle position of each segment may be important for continuation of the 
directional zipping process. This process starts at the PAM and leads to the formation 
of a canonical locked R-loop, which is required for Cas3 recruitment and target DNA 
degradation (Blosser et al., 2015; Redding et al., 2015; Rutkauskas et al., 2015; 
Sashital et al., 2012; Semenova et al., 2011; Szczelkun et al., 2014). We stress that 
we have used variants with CTT PAMs only, which can be engaged by Cascade in the 
canonical PAM-dependent binding mode (Blosser et al., 2015; Hayes et al., 2016; 
Redding et al., 2015; Rutkauskas et al., 2015; Sashital et al., 2012; Semenova et al., 
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2011), and can also trigger priming. It has become clear, however, that targets with 
mutations in the PAM display a broad spectrum of distinct characteristics depending 
on the chosen PAM, including a range of efficiencies of direct interference (Westra 
et al., 2013) and the reluctance to trigger efficient Cas3 target DNA degradation 
(Blosser et al., 2015; Hochstrasser et al., 2014; Mulepati and Bailey, 2013; Redding 
et al., 2015; Rutkauskas et al., 2015; Xue et al., 2015). In many cases these PAMs still 
support the priming process (Datsenko et al., 2012; Fineran et al., 2014; Xue et al., 
2015). Targets with highly disfavored PAMs (Hayes et al., 2016) are likely engaged in 
the non-canonical PAM-independent binding mode (Blosser et al., 2015) and may 
require recruitment and translocation events of Cas1-2 and Cas3 proteins to initiate 
the target degradation needed to acquire new spacers. 
Conclusion
The findings presented here, showcase the intricate PAM-interplay of all Cas 
proteins in type I systems to update the CRISPR memory when receiving positive 
feedback about the presence of an invader. The robustness of priming is achieved 
by three components that co-evolved to work with PAM sequences: Cas3 producing 
spacer precursors enriched for correct PAM ends, Cas1-2 selecting PAM-compliant 
spacer precursors and Cascade efficiently recognizing targets with PAMs. This 
process stimulates the buildup of multiple spacers against an invader, preventing 
the formation of escape mutants (Datsenko et al., 2012; Richter et al., 2014; Swarts 
et al., 2012). When the original spacer triggers sufficiently strong interference, 
priming acquisition does not frequently occur. This prevents the unnecessary 
buildup of spacers and keeps the CRISPR array from getting too long. Any subsequent 
reduction in effectivity of the immune response by further mutations of the invader 
will in turn allow priming acquisition, restoring immunity.
Materials and Methods
Bacterial Strains and Growth Conditions. Escherichia coli strain KD263 was obtained 
from (Shmakov et al., 2014). E. coli strains were grown at 37 °C in Luria Broth (LB; 5 
g/L NaCl, 5 g/L yeast extract, and 10 g/L tryptone) at 180 rpm or on LB-agar plates 
containing 1.5% (wt/vol) agar. When required, medium was supplemented with 
the following: ampicillin (Amp; 100 μg/mL), chloramphenicol (Cm; 34 μg/mL), or 
kanamycin (Km; 50 μg/mL). Bacterial growth was measured at 600 nm (OD600).
Molecular Biology and DNA Sequencing. All oligonucleotides are listed in Table S1. 
All plasmids are listed in Table S2. All strains and plasmids were confirmed by PCR 
and sequencing (GATC-Biotech). Plasmids were prepared using GeneJET Plasmid 
Miniprep Kits (Thermo Scientific). DNA from PCR and agarose gels was purified 
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using the DNA Clean and Concentrator and Gel DNA Recovery Kit (Zymo Research). 
The library of pGFPuv sp8 mutants was available from a previous study (Fineran 
et al., 2014). pMAT MBP-Cas3 was a kind gift from Scott Bailey lab (Mulepati and 
Bailey, 2013).
Transformation assay. Transformation assays were carried out in E. coli KD263. 
Cells were grown to OD600 ~0.4, induced with 0.2% L-arabinose and 0.5 mM IPTG 
and allowed to grow for 1h. Cells were then made chemically competent for heat 
shock transformation using the RuCl2 method. Cells were co-transformed with 10 ng 
target plasmid (pWUR836-868, KanR) and 10 ng control plasmid (pWUR835, AmpR) 
simultaneously (Almendros and Mojica, 2015). Dilutions of transformants were 
then plated on LBA plates with Amp and LBA plates with Kan. The transformation 
efficiency of mutated target plasmids was normalized against the transformation 
efficiency of the control plasmid. 
Plasmid loss assay. E. coli KD263 cells were transformed with the target plasmids 
(pWUR836-868) by heat shock. Individual colonies were picked in triplicate and 
grown overnight in 5 ml LB supplemented with 2% glucose to repress cas gene 
expression. The next day, cultures were transferred 1:100 into induced medium 
(0.2% L-Arabinose, 0.5 mM IPTG) and plasmid loss was monitored. Samples were 
taken every hour until 5h, and then again at 24h and 48h. Dilutions were plated on 
non-selective plates and plasmid loss was counted based on loss of fluorescence 
using a Syngene G-box imager. Plasmid-free colonies were screened for spacer 
integration by colony PCR using DreamTaq Green DNA polymerase (Thermo 
Scientific). Acquisition of spacers was detected by PCR using primers BG5301 and 
BG5302. PCR products were visualized on 2% agarose gels and stained with SYBR-
safe (Invitrogen). PCR products were sequenced using Sanger sequencing at GATC 
(Konstantz, Germany) using primer BG5301.
EMSA assays. Purified Cascade complex with spacer8 crRNA was incubated with 
plasmid at a range of molar ratios (1:1-100:1, Cascade:DNA) in buffer A (20 mM 
HEPES pH7.5, 75 mM NaCl, 1 mM DTT) for 30 min. Reactions were run on 1% native 
agarose gels for 18h at 22 mA in 8 mM sodium-borate buffer. Gels were post stained 
with SYBR Safe (Invitrogen). Shifted (Cascade bound DNA) and unshifted (free DNA) 
bands were quantified using the GeneTools software (Syngene) and total Cascade 
concentration (X) was plotted against the fraction of bound DNA (Y). The curves 
were fitted with the following formula: Y = (amplitude * X)/(Kd + X) (van Erp et al., 
2015). The amplitude is the maximum fraction of bound DNA. Since the amplitude 
is not always 1, we cannot directly compare Kd values, instead the ‘affinity ratio’ was 
calculated as: amplitude/Kd (i.e. normalizing the Kd against the variable amplitude).
Cas3 DNA degradation assays. Cas3 DNA degradation activity was routinely tested 
by incubating 500 nM Cas3 with 4 nM M13mp8 single stranded circular DNA in 
Cas3-derived target DNA degradation fragments fuel primed CRISPR adaptation
129
5
buffer R (5 mM HEPES, pH8, 60 mM KCl) supplemented with 100 µM Ni2+ at 37 °C 
for 1 h. Plasmid-based assays were performed by incubating 70 nM Cas3 with 70 
nM Cascade, 3.5 nM plasmid DNA in buffer R (+ 10 µM CoCl2, 10 mM MgCl2, 2 mM 
ATP) at 37 °C for 10-60 minutes unless indicated otherwise. For quantifying Cas3 
activity, assays were run at normal conditions and samples were taken at 0 min, 1 
min, 10 min and 30 min. Samples were immediately quenched with 6x DNA loading 
dye (Thermo scientific) on ice. Samples were run on agarose gels and supercoiled 
plasmid bands were quantified using the GeneTools software (Syngene). The DNA 
degradation was plotted (X: time [min]; Y: Intact Plasmid [%]) and the initial activity 
of Cas3 [%/min] calculated from the initial slope of the curve.
Protein purification. All proteins were expressed in Bl21-AI cells. Cascade was 
purified as described earlier (Jore et al., 2011a). MBP-Cas3 was purified as 
described in (Mulepati and Bailey, 2013). The Cas1-2 complex was purified as 
follows. The Cas1-2 operon was PCR amplified with primers BG4556/7 and cloned 
into pET52b (SmaI/SacI) to make pWUR871. The Cas1-2 complex was purified using 
the N-terminal StrepII tag on Cas1. Briefly, cells were grown to an OD
600
 of 0.4, 
cooled on ice for 30 minutes and induced with 0.5 mM IPTG and 0.2% l-arabinose. 
Protein was expressed at 20 °C overnight. Cells were collected by centrifugation and 
lysed in buffer L (20mM HEPES pH 7.5, 75mM NaCl, 1mM DTT, 5% glycerol, 0.1% 
Triton X100) using a Stansted pressure cell homogenizer. The lysate was cleared 
by centrifugation and filtration. The cleared lysate was incubated with Strep-tactin 
beads (IBA) for 30 minutes at 4 °C and loaded into a gravity column. The column was 
washed with buffer A (20mM HEPES pH 7.5, 300mM NaCl, 1mM DTT, 5% glycerol) 
and the proteins eluted in buffer B (20mM HEPES pH 7.5, 75mM NaCl, 1mM DTT, 
5% glycerol, 2.5 mM biotin). The presence and purity of the Cas1-2 complex was 
checked via Tris-tricing SDS PAGE (10-20%). The final complex was snap frozen in 
liquid nitrogen and stored at -80 °C.
Degradation product analysis. To test if Cas3 produces single- or double-stranded 
DNA products, the reaction products of the plasmid based assay were incubated 
with dsDNase (Thermo Scientific) according to manufacturer’s protocol. dsDNase 
exclusively degrades double-stranded DNA. Products were run on a 5% denaturing 
PAGE gel and visualized using Sybr-Gold (Thermo Scientific). To determine the 
phosphorylation state of the degradation products, the products were 32P labelled 
with T4 PNK (Thermo) using the forward and exchange reaction according to the 
manufacturer’s protocol. Labelled DNA was run on an 8% PAGE gel and visualized 
using a phosphor imaging screen (GE healthcare) and a Personal molecular imager 
(Bio-Rad).
Statistical testing against the null hypothesis. We used a version of the empirical 
bootstrap method (Dekking, 2005) to test our data against the null hypothesis that 
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observed behaviors (D±P±) do not correlate with a particular sequence property. 
To establish the confidence with which the null hypothesis can be disregarded, we 
construct randomized mock behavioral groups by repeatedly (105 times, resulting 
in an accuracy in the significance intervals of about 1/√(105) ≈ 0.3% ) drawing a 
random selection (allowing repetitions) of sequences from the complete set of 31 
protospacers (including the bona fide spacer). The average property of interest 
is then calculated for the generated mock behavioral groups, giving histograms 
showing the distribution over the mock sets. The above procedure is performed 
for the total number of effective mismatches, and the number of mutations 
within segment 1, and the number of mutations on position 3 within all segments 
combined.
In vitro acquisition assay. Two types of assays were performed. 1) Cas3 plasmid 
DNA degradation assays were carried out as described above, the reaction products 
were incubated with Cas1-2 and pWUR869 in buffer R for 60 min. 2) Target 
plasmid, Cascade, Cas3, Cas1-2 and pWUR869 were incubated in buffer R for 60 
min. Component concentrations for assay 1 and 2 were as follows: 70 nM Cascade, 
70 nM Cas3, 300 nM Cas1-2, 3.5 nM target plasmid, 5 nM pWUR869 (pCRISPR). 
Reaction products of both assays were run on a 1.8% TAE-agarose gel. To verify half-
site integration of spacers in the CRISPR array as described in (Nunez et al., 2015b), 
nicked pWUR869 was isolated from gel and analyzed by PCR. PCR was performed 
with forward primer BG5301 (site2) or BG7522 (site1) and reverse primers 
BG7415/6 (control) or BG6713-15 (3 hotspots) or BG7215/6 (fw/rv of hotspot3). 
These primers match spacers that are frequently incorporated in vivo (Fineran et al., 
2014). To verify and analyze integration, PCR products were cloned into a pGEMT-
easy vector (Promega) and individual clones were sequenced.
NGS library construction. Plasmid degradation assays were performed as 
previously described. Three different targets were chosen: bona fide target plasmid 
(pWUR836) or M4 target plasmid (pWUR853) with 0.13 mM ATP and the m13mp8 
assay as described above. Degradation fragments were processed for Illumina 
MiSeq sequencing as follows. Degradation products were gel purified using the 
Zymoclean Gel DNA Recovery Kit (Zymo Research), cutting out DNA up to ~500bp. 
DNA was then poly-A tailed with TdT (Invitrogen) according to manufacturer’s 
protocol (approximately 100 nt tails). Tailed DNA was purified using the DNA Clean 
and Concentrator Kit (Zymo Research). Subsequently, tailed products were 5’ 
phosphorylated with T4-PNK (Thermo Scientific). Next, the DNA was heated to 95°C 
to separate DNA strands and a barcoded ssDNA adapter (BG6170/4/6) was ligated 
to the 5’ end of the products. Unincorporated adapters were removed using the 
DNA Clean and Concentrator Kit (Zymo Research). PCR amplification was performed 
with BG6179 and BG6180. A second round of PCR amplification was performed 
with BG6179 and BG6183/7/9 (barcoded). PCR products were purified and sent 
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to the Imagif, Centre for Molecular Genetics, Centre National de la Recherche 
Scientifique, France for sequencing (paired-end, 2x250nt). Based on the procedure 
outlined above, a fraction of degradation fragments smaller than 50 nucleotides 
was purified with lower yields during the initial agarose gel extraction, and could be 
less populated in the size distribution shown in Fig 3B/S6A. 
NGS Data analysis. Sequencing data was deposited at the European Nucleotide 
Archive under the accession number PRJEB13999. Samples were de-multiplexed 
using their barcodes. All pair-end reads were mapped to their originating sequences 
(pWUR836/853, m13mp8) using BLAST and allowing for up to one mismatch. Reads 
for which both ends could not be aligned to the reference sequence were discarded. 
For the cleavage sites, distinct start/end positions were analyzed independently 
(see Table S4 and Table S5 for details). For the duplets a sliding window around the 
cut point was used. For the duplets the following positions were considered: (-2,-1), 
(-1,1) and (1,2). In this notation the cut point is between -1 and 1, positive positions 
are inside the considered fragment and negative positions are outside. Enrichment 
analysis was performed using a hypergeometric probability distribution to model 
the background probability density associated to the originating sequence. R 
packages stats (R-Development-Core-Team, 2008) and ggplot2 (Wickham, 2009) 
were used for these computations and to generate corresponding graphics.
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Figure S1. Related to Figure 1: Overview of Protospacer8 mutants. 30 mutants of protospacer8 
containing either 3 or 5 total mutations were used throughout the study. Mutations on positions 6, 
12, 18, 24, 30 (empty circles) are not participating in base-pairing and are therefore not considered 
as effective mutations. Types of mutations are indicated by colored symbols.  Mutants are separated 
into categories based on their behavior in plasmid loss assays (see also Figure 1B).
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Figure S2. Related to Figure 1: Individual plasmid loss assays. Panels for each plasmid mutant with 
(top to bottom): Sequence with indicated mutations, plasmid loss curves from 0 h to 24 h or 48 h, 
duplicate of CRISPR PCR showing spacer acquisition. The bottom bands in the PCR gels represent the 
unextended array, higher bands represent the array with an extra spacer. Error bars in plasmid loss 
graphs represent the standard deviation of replicate experiments. The bona fide target is abbreviated 
as WT.
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Figure S3. Related to Experimental Procedures, Statistical testing: Statistical pattern analysis of 
30 mutants set.  Three properties were analyzed separately for each group of plasmid behavior. 
The average of each behavioral group is indicated by the yellow vertical line. To test if the plasmid 
behavior depends on a certain property, for each property a distribution was made based on empirical 
bootstrapping of the whole set of 30 mutants (blue line). The 95% and 68% confidence intervals of 
each distribution are indicated by the light and dark grey boxes respectively. A) Average number of 
effective mutations. B) Average number of mutations in segment 1. C) Average number of mutations 
on position 3 within all segments combined. D) Average number of mutations on position 3 within all 
segments combined but the analysis was performed on a previously published large dataset (Fineran 
et al., 2014). From this dataset, mutants with 3 mutations (all canonical PAM) were analyzed. The 
average of the direct interference group is indicated by the red square. 
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Figure S4. Related to Figure 2B. Representative gels of Cas3 activity assays. Individual gels for each 
mutant showing Cas3 plasmid degradation reactions at time points 0, 1, 10, 30 minutes. Vertical 
black lines indicate removal of 3 gel lanes with irrelevant samples. Supercoiled plasmid is indicated 
with an asterisk, gel lanes above are linearized and nicked plasmids, which are not considered in 
quantification.
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Figure S5. Related to Figure 3: Biochemical analysis of Cas3 DNA degradation fragments. A) 32P PNK 
labeling of degradation fragments from bona fide target plasmid, M4 target plasmid and m13mp8 
single stranded plasmid. Forward reaction can only label non-phosphorylated 5’ends, exchange 
reaction can label both phosphorylated and non-phosphorylated 5’ ends. Non-phosphorylated PCR 
product for reference. B) dsDNase incubation with degradation fragments of bona fide target plasmid 
and M4 target plasmid. dsDNase is a double stranded DNA specific endonuclease with no activity on 
single stranded DNA.
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Figure S6. Related to Figure 3: Next generation sequencing analysis of Cas3 DNA degradation 
products. A) Length distribution bar charts for Cas3 DNA degradation products of bona fide target 
plasmid, M4 target plasmid and m13mp8 single stranded plasmid. B) Heat maps of nucleotide 
frequencies around cleavage sites for bona fide target plasmid, M4 target plasmid and m13mp8 single 
stranded plasmid. 5’ and 3’ cut sites are displayed separately for both target and non-target strand. 
The cleavage site is between position -1 and 1. Positions indicated in black are on the fragments, 
positions indicated in grey are outside of fragments.
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Table S1. Related to Figures 1-6: Oligo nucleotides used in this study
Name Sequence Description
BG4556 ATCCCGGGATGACCTGGCTTCCCCTT Cas1 fw (SmaI)
BG4557 AGTGAGCTCTCAAACAGGTAAAAAAGACACC Cas2 rv (SacI)
BG5301 AAGGTTGGTGGGTTGTTTTTATGG CRISPR leader forward primer
BG5302 GGATCGTCACCCTCAGCAGCG M13_g8 spacer reverse primer
BG6170 CACTCTTTCCCTACACGACGCTCTTCCGATCTGCCTAA
NGS PE 5’Adapter 3
BG6174 CACTCTTTCCCTACACGACGCTCTTCCGATCTGATCTG
NGS PE 5’Adapter 7
BG6176 CACTCTTTCCCTACACGACGCTCTTCCGATCTCTGATC
NGS PE 5’Adapter 9
BG6179 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCT-
ACACGACGC NGS PE 5’Adapter extension primer
BG6180 GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-
TTTTTTTTTTTTTTTTTTTTTTTTTTTTVN NGS PE 3’ Tail primer 1
BG6183 CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTG-
GAGTTCAGACGTGTG NGS PE 3’ Tail primer 2.3
BG6187 CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTG-
GAGTTCAGACGTGTG NGS PE 3’ Tail primer 2.7
BG6189 CAAGCAGAAGACGGCATACGAGATCTGATCGTGACTG-
GAGTTCAGACGTGTG NGS PE 3’ Tail primer 2.9
BG6713 GCTCTGCTGAAGCCAGTT Reverse S437 hot spot pBR322
BG6714 GATCCTCTAGAGTCGACCT Reverse S429 hot spot bb
BG6715 GCTAGTTGAACGGATCCAT Reverse S416 hot spot GFP
BG7213 CGCTGCTGCGAAATTTGAAC pWUR477 single repeat fw
BG7214 AACTCTGCGTGAGCGTATCG pWUR477 single repeat rv
BG7215 ATCCGTTCAACTAGCAGACC GFP hotspot nested forward
BG7216 GGTCTGCTAGTTGAACGGAT GFP hotspot nested reverse
BG7415 CAATTTACTACTCGTTCTGGTGTTTCTCGTCAGGG Protospacer 35 forward
BG7416 ACGAGAAACACCAGAACGAGTAGTAAATTGGGCTT Protospacer 35 reverse
BG7522 CTGCGCTAGTAGACGAGTC pWUR477 behind array reverse
Table S2. Related to Figures 1-6: Plasmids used in this study
Plasmid Description (positions of all mutations) Name in 
paper
source
pWUR835 pGFP-UV Amp - (Fineran et al., 2014)
pWUR836 pGFP-UV Km protospacer8 WT pTarget bona 
fide 
(Fineran et al., 2014)
pWUR837 pGFP-UV Km protospacer8 mutant pos. 1, 3, 24 pTarget M14 (Fineran et al., 2014)
pWUR838 pGFP-UV Km protospacer8 mutant pos. 10, 11, 25 pTarget M12 (Fineran et al., 2014)
pWUR839 pGFP-UV Km protospacer8 mutant pos. 1, 4, 16 pTarget M30 (Fineran et al., 2014)
pWUR840 pGFP-UV Km protospacer8 mutant pos. 2, 3, 4 pTarget M17 (Fineran et al., 2014)
pWUR841 pGFP-UV Km protospacer8 mutant pos. 3, 7, 19 pTarget M26 (Fineran et al., 2014)
pWUR842 pGFP-UV Km protospacer8 mutant pos. 4, 8, 26 pTarget M23 (Fineran et al., 2014)
pWUR843 pGFP-UV Km protospacer8 mutant pos. 2, 10, 16 pTarget M16 (Fineran et al., 2014)
pWUR844 pGFP-UV Km protospacer8 mutant pos. 2, 18, 22 pTarget M9 (Fineran et al., 2014)
pWUR845 pGFP-UV Km protospacer8 mutant pos. 10, 14, 17 pTarget M5 (Fineran et al., 2014)
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pWUR846 pGFP-UV Km protospacer8 mutant pos. 11, 16, 17 pTarget M7 (Fineran et al., 2014)
pWUR847 pGFP-UV Km protospacer8 mutant pos. 11, 22, 32 pTarget M1 (Fineran et al., 2014)
pWUR848 pGFP-UV Km protospacer8 mutant pos. 5, 6, 25 pTarget M2 (Fineran et al., 2014)
pWUR850 pGFP-UV Km protospacer8 mutant pos. 2, 8, 26 pTarget M10 (Fineran et al., 2014)
pWUR851 pGFP-UV Km protospacer8 mutant pos. 19, 27, 32 pTarget M27 (Fineran et al., 2014)
pWUR852 pGFP-UV Km protospacer8 mutant pos. 12, 17, 31 pTarget M3 (Fineran et al., 2014)
pWUR853 pGFP-UV Km protospacer8 mutant pos. 6, 7, 32 pTarget M4 (Fineran et al., 2014)
pWUR854 pGFP-UV Km protospacer8 mutant pos. 1, 10, 15, 
18, 29
pTarget M25 (Fineran et al., 2014)
pWUR855 pGFP-UV Km protospacer8 mutant pos. 1, 16, 19, 
25, 29
pTarget M13 (Fineran et al., 2014)
pWUR856 pGFP-UV Km protospacer8 mutant pos. 1, 4, 19, 
27, 28
pTarget M20 (Fineran et al., 2014)
pWUR857 pGFP-UV Km protospacer8 mutant pos. 2, 12, 23, 
26, 27
pTarget M11 (Fineran et al., 2014)
pWUR859 pGFP-UV Km protospacer8 mutant pos. 3, 8, 10, 
11, 22 
pTarget M29 (Fineran et al., 2014)
pWUR860 pGFP-UV Km protospacer8 mutant pos. 3, 15, 20, 
25, 26
pTarget M18 (Fineran et al., 2014)
pWUR859
pGFP-UV Km protospacer8 mutant pos. 3, 9, 13, 
22, 26
pTarget M19 (Fineran et al., 2014)
pWUR860
pGFP-UV Km protospacer8 mutant pos. 5, 6, 8, 24, 
31
pTarget M8 (Fineran et al., 2014)
pWUR861
pGFP-UV Km protospacer8 mutant pos. 4, 5, 6, 15, 
24
pTarget M24 (Fineran et al., 2014)
pWUR862
pGFP-UV Km protospacer8 mutant pos. 1, 2, 9, 14, 
21
pTarget M22 (Fineran et al., 2014)
pWUR863
pGFP-UV Km protospacer8 mutant pos. 6, 22, 27, 
31, 32
pTarget M28 (Fineran et al., 2014)
pWUR864
pGFP-UV Km protospacer8 mutant pos. 12, 13, 23, 
24, 30
pTarget M6 (Fineran et al., 2014)
pWUR866
pGFP-UV Km protospacer8 mutant pos. 3, 9, 12, 
16, 32
pTarget M21 (Fineran et al., 2014)
pWUR867
pGFP-UV Km protospacer8 mutant pos. 17, 27, 28, 
29, 30
pTarget M15 (Fineran et al., 2014)
pWUR868 pGFP-UV Km non-target pTarget NT (Fineran et al., 2014)
pWUR748 pMAT11-MBP-Cas3 (Mulepati and Bailey, 
2013)
pWUR868 pACYC poly spacer8 CRISPR array This study
pWUR514 cse2 with Strep-tag II (N-term)-cas7-cas5-cas6e in
pET52b
(Jore et al., 2011a)
pWUR408 cse1 in pRSF-1b, no tags (Brouns et al., 
2008b)
pWUR477 pACYC with artificial CRISPR array (Brouns et al., 
2008b)
pWUR872 pWUR477 with only one repeat pCRISPR This study
pWUR871 Cas1-Cas2 operon with Strep-tag II (N-term) in 
pET52b
This study
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Table S3. Related to Figure 2A: EMSA data from regression analysis
Plasmid Amplitude Kd (nM) Amplitude/Kd
bona fide (WT) 1.0 ± 0.01 7.6 ± 0.8 1.31E-01
M1 0.85 ± 0.01 23.6 ± 2.0 3.59E-02
M2 0.92 ± 0.04 23.6 ± 4.6 3.92E-02
M3 0.99 ± 0.02 18.5 ± 2.7 5.35E-02
M4 1.02 ± 0.04 16.4 ± 3.34 6.23E-02
M5 0.87 ± 0.03 34.3 ± 5.3 2.54E-02
M6 0.0 -- 0.00E+00
M7 0.69 ± 0.01 31.6 ± 2.7 2.17E-02
M8 0.65 ± 0.01 17.4 ± 2.0 3.71E-02
M9 0.94 ± 0.03 24.8 ± 4.7 3.78E-02
M10 1.05 ± 0.05 23.4 ± 5.3 4.50E-02
M11 0.39 ± 0.02 22.1 ± 6.0 1.77E-02
M12 0.0 -- 0.00E+00
M13 0.0 -- 0.00E+00
M14 1.2 ± 0.13 360 ± 79.4 3.46E-03
M15 0.46 ± 0.01 4.4 ± 0.4 1.04E-01
M16 0.78 ± 0.02 46.3 ± 6.7 1.69E-02
M17 1.19 ± 0.02 152.6 ± 10.0 7.79E-03
M18 0.0 -- 0.00E+00
M19 0.0 -- 0.00E+00
M20 0.0 -- 0.00E+00
M21 0.0 -- 0.00E+00
M22 0.94 ± 0.01 55.9 ± 2.7 1.69E-02
M23 0.69 ± 0.02 54.1 ± 5.3 1.27E-02
M24 0.9 ± 0.03 22.4 ± 4.0 4.03E-02
M25 0.31 ± 0.01 34.6 ± 6.0 9.02E-03
M26 0.93 ± 0.03 79.4 ± 8.7 1.17E-02
M27 0.74 ± 0.02 20.7 ± 2.7 3.59E-02
M28 1.04 ± 0.04 17.4 ± 3.3 5.97E-02
M29 0.4 ± 0.02 74.2 ± 18.0 5.40E-03
M30 0.0 -- 0.00E+00
Table S4. Related to Figure 3: NGS data processing and mapping
Sample name Total number 
of reads
Reads mapping 
to NT strand
Reads mapping 
to NT strand 
(%)
Reads mapping 
to T strand
Reads mapping 
to T strand (%)
bona fide (WT) 215218 57217 26.6 158001 73.4
M4 101327 23334 23 77993 77
M13mp8 46205 46109 >0.99 96 <0.01
Chapter 5
142
5
Table S5. Related to Figure 3: NGS data processing for cleavage sites
Non-target strand (NT) Target strand (T)
Sample name
# Distinct 
Fragments 
# Distinct 
Start 
# Distinct 
End
# Distinct 
Fragments
# Distinct 
Start # Distinct End
bona fide (WT) 8777 1381 1479 7448 1318 1151
M4 4432 971 1076 4784 1029 920
M13mp8 12243 3737 2620
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Abstract
Prokaryotes use the CRISPR-Cas system to remove unwanted nucleic acid invaders 
from the cell. Immunity is based on the complementarity of host-encoded spacer 
sequences with protospacers on the foreign genetic element. Matching protospacers 
are detected by RNA-guided effector complexes and flagged for destruction. Invaders 
can evade this interference by acquiring mutations in the protospacer or in the 
protospacer adjacent motif (PAM). The type I-E system in Escherichia coli can tackle 
these invaders using a primed acquisition process that rapidly restores immunity by 
incorporating new spacers. The efficiency of both direct CRISPR interference and 
primed acquisition depends on the degree of complementarity between spacer and 
protospacer. Previous studies focused on the number and positions of mutations in 
the protospacer, not on the identity of the substituted nucleotide. We previously 
detected that nucleotide-dependent effects rule priming, showing a positive effect 
of C mismatches and a negative effect of G mismatches. Here we show that these 
substitutions in the protospacer dictate the efficiency of interference and therefore 
determine the efficiency of interference-dependent priming. We show that G 
substitutions in the target strand of the protospacer are detrimental to interference, 
while C substitutions are readily tolerated. Furthermore, we show that this effect 
is based on strongly decreased binding affinity of the effector complex Cascade for 
G mismatches, while C mismatches only minimally affect binding. This effect has 
strong implications for the mutations that mobile genetic elements can introduce 
to escape CRISPR systems more effectively.
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Introduction
Clustered regularly interspaced short palindromic repeats (CRISPR) together with 
CRISPR-associated (Cas) proteins provide immunity against foreign nucleic acids 
in prokaryotes (Barrangou et al., 2007; Brouns et al., 2008a). The constant battle 
between prokaryotes and their viruses is one of the oldest and most prominent 
predator-prey interactions on our planet (Breitbart and Rohwer, 2005; Rohwer and 
Thurber, 2009). The CRISPR array consists of identical repeat units separated by 
unique spacers. In many cases spacer sequences are derived from foreign genetic 
elements although ‘self’-derived spacers can also be found (Bolotin et al., 2005; 
Makarova et al., 2006; Mojica et al., 2005; Pourcel et al., 2005; Stern et al., 2010). 
CRISPR-Cas systems are currently divided into class 1 and class 2 systems, with 
class 1 consisting of type I, III and IV, and class 2 consisting of type II, V and VI 
(Makarova et al., 2015; Makarova et al., 2017a, b). Each type (except IV) contains 
a number of subtypes. Type I systems contain the universally conserved cas1 and 
cas2 genes, the hallmark cas3 helicase-nuclease and a set of genes encoding for the 
Cascade-like effector complexes. The mechanism of CRISPR-Cas defence is divided 
into three stages: Adaptation, expression and interference (van der Oost et al., 
2014). First, a new spacer is acquired from an invader DNA that has not previously 
been encountered and is incorporated into the CRISPR array by the Cas1-2 complex 
(adaptation) (Barrangou et al., 2007; Jackson et al., 2017). Next, the whole array 
is transcribed from the AT-rich leader sequence into long pre-CRISPR RNA (pre-
crRNA) and subsequently processed into mature crRNAs that each carry one spacer 
(expression) (Brouns et al., 2008a; Charpentier et al., 2015). The latter assembles 
with Cas proteins to form surveillance complexes that make up the core of all CRISPR 
systems (Makarova et al., 2015). In the last stage (interference), these surveillance 
complexes scan the cell for complementary targets and flag them for destruction, 
leading to immunity (Garneau et al., 2010; Hale et al., 2009; Marraffini and 
Sontheimer, 2008; Westra et al., 2012c). Invaders can escape immunity by acquiring 
mutations in their recognition sequence (protospacer) or PAM, which implies that 
the host has to acquire a new spacer in order to regain immunity. Several type I 
systems possess a primed acquisition mechanism that leads to rapid acquisition of 
new spacers when escape protospacers are detected (Datsenko et al., 2012; Li et al., 
2014; Richter et al., 2014; Swarts et al., 2012; Vorontsova et al., 2015). Unlike naïve 
acquisition, which requires only cas1 and cas2, primed acquisition requires all cas 
genes and a targeting spacer (Datsenko et al., 2012; Yosef et al., 2012). A number 
of studies have described the effect of mutations on interference and priming in 
the type I-E system of E. coli. Two early studies have shown on a small scale that 
interference tolerates only few mutations in the protospacer and no mutations in 
the seed and PAM, while priming is slightly more tolerant (Datsenko et al., 2012; 
Semenova et al., 2011). Our previous work has extended this knowledge on a large 
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scale, showing that interference tolerates mutations in the seed to a low degree 
and that priming is extremely robust against mutations in the entire protospacer 
(Chapter 4) (Fineran et al., 2014). More recently, it was shown that mutation 
tolerance of the different immune responses is highly dependent on the primary 
sequence of the spacer/protospacer (Xue et al., 2015). 
 These studies mainly focussed on the number and position of the mutations, 
not on the individual nucleotides, thus we know little about the effect of different 
types of nucleotide substitutions. Interestingly, however, in a previous study we did 
observe a nucleotide bias that affected priming acquisition (Fineran et al., 2014). 
Having more cytosine substitutions in the target strand of the protospacer resulted 
in a positive correlation with the ability to induce priming, while an increasing 
number of guanine substitutions negatively correlated with the induction of 
priming. In contrast, adenine and thymine did not show any significant effect. In this 
analysis, the number of C or G substitutions was scored irrespective of any other 
mutations present in a particular mutant. We therefore set out to test whether this 
holds true for individual mutants with only C or G mutations. More specifically, we 
were wondering whether the behavior of a mutant (priming or stable) could be 
reversed by switching C mutations to G mutations in the same positions or vice 
versa. Moreover, we analyzed whether C mutations, on an individual level, actually 
promote priming or rather repress it not as strong as other mutations. Finally, 
attempts were made to reveal the mechanism that causes this opposing behavior 
of C and G mutations. 
 Here we show that C and G mutations affect priming indirectly, by altering 
the efficiency of interference (target degradation), which in turn has an effect on 
priming. We show that, while the overall effect is strongly dependent on the position 
of the mutations, C mutations repress interference only moderately compared to 
G mutations at the same positions. The effect on priming is more complex, not 
correlating directly with the type of mutation. Instead, priming is stimulated by 
intermediate interference rates, while high or low interference appears to repress 
priming. This is in agreement with previous studies that have shown the same 
dependence of priming on interference (Künne et al., 2016; Semenova et al., 2016; 
Staals et al., 2016). Furthermore we show that this behavior is caused by a higher 
mismatch penalty for G’s in the target strand of the protospacer compared to 
C’s, resulting in lower Cascade binding affinities for mutant targets containing G 
substitutions.
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Figure 1 – Statistics of G/C bias. Statistical analysis of the high throughput plasmid loss dataset 
from (Fineran et al., 2014). Only effective mutations, thus excluding positions 6, 12, 18, 24, 30, are 
considered. A) Mutants with only C or G mutations (> 2) are counted for each group of immune 
responses (Interference, Priming, Stable). B) Same as in (A) but in addition to the C or G mutations, 
one random mutation is allowed when there are at least 3 C or G mutations.
Statistical scoring of C and G mutants
In chapter 4, we performed a high throughput plasmid loss assay with a large library 
of PAM/protospacer mutants, which lead to their classification as causing either (i) 
interference, (ii) priming, or (iii) stable plasmid maintenance. Analysis showed the 
aforementioned nucleotide bias, but mutants were scored for the number of C or 
G mutations irrespective of the presence of any other mutations (Fineran et al., 
Chapter 6
6
148
2014). To verify that the observed effect is purely based on the C and G mutations, 
we re-analyzed the original dataset, but this time we selected mutants with only C 
or G mutations to exclude the influence of other mutations. All analyses were done 
using effective mutations, thus excluding positions 6, 12, 18, 24, 30 (pinch points), 
which do not participate in base pairing (Jackson et al., 2014; Mulepati et al., 2014; 
Zhao et al., 2014). We included mutants with at least 2 effective mutations, since 
single mutants are unlikely to have a nucleotide specific effect and most single 
mutants lead to direct interference. The pure Cn or Gn mutants (n≥2) were grouped 
according to their classifications and counted (Figure 1A). Due to the relatively 
small resulting sample set, we repeated the same analysis, this time allowing one 
additional random mutation in mutants with at least 3 C or G mutations (n≥3; Figure 
1B). The results of the two analyses are almost identical, showing the same effect 
that was observed previously (Fineran et al., 2014). The priming group in both 
analyses contains mainly C mutants (117 out of 152, 77%; 345 out of 450, 77%), 
while the stable group contains mostly G mutants (94 out of 108, 87%; 290 out 
of 326, 89%). This confirms that C mutations generally stimulate priming, while G 
mutations generally repress priming. Interference has only a slight preference for 
C mutants over G mutants (56 %/ 44 % for C/G respectively). This suggests either 
that interference is largely unaffected by the type of mutation or that the effect of 
the mutations on interference is hard to detect because the majority of mutants 
in this group carry only 2 effective mutations which likely do not show a strong 
effect. It is considered very likely that interference is indeed also affected by the 
type of mutations, because priming is directly dependent on interference (Künne 
et al., 2016).
Table 1: Overview of mutant set
Original mutant Original classification Conversion mutant Predicted classification
C1 Priming G1 Predicted stable
C2 Priming G2 Predicted stable
C3 Priming G3 Predicted stable
C4 Priming G4 Predicted stable
G5 Stable C5 Predicted priming
G6 Stable C6 Predicted priming
G7 Stable C7 Predicted priming
G8 Stable C8 Predicted priming
G9 Stable C9 Predicted priming
 To address the question to what extent priming and interference are 
influenced by the type of mutations, and to analyze the effect of the mutations in 
more detail, we selected four priming protospacers from the dataset with only C 
mutations (C1-4) and five stable protospacers with only G mutations (G5-9) (Table 
1, Table S1). The mutants were selected based on two restrictions: (i) the mutations 
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had to be effective mutations, meaning they could not be on a pinch point, and (ii) 
the original nucleotide must be A or T, so that we can switch the mutations from C 
to G or vice versa without reverting to WT. After selecting the mutants, we designed 
the respective conversion mutants (G1-4, C5-9). 
A B
C
Figure 2 – Phenotypes of E. coli with reporter plasmids. Microscopy pictures of E. coli KD263 cells 
used in this study during growth with different reporter plasmids. A) Without reporter plasmid. B) 
With pGFP-UV plasmid (constitutive GFP expression) used in earlier studies, showing elongated cells 
C) With pBex plasmid (Rhamnose inducible RFP expression).
RFP-reporter plasmids for optimized in vivo assays
The selected protospacers and their corresponding conversion mutants were 
cloned into plasmids carrying an inducible RFP reporter. We used the inducible 
RFP reporter instead of the constitutive GFP reporter from our previous studies, 
because we observed an aberrant growth phenotype in E. coli cells expressing 
GFP (Figure 2B). Cells expressing GFP were elongated and this might lead to an 
increased selective advantage/growth rate for cells that lost the plasmid over cells 
that carry the plasmid. RFP expression does not show this effect (Figure 2C) and 
the inducible promoter further reduces the energetic burden and thereby growth 
disadvantage of plasmid carrying cells. Although we did not observe any problems 
with the previously used GFP-based system, the RFP system further reduced the 
background of CRISPR-independent plasmid loss to undetectable levels in the 
timeframe of our experiments (≤48 h). Moreover, the new system reduces the 
potential overestimation of plasmid loss, due to the reduced growth rate advantage 
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Figure 3 – Plasmid loss and spacer acquisition. Plasmid loss and spacer acquisition assays of individual 
mutant plasmids. Two independent assays were carried out, each in duplicate. The standard error 
of the mean of the measurements can be found in figure S1. A) Plasmid loss curves of C/G pairs 1-4 
and the WT. B) Plasmid loss curves of C/G pairs 5-9. C) Analysis of priming during plasmid loss assays, 
indicating the first occurrence of visible CRISPR array expansion (X-axis) and the extent of priming 
(fraction of population with expanded array after 48 h, Y-axis). D) Plot showing the correlation of 
speed of plasmid loss (represented by the remaining plasmid after 10 h) with the extent of priming 
(represented by the fraction of the population with an expanded array after 48 h. Distribution is fitted 
with a parabola, indicating optimal array expansion at intermediate plasmid loss speeds.
G mutants strongly inhibit direct interference
First we performed plasmid loss assays to accurately determine and quantify the 
ability of the mutant protospacers to trigger direct interference and priming. No 
plasmid loss and no spacer acquisition was observed with a non-target plasmid 
after 48h, showing that CRISPR-independent plasmid loss and naïve acquisition do 
not occur at detectable levels in this timeframe (not shown). When comparing the 
respective pairs of C and G mutants, we observed that the C mutants consistently 
showed more rapid plasmid loss than the G mutants (Figure 3AB, Figure S1). 
Especially, some mutants that were switched from G to C (C5, C7, C8) drastically 
increased their speed of plasmid loss to almost WT levels. Two pairs of mutants show 
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only small differences between the C and G version (C6/G6, G9/C9). The original G9 
mutant already shows rapid plasmid loss, which simply cannot be increased much 
more in the C9 mutant. The original G6 mutant is stable and the C6 mutant is only 
able to show strongly delayed priming. This is likely an effect of the positions of the 
mutations, which are detrimental for interference/priming regardless of nucleotide 
identity. In many of the mutants, significant plasmid loss was observed within 5 
hours, indicating that this was caused by direct interference rather than priming 
(Figure 3AB). This is supported by the analysis of spacer acquisition that showed 
observable spacer acquisition initiated after the onset of plasmid loss (Figure 3C). 
Spacer acquisition also initiated consistently earlier in the C mutants than their 
respective G mutants. The extent of priming, i.e. the fraction of the population 
that acquired new spacers, on the other hand is not consistent with the type of 
mutations. For example, the G9/C9 mutant pair where the interference is already 
very high in the G mutant (and even higher in the C mutant) show opposite behavior 
with respect to their priming response. Here, the G mutant shows a low level of 
early priming, while the C mutant shows no priming. We observe that the extent 
of priming is the highest when plasmid loss is occurring at intermediate speeds, 
while rapid or slow plasmid loss leads to a low extent of priming (Figure 3D). This 
is very well in line with the model proposed in our and others previous work, i.e. 
that priming is not only dependent on interference, but also on persistence of the 
invader in the host cell in order to provide sufficient time for spacer acquisition 
(Künne et al., 2016; Semenova et al., 2016; Severinov et al., 2016; Staals et al., 
2016). 
 In conclusion, G mutants strongly inhibit interference while C mutants are 
much more tolerated. The effect on priming that has been observed in the original 
dataset therefore results from the effects of mismatched C/G bases on direct 
interference rates.
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Figure 4 – In vitro Cas3 activity assays. The initial Cas3 reaction rate (over first 10 minutes) is plotted 
for each mutant plasmid. The rate is measured as the percentage of plasmid degradation per minute. 
The rates are the average of two independent experiments. The plasmids are split into groups based 
on their type of mutations. C mutants are indicated by full circles, G mutants are indicated by empty 
circles. The mean rate and standard error of the mean (SEM) are indicated for each group. Individual 
Cas3 activity graphs can be found in figure S2.
G mutants inhibit Cas3 degradation rate
To elucidate the molecular basis of this difference in interference of C and G mutants, 
we initially tried to measure the binding affinity of Cascade for the mutant plasmids. 
Unfortunately, the used EMSA approach did not allow for detecting binding in the 
majority of the used mutants, indicating that the interaction is too weak to be 
detected by EMSA analysis. Instead, we performed Cas3 activity assays with the 
set of plasmids. We have previously shown that Cas3 activity in vitro is a very good 
indicator for the level of direct interference and consequently for priming (Künne 
et al., 2016). Cas3 assays consistently show a higher average activity of C mutants 
over G mutants (Figure 4, Figure S2). Furthermore, looking at the individual C/G 
mutant pairs, we see consistently higher activity of the C mutants compared to 
their corresponding G mutants. This confirms that the more rapid plasmid loss of C 
mutants is indeed caused by a more efficient plasmid degradation by Cas3. 
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Figure 5 – Oligo EMSA. A) Overview of oligonucleotide duplex combinations tested. Each combination 
contains one WT strand and one mutated strand. B) EMSA of Cascade with 32P labelled oligo duplexes. 
Cascade to DNA molar ratios are indicated above each lane. Top bands are Cascade bound DNA and 
bottom bands are free DNA.
G mutations in the target strand disrupt Cascade binding
Since the plasmid EMSAs were unsuccessful, we wondered whether the difference 
in Cas3 activity is caused by affinity differences of Cascade for the mutant 
protospacers, by conformational differences of the Cascade/R-loop complexes or 
just by differences in Cas3 activity. Furthermore, it is currently unknown whether 
the effect is caused only by the mismatches between the crRNA and the DNA 
target strand, or whether the non-target strand plays a role as well. The non-target 
strand has been proposed to make interactions with the Cse2 dimer and might 
therefore have an effect on overall R-loop stability (Jackson et al., 2014; Nam et 
al., 2012b; Wiedenheft et al., 2011a). To address these matters, we designed oligo 
nucleotides for each strand carrying a protospacer with either the WT sequence, C 
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mutations or G mutations. The sequences were chosen based on the mutant pair 
C7/G7. The oligos were annealed in certain combinations that allow investigation 
of the effect of the mutations in either strand separately (Figure 5A). We performed 
EMSA assays to measure the binding affinity of Cascade with the 5 oligo duplex 
combinations (Figure 5B). We observed the highest binding affinity for the C and 
G mutants of the non-target strand with a WT target strand (WT
T
/C
NT
, WT
T
/G
NT
). 
These two mutants have near identical binding, showing that the mutations in the 
non-target strand have no effect on the affinity. The C mutant in the target strand 
(C
T
/WT
NT
) has a considerably higher binding affinity than the G mutant in the target 
strand (G
T
/WT
NT
). The latter shows almost no detectable binding, while the former 
shows binding comparable to the full WT (WT
T
/WT
NT
). The full WT oligos (WT
T
/
WT
NT
) show lower binding affinity than the two non-target strand mutants with a 
WT target strand, probably due to the fact that the mismatches between the two 
strands in the mutants lower the energetic barrier of strand invasion and R-loop 
formation. Cascade strongly favors these destabilized duplexes, which agrees with 
the observation that it prefers negatively supercoiled target plasmids (Westra et al., 
2012c). Overall, these affinity measurements show that G mutations in the target 
strand disrupt Cascade binding to a much greater extent than C mutations. The 
bases in the non-target strand have no effect on the Cascade affinity.
Discussion
In this study, we have shown that the type I-E CRISPR-Cas system readily tolerates 
cytosine mutations in the target strand of the protospacer, while guanine mutations 
severely reduce the efficiency of direct interference. This difference is caused 
by a strong reduction of Cascade binding affinity towards targets with guanine 
substitutions, while the binding affinity is hardly affected in case of cytosine 
substitutions. Thus, these mutations do not directly influence the priming process 
as originally thought (Fineran et al., 2014), but instead alter target degradation 
rates and consequently the interference-dependent priming process. The fact that 
we did not observe a nucleotide-dependent effect on interference in the original 
dataset (Fineran et al., 2014), may have two reasons: the conservative classification 
in the high throughput assay of that study, leaving many mutants unclassified, and 
the fact that the mutants in the direct interference category carry very low numbers 
of mutations which likely does not produce the nucleotide specific effect. The direct 
effect on interference and the indirect effect on priming of the C/G mutants is also 
shown by the fact that, although C mutants in all cases lead to earlier priming than 
G mutants, the extent of priming in the whole population is not directly related to 
the type of mutation. Instead, the extent of priming follows the model that was 
conceived in an early study (Swarts et al., 2012) and established in three recent 
studies. These studies showed that the priming process is directly dependent on 
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direct interference and that in fact direct interference produces the precursor 
molecules for new spacers during priming (Künne et al., 2016; Semenova et al., 
2016; Staals et al., 2016). However, next to requiring interference for the production 
of precursors, priming is also dependent on sufficient time of persistence of the 
invader in the cell. Only prolonged persistence gives sufficient opportunity for 
spacer capture and integration. Thus, a very high rate of direct interference, such as 
for a WT target or the C9/G9 mutant pair in this study, on the one hand leads to a 
very early onset of priming, but on the other hand to a very low extent of priming. 
Mutants with low rates of direct interference lead to late onset of priming and a 
low extent of priming due to the lack of precursor generation. Mutants with an 
intermediate rate of direct interference, however, result in relatively early and a 
high extent of priming, due to prolonged persistence and simultaneous degradation 
of the invader.
 This study confirms that priming in protospacer mutants (not PAM mutants) 
is dominantly occurring via the interference-dependent pathway (Künne et al., 2016; 
Semenova et al., 2016; Staals et al., 2016) and not the interference-independent 
pathway (Redding et al., 2015). 
 A possible explanation as to why G mutations are so much more detrimental 
for protospacer binding by Cascade than C mutations may be found in the bulkiness of 
mismatched C and G nucleotides and their effects on R-loop progression and stability. 
Guanine, being a purine, is bulkier than cytosine which is a pyrimidine. However, in 
this case we would expect to see the same effect for adenine (purine) and thymine 
(pyrimidin). The difference between C and G mutations also cannot be explained by 
pure thermodynamics of RNA-DNA mismatches for several reasons. First, the effect 
of mismatches on the total duplex free energy is highly context dependent. Thus 
both the identity of the opposing RNA base as well as both neighboring base pairs 
influence the free energy (Huang et al., 2009; Sugimoto et al., 2000; Watkins et al., 
2011; Wu et al., 2002; Zhu and Wartell, 1999). This would mean that the effect of dC 
or dG mismatches should average out, rather than show the clear opposing effect 
that we observed. Second, the experimental analysis of many RNA/DNA mismatch 
combinations has shown that some combinations containing a dG mismatch are 
actually more stable than combinations containing a dC mismatch (e.g. rU·dG ≈ rG·dG 
> rA·dG ≈ rA·dC > rU·dC>rC·dC) (Sugimoto et al., 2000; Watkins et al., 2011). The 
complete estimation of duplex free energies remains difficult, because only around 
72 of the 240 possible RNA-DNA mismatches (dinucleotide nearest-neighbor model) 
have been experimentally measured (Farasat and Salis, 2016). Another complicating 
factor in predicting the mismatch energies might be found in the distorted nature 
of the crRNA:DNA duplex which does not perfectly resemble an A-form helix (Hayes 
et al., 2016). Thus it is likely that the effect we observe is caused by the differential 
tolerance to G and C mutations in the context of the Cascade associated R-loop.
Chapter 6
6
156
 The detrimental effect of G mismatches also has consequences for the 
success of viral escape mutants. Although viruses have been shown in a number 
of systems to preferably mutate the PAM or seed to escape CRISPR-Cas immunity 
(Box et al., 2015; Deveau et al., 2008; Kupczok and Bollback, 2014; Paez-Espino et 
al., 2015; Semenova et al., 2011), systems capable of priming can rapidly regain 
immunity against these mutants (Datsenko et al., 2012; Fineran et al., 2014; Li 
et al., 2014; Richter et al., 2014). Thus, only mutants with sufficient mutations to 
completely escape immunity have increased long-term survival. For these escape 
viruses it would be very beneficial to accumulate G mutations in the targeted strand 
of their protospacers to maximize the chances of escape. Since the CRISPR-Cas 
system can target either strand, viruses cannot simply prefer G over C mutations in 
general. Instead, the selective pressure on the viruses by the type I-E system should 
lead to a overrepresentation of G mutations in protospacers of viruses in natural 
ecosystems. 
Materials and Methods
Bacterial Strains and Growth Conditions. Escherichia coli strain KD263 was obtained 
from (Shmakov et al., 2014). E. coli strains were grown at 37 °C in Luria Broth (LB; 5 
g/L NaCl, 5 g/L yeast extract, and 10 g/L tryptone) at 180 rpm or on LB-agar plates 
containing 1.5% (wt/vol) agar. When required, medium was supplemented with 
the following: ampicillin (Amp; 100 μg/mL), chloramphenicol (Cm; 34 μg/mL), or 
kanamycin (Km; 50 μg/mL). Bacterial growth was measured at 600 nm (OD600).
Molecular Biology and DNA Sequencing. All oligonucleotides are listed in Table S2. 
All plasmids are listed in Table S3. All strains and plasmids were confirmed by PCR 
and sequencing (GATC-Biotech). Plasmids were prepared using GeneJET Plasmid 
Miniprep Kits (Thermo Scientific). DNA from PCR was purified using the DNA Clean 
and Concentrator and Gel DNA Recovery Kit (Zymo Research). The protospacer 
plasmid set was constructed by cutting pWUR925 with XbaI and SacI, removing the 
kanamycin resistance marker, and ligating a PCR product containing the streptomycin 
resistance marker and the desired protospacer (primers: BG7167/7395-7 for 
controls, BG7167/8393-8410 for mutant set). 
Plasmid loss assay. The assay was carried out in E. coli KD263 cells, which have 
inducible cas gene expression. Expression was induced with 0.2 % L-arabinose and 
0.5 mM IPTG where appropriate. E. coli KD263 cells were transformed with the 
target plasmids (pWUR926-946) by heat shock. Individual colonies were picked in 
duplicate and grown overnight in 5 ml LB supplemented with 2% glucose to repress 
cas gene expression. The next day, cultures were transferred 1:100 into induced 
medium (0.2% L-Arabinose, 0.5 mM IPTG) and plasmid loss was monitored. Samples 
were taken at the time of induction and 1.5 h, 3 h, 4.5 h, 6 h, 7 h, 24 h and 48 h 
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post induction (HPI). Dilutions were plated on non-selective plates containing 0.2 % 
rhamnose and plasmid loss was quantified based on loss of red color. Liquid culture 
samples were screened for spacer integration by colony PCR using OneTaq (NEB). 
Acquisition of spacers was detected by PCR using primers BG5301 and BG5302. PCR 
products were visualized on 2% agarose gels and stained with SYBR-safe (Invitrogen). 
PCR products were sequenced using Sanger sequencing at GATC (Konstantz, Germany) 
using primer BG5301.
Protein purification. All proteins were expressed in Bl21-AI cells. Cascade was purified 
as described earlier (Jore et al., 2011b). MBP-Cas3 was purified as described in 
(Mulepati and Bailey, 2013).
Oligo annealing and labelling. Complementary oligo nucleotides (BG9069-9074) 
were mixed (1:1) in a tris-sodium buffer, heated to 95 °C and slowly cooled to room 
temperature. Duplexes were checked on a native 20% acrylamide gel for residual single 
stranded oligo. The non-target substrate was PCR amplified from pWUR928 using 
BG9141/2. Duplexes were then labelled with γ-32P-ATP using T4 PNK (NEB) and free 
label was removed using a G25 column.
EMSA assays. Purified Cascade complex with spacer8 crRNA was incubated with 
plasmid or oligos at a range of molar ratios (1:1-96:1, Cascade:DNA) in buffer A (20 
mM HEPES pH7.5, 75 mM NaCl, 1 mM DTT) for 30 min. Plasmid reactions were run on 
1% native agarose gels for 18h at 22 mA in 8 mM sodium-borate buffer. Gels were post 
stained with SYBR Safe (Invitrogen). Oligo reactions were run on 5 % native acrylamide 
gels at 4 mA for 18 h. Gels were exposed to a phosphor screen (GE Healthcare) and 
scanned using a phosphor imager (Bio-Rad PMI). Shifted (Cascade bound DNA) and 
unshifted (free DNA) bands were quantified using the GeneTools software (Syngene) 
or ImageJ and free Cascade concentration (X) was plotted against the fraction of bound 
DNA (Y). The curves were fitted with the following formula: Y = (amplitude * X)/(Kd + X) 
(van Erp et al., 2015). The amplitude is the maximum fraction of bound DNA. 
Cas3 DNA degradation assays. Plasmid-based assays were performed by incubating 
70 nM Cas3 with 100 nM Cascade and 3.5 nM plasmid DNA. Oligo-based assays were 
performed by incubating 110 nM or 220 nM Cascade with 75 nM Cas3 and 5.5 nM oligo. 
Reactions were incubated in buffer R (5 mM HEPES, pH8, 60 mM KCl) supplemented 
with 10 µM CoCl2, 10 mM MgCl2, 2 mM ATP at 37 °C for the indicated amount of time. 
Plasmid samples were immediately quenched on ice with 6x DNA loading dye (Thermo 
scientific), oligo samples were quenched on ice in 2x RNA loading dye (NEB). Plasmid 
samples were run on 0.8 % agarose gels at 100 V for 40 minutes and supercoiled 
plasmid bands were quantified using the GeneTools software (Syngene). 
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Figure S1 – Individual plasmid loss assays. Individual plasmid loss graphs of C/G mutant pairs. Graphs 
show standard error of the mean (SEM) of two independent experiments
Chapter 6
6
160
0 10 20 30
0
50
100
C1
G1
WT
minutes
In
ta
ct
 p
la
sm
id
 [%
]
0 10 20 30
0
50
100
C2
G2
minutes
In
ta
ct
 p
la
sm
id
 [%
]
0 10 20 30
0
50
100
C3
G3
minutes
In
ta
ct
 p
la
sm
id
 [%
]
0 10 20 30
0
50
100
C4
G4
minutes
In
ta
ct
 p
la
sm
id
 [%
]
0 10 20 30
0
50
100
C5
G5
minutes
In
ta
ct
 p
la
sm
id
 [%
]
0 10 20 30
0
50
100
C6
G6
minutes
In
ta
ct
 p
la
sm
id
 [%
]
0 10 20 30
0
50
100
C7
G7
minutes
In
ta
ct
 p
la
sm
id
 [%
]
0 10 20 30
0
50
100
C8
G8
minutes
In
ta
ct
 p
la
sm
id
 [%
]
0 10 20 30
0
50
100
C9
G9
minutes
In
ta
ct
 p
la
sm
id
 [%
]
Figure S2 – Individual Cas3 activity assays. Individual graphs of C/G mutant pairs showing plasmid 
degradation by Cas3. The standard error of the mean of two independent experiments is indicated.
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Table S2: Oligo nucleotides used in this study
Name Sequence Description
BG5301 AAGGTTGGTGGGTTGTTTTTATGG Primer fw for CRISPR array 
PCR
BG5302 GGATCGTCACCCTCAGCAGCG Primer rv for CRISPR array 
PCR
BG6577 ATGTCATTGCGCTGCCATTC Sequencing primer for pro-
tospacers (StrepR)
BG7157 TTTGAGCTCTTATTTGCCGACTACCTTGGTGATCTC StrepR fw SacI
BG7395 TTTTCTAGAAAAAGTGCCACTTGCGGAGACCCGGTCGTCAGCT-
TACATTCAAATATGTATCCGCTC
PCR primer StrepR+sp8 
protospacer
BG7396 TTTTCTAGAAAAAGTGCCACTTGCGGAGACCCGGTCGTCAGCGT-
ACATTCAAATATGTATCCGCTC
PCR primer StrepR+mut-
PAMsp8 protospacer
BG7397 TTTTCTAGACAACCGGGGCAGATCATTAGTTGCACCGCGATTCGA-
CATTCAAATATGTATCCGCTC
PCR primer StrepR+scram-
bled protospacer
BG8393 TTTTCTAGAaagctgacgGccgggtcGccgcaagGggcacttGtACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutC1 sp8 
protospacer
BG8394 TTTTCTAGAaagcGgacgGccgggtctccgcaagtggcacGAttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutC2 sp8 
protospacer
BG8395 TTTTCTAGAaagctgacgaccgggtctccgcTGgGggcactttGACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutC3 sp8 
protospacer
BG8396 TTTTCTAGAaagctgacgaccgggGcGccgcGagtggcacttttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutC4 sp8 
protospacer
BG8397 TTTTCTAGAaagctgacgCccgggtcCccgcaagCggcacttCtACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutG1 sp8 
protospacer
BG8398 TTTTCTAGAaagcCgacgCccgggtctccgcaagtggcacCAttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutG2 sp8 
protospacer
BG8399 TTTTCTAGAaagctgacgaccgggtctccgcTCgCggcactttCACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutG3 sp8 
protospacer
BG8400 TTTTCTAGAaagctgacgaccgggCcCccgcCagtggcacttttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutG4 sp8 
protospacer
BG8401 TTTTCTAGAaagctgacgaccgggtcCccCcCCgtggcactttCACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutG5 sp8 
protospacer
BG8402 TTTTCTAGAaagctgacgCccgggCcCccgcaagtCgcacCtttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutG6 sp8 
protospacer
BG8403 TTTTCTAGAaagctgCcgaccggACctccgcaagtggcCcttCtACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutG7 sp8 
protospacer
BG8404 TTTTCTAGAaagctgacgCccgggCctccgcaagtggcacCtttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutG8 sp8 
protospacer
BG8405 TTTTCTAGAaagctgacgCccgggtctccgcaCgtggcCcttttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutG9 sp8 
protospacer
BG8406 TTTTCTAGAaagctgacgaccgggtcGccGcGGgtggcactttGACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutC5 sp8 
protospacer
BG8407 TTTTCTAGAaagctgacgGccgggGcGccgcaagtGgcacGtttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutC6 sp8 
protospacer
BG8408 TTTTCTAGAaagctgGcgaccggAGctccgcaagtggcGcttGtACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutC7 sp8 
protospacer
BG8409 TTTTCTAGAaagctgacgGccgggGctccgcaagtggcacGtttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutC8 sp8 
protospacer
BG8410 TTTTCTAGAaagctgacgGccgggtctccgcaGgtggcGcttttACAT-
TCAAATATGTATCCGCTC
StrepR rv XbaI + mutC9 sp8 
protospacer
BG9069 ACTCCAAGCGACCGGAGGCTTTTGACTTGATCGGCACGTAA-
GAGTCTAGAaagctgCcgaccggACctccgcaagtggcCcttCtACAT-
TCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTC
mutG7 sp8 non-target 
strand
BG9070 GAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTT-
GAATGTaGaagGgccacttgcggagGTccggtcgGcagcttTCTAGACTCT-
TACGTGCCGATCAAGTCAAAAGCCTCCGGTCGCTTGGAGT
mutG7 sp8 target strand
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BG9071 ACTCCAAGCGACCGGAGGCTTTTGACTTGATCGGCACGTAA-
GAGTCTAGAaagctgGcgaccggAGctccgcaagtggcGcttGtACAT-
TCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTC
mutC7 sp8 non-target 
strand
BG9072 GAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTT-
GAATGTaCaagCgccacttgcggagCTccggtcgCcagcttTCTAGACTCT-
TACGTGCCGATCAAGTCAAAAGCCTCCGGTCGCTTGGAGT
mutC7 sp8 target strand
BG9073 ACTCCAAGCGACCGGAGGCTTTTGACTTGATCGGCACGTAA-
GAGTCTAGAaagctgacgaccgggtctccgcaagtggcacttttACAT-
TCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTC
Sp8-WT non-target strand
BG9074 GAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTT-
GAATGTaaaagtgccacttgcggagacccggtcgtcagcttTCTAGACTCT-
TACGTGCCGATCAAGTCAAAAGCCTCCGGTCGCTTGGAGT
Sp8-WT target strand
BG9141 GAAGCATTTATCAGGGTTATTG pBex_50nt_flank-protospac-
er_fw
BG9142 AAAGCCTCCGACCGGAGG pBex_50nt_flank-protospac-
er_rv
Table S3: Plasmids used in this study
Plasmid Description Name in 
paper
source
pWUR925 Rhamnose inducible promotor – RFP, ColE1, KanR pBEX05 (Lee et al., 2011)
pWUR926 pBex05 backbone, sp8 protospacer, StrepR pBEX06 This study
pWUR927 pBex05 backbone, mutPAM sp8 protospacer, StrepR pBEX07 This study
pWUR928 pBex05 backbone, scrambled protospacer, StrepR pBEX08 This study
pWUR929 pBex05 backbone, mutC1 sp8 protospacer, StrepR pBEX-C1 This study
pWUR930 pBex05 backbone, mutC2 sp8 protospacer, StrepR pBEX-C2 This study
pWUR931 pBex05 backbone, mutC3 sp8 protospacer, StrepR pBEX-C3 This study
pWUR932 pBex05 backbone, mutC4 sp8 protospacer, StrepR pBEX-C4 This study
pWUR933 pBex05 backbone, mutG1 sp8 protospacer, StrepR pBEX-G1 This study
pWUR934 pBex05 backbone, mutG2 sp8 protospacer, StrepR pBEX-G2 This study
pWUR935 pBex05 backbone, mutG3 sp8 protospacer, StrepR pBEX-G3 This study
pWUR936 pBex05 backbone, mutG4 sp8 protospacer, StrepR pBEX-G4 This study
pWUR937 pBex05 backbone, mutG5 sp8 protospacer, StrepR pBEX-G5 This study
pWUR938 pBex05 backbone, mutG6 sp8 protospacer, StrepR pBEX-G6 This study
pWUR939 pBex05 backbone, mutG7 sp8 protospacer, StrepR pBEX-G7 This study
pWUR940 pBex05 backbone, mutG8 sp8 protospacer, StrepR pBEX-G8 This study
pWUR941 pBex05 backbone, mutG9 sp8 protospacer, StrepR pBEX-G9 This study
pWUR942 pBex05 backbone, mutC5 sp8 protospacer, StrepR pBEX-C5 This study
pWUR943 pBex05 backbone, mutC6 sp8 protospacer, StrepR pBEX-C6 This study
pWUR944 pBex05 backbone, mutC7 sp8 protospacer, StrepR pBEX-C7 This study
pWUR945 pBex05 backbone, mutC8 sp8 protospacer, StrepR pBEX-C8 This study
pWUR946 pBex05 backbone, mutC9 sp8 protospacer, StrepR pBEX-C9 This study
pWUR748 pMat11-MBP-Cas3 (Mulepati and Bailey, 
2013)
pWUR868 pACYC poly spacer8 CRISPR array (Künne et al., 2016)
pWUR514 cse2 with Strep-tag II (N-term)-cas7-cas5-cas6e in
pET52b
(Jore et al., 2011a)
pWUR408 cse1 in pRSF-1b, no tags (Brouns et al., 2008b)
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Abstract
The development of genome editing tools has made major leaps in the last 
decade. Recently, RNA guided endonucleases (RGENs) such as Cas9 and Cpf1 have 
revolutionized genome editing. These RGENs are the hallmark proteins of class 2 
CRISPR-Cas systems. In this study we have explored the possibility to develop a new 
genome editing tool that makes use of the class 1 CRISPR-associated complex for 
antiviral defense (Cascade) from E. coli. This RNA guided protein complex is fused to 
a FokI nuclease domain to sequence-specifically cleave DNA.  We validate the tool 
in vitro using purified protein and two sets of guide RNAs, showing specific cleavage 
activity. The tool requires two target sites of 32 nt each at a distance of 30-40 nt 
and inward facing three nucleotide flexible PAM sequences. Like class 1 systems, 
the guide RNA sequence can easily be designed. Furthermore, we show that an 
additional RFP can be fused to FokI-Cascade, allowing visualization of the complex 
in target cells.
Keywords
CRISPR-Cas; genome editing, Cas9
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Introduction
The ability to edit genomes in a precise and controlled manner is of high importance 
for both fundamental biological research as well as applications such as therapy of 
genetic diseases and crop improvement (Ma et al., 2016; Paul and Qi, 2016; Porteus, 
2016). Genome editing harnesses targetable nucleases with tailored specificity to 
induce a double-stranded break (DSB) at a DNA target site. In a wide variety of 
cell types, these DSBs are then usually repaired via either one of two predominant 
endogenous repair pathways: non-homologous end-joining (NHEJ) or homology-
directed repair (HDR) (Kim, 2016). Repair via the error-prone NHEJ pathway usually 
results in insertions or deletions (indels) of varying size, which is convenient when 
aiming for inactivation of genes or disruption of transcription factor binding sites 
(Weterings and Chen, 2008). HDR-mediated repair can be utilized for seamless 
introduction of a piece of DNA when it is exogenously supplied as donor template. 
This has multiple applications like the introduction of precise point mutations 
or desired coding sequences (Tóth et al., 2016). Targetable nucleases generally 
consist of two components: a target DNA binding module and an dsDNA cleavage 
(endonuclease) module. Until recently, the repertoire of genome editing tools 
consisted of proteins that bind DNA via protein-DNA interactions. These include the 
natural meganucleases (homing enzymes), and the synthetic zinc finger nucleases 
(ZFNs) and transcription activator-like effector nucleases (TALENs) (Kim, 2016). 
Using protein engineering, the latter two can be customized to recognize any DNA 
sequence, however this process is complex and laborious. ZFNs have the additional 
problem of considerable levels of cytotoxicity, likely caused by off-target cleavage 
(Kim et al., 2009). Recently, the field of genome editing has been revolutionized 
by the introduction of RNA-guided endonucleases (RGENs), most prominently Cas9 
from Streptococcus pyogenes (Cho et al., 2013; Cong et al., 2013; Jinek et al., 2013), 
but also Cpf1 from Acidaminococcus sp. (Zetsche et al., 2015). RGENs are nucleases 
that make use of a guide RNA molecule that is used to identify bona fide target 
sequences via RNA-DNA base-pairing. Cleavage occurs after full base-pairing and 
formation of an R-loop structure. Only few mismatches between guide RNA and 
DNA target are tolerated, leading to highly specific cleavage and low cytotoxicity. 
Cas9 is part of class 2, type II CRISPR-Cas systems (Clustered Regularly Interspaced 
Short Palindromic Repeats, CRISPR-associated), which are found almost exclusively 
in bacteria (Makarova et al., 2015). CRISPR-Cas systems are best known for their 
function as an adaptive immune system, although recent studies suggest a number 
of non-defence roles (Louwen et al., 2013; Louwen et al., 2014; Vercoe et al., 2013; 
Westra et al., 2014). The CRISPR-Cas system provides resistance to mobile genetic 
elements by storing short memory sequences of invaders in the CRISPR array on 
the genome (Mohanraju et al., 2016). These short sequences can be transcribed 
into pre-crRNA, and after processing to mature crRNA guides assembled with Cas 
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proteins to form CRISPR-ribonucleoprotein (crRNP) surveillance complexes. These 
complexes can either be a single protein (class 2 systems) or a multiprotein complex 
(class 1 systems) (Makarova et al., 2015). Class 2 surveillance complexes, such as 
Cas9, contain in almost all cases nuclease domains that are capable of cleaving the 
target, making them ready-to-use RGENs. Class 1 systems are most prominently 
represented by type I and type III systems, the latter of which also contain 
surveillance complexes with nuclease functionality. Type I complexes, however, do 
not possess nuclease functionality. Instead, they are dependent on the recruitment 
of nucleases such as Cas3 to degrade the target after binding.
 In this study we developed a new type of RGEN, based on the type I-E CRISPR 
associated complex for antiviral defence (Cascade) protein complex (Brouns et al., 
2008a). Cascade is a ribonucleoprotein complex, consisting of 6 different subunits in 
uneven stoichiometry (Cse11, Cse22, Cas76, Cas51, Cas6e1) and a single 61 nt CRISPR 
RNA (crRNA). The crRNA consist of a 32 nt spacer sequence (targeting sequence) 
flanked by an 8 nt 5’ handle and a 21 nt 3’ stem loop (Jore et al., 2011a). In CRISPR 
immunity, Cascade plays a similar role to Cas9, it is responsible for finding and 
binding invader DNA. However, unlike Cas9, Cascade does not possess any nuclease 
functionality to destroy the invader DNA, but recruits an external nuclease, Cas3, to 
degrade the target (Westra et al., 2012c). To turn Cascade into an RGEN, we made 
use of the well-established FokI nuclease domain, by fusing it to the Cse1 subunit of 
Cascade. To allow for generating a DSB in target DNA, two FokI-Cascade complexes 
are required to bind in close proximity via their guide-RNA to allow for dimerization 
of the FokI monomers. This approach is reminiscent of ZFNs, TALENs and the FokI-
Cas9 system, and promises high specificities. 
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Figure 1 – Design and strategy of FokI-Cascade genome editing. A) Schematic representation of 
fokI-cse1 (top), fokI-cse1-mRFP (middle) and tagged Cascade operon (bottom) constructs. Top and 
middle, from left to right: 6x Histidine tag (HIS), dual monopartite SV40 nuclear localization signal 
(NLS), fokI nuclease domain (Sharkey and KKR/ELD mutations), linker from natural cse1-cas3 fusion in 
Streptomyces griseus (linker1), cse1 gene from E. coli, glycine or proline linker (linker2), mRFP1 gene. 
Amino acid positions of individual parts are indicated below. Bottom from left to right: StrepII-tag, 
cas operon consisting of cse2, Cas7, Cas5, Cas6e. B) Schematic of DNA cleavage strategy. Two FokI-
Cascade complexes with negative (ELD) and positive (KKR) dimerization interface bind on opposite 
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DNA strands, facing each other with their FokI domains. DNA binding is achieved by base-pairing of 
the crRNA with the target DNA strand and PAM recognition. The flexible linker allows dimerization of 
the FokI monomers resulting in cleavage of the DNA. C) Sequence representation of DNA binding site 
2 with corresponding crRNA (in green) and PAM (in red). Below is a minimal CRISPR array with one 
spacer and two repeats, encoding for the crRNA. D) Summary of target site criteria. Two target sites 
of 32 nt each have to be chosen, both need to be flanked by one of the permitted PAMs (facing each 
other). PAMs are listed by order of preference (top=best). The distance between the target sites can 
be between 30-40 nt.
Design of the tool
To develop a novel RNA guided nuclease, the well-established FokI nuclease domain 
was fused to the N-terminus of the Cse1 subunit of Cascade (Figure 1A). For this, we 
made use of a naturally occurring linker that connects Cse1 with Cas3 in Streptomyces 
griseus and has been previously applied in E. coli to fuse Cse1 with Cas3 (Westra 
et al 2012). Fusing the FokI nuclease domain to a DNA binding protein has been 
widely used with ZFNs, TALENs and recently Cas9 (REF). This strategy depends on 
the dimerization of two opposing FokI nuclease monomers which are only active 
as a dimer (Figure 1B). We used ‘sharkey’ mutants of the FokI nuclease domain 
which have enhanced activity (Guo et al., 2010). In addition, the two FokI domains 
carry opposite charges in their dimerization interface (noted as FokIKKR-Cascade 
and FokIELD-Cascade), requiring hetero-dimerization for activity, which has been 
shown to reduce off-target activity (Doyon et al., 2011). We included an N-terminal 
HIS tag and a dual monopartite SV40 nuclear localization signal (NLS) on FokI for 
flexibility with affinity purification and efficient nuclear localization, respectively. 
As Cas9, FokI-Cascade can be reprogrammed to target any sequence by changing 
its short crRNA sequence (Brouns et al., 2008a). Target sequences can be any 32 
nt sequences that are flanked by a three nt PAM sequence. To achieve a double 
stranded break, two target sequences on opposite strands with PAM flanks facing 
each other have to be chosen (Figure 1B). Cascade tolerates a set of 5 different 
PAMs with relatively high efficiency, allowing flexibility in the choice of target 
site (Figure 1D). For application, the two individual FokI-Cascade complexes are 
expressed separately in E. coli and purified. There are separate expression cassettes 
for fokI-cse1, the tagged cas operon and the CRISPR array. The CRISPR array contains 
four identical spacers which serve as the guide RNA sequences (Figure 1D) and the 
crRNA-expression plasmid can simply be exchanged in order to obtain complexes 
targeting the desired sequence. After purification the active protein can be used in 
vitro, or injected or transfected (via electroporation or iTOP technology (D’Astolfo et 
al., 2015)) into the cell type of choice.
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Figure 2 – Fusion protein purification and DNA binding. A) SDS PAGE showing the stoichiometry 
of native Cascade with J3 crRNA, FokIKKR -Cascade with R44 crRNA and FokIELD -Cascade with G8 
crRNA  after single step affinity purification using Streptactin. Bands in native Cascade are from top 
to bottom: Cse1, Cas7, Cas5, Cas6e, Cse2. FokI-Cascades show the FokI-Cse1 fusion band and an 
additional band representing Cse1 with a small part of FokI as a result of proteolytic degradation. 
B) SDS PAGE of FokI-Cascade complexes with cd8a targeting crRNAs. The complexes show minimal 
proteolytic degradation of FokI-Cse1. C) SDS PAGE showing FokI-Cascade elutions after washing with 
increasing salt concentrations (75 mM – 2 M). Although lower protein bands are not visible at high 
salt concentrations, the presence of Cas7 and FokI-Cse1 in the elution confirms that complexes are 
intact, since the streptag is on Cse2. D) Electrophoretic mobility shift assay (EMSA) of FokI-Cascade 
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complexes with target and non-target plasmid (molar ratio 20:1 protein:DNA). Binding of a plasmid by 
FokI-Cascade causes an upward shift in the gel. Single complexes result in upward shift of target DNA, 
while both complexes result in a double shift of target DNA. Non-target DNA is not shifted.
Protein complex purification
The FokIKKR/ELD-Cascade complexes with their respective crRNAs were separately 
produced in E. coli and isolated using one step affinity purification. We made use of 
the StrepII-tag on the Cse2 subunit of Cascade, which has proven to yield high purity 
Cascade in earlier studies (Jore et al., 2011a; Westra et al., 2012c). SDS PAGE analysis 
shows a high purity as well as correct subunit stoichiometry of the complex (Figure 
2A). However, next to the expected band for FokI-Cse1, a band is visible that runs 
slightly above the Cse1 protein of the native Cascade control. Mass spectrometry 
analysis shows this to be Cse1 with the linker and part of the C-terminal end of 
FokI (Figure S1). The ratio of intact and shortened fusion protein varied between 
purifications, but optimized expression and isolation resulted in 65-75% of intact 
FokI-Cse1 (Figure 2B). Degradation of FokI-Cse1 continues after purification at 37 
°C, leading to near complete cleavage of the fusion complex within a few hours 
(data not shown). Protein was therefore snap frozen in liquid nitrogen and stored 
at -80 °C. Unfortunately, we were not yet successful in utilizing the His-tag on FokI 
to perform a two-step purification that should assure only fully intact complexes to 
be purified.
 Since Cascade is a multiprotein complex, we questioned if it remains intact 
at elevated salt concentrations. High salt concentrations are often used during 
purification to achieve higher purities. Furthermore, a novel method of protein 
transfection into mammalian cells (iTOP) exposes the protein to NaCl concentrations 
above 1 M (D’Astolfo et al., 2015). To test the salt stability of the complex, we used 
increasing salt concentrations during the washing step of the affinity purification. 
Increasing salt concentrations resulted in a decrease of overall protein yield from 500 
mM NaCl onwards, however, the subunit stoichiometry remained constant (Figure 
2C). This shows that the complexes stay intact even at very high salt concentrations 
(2 M) and that the lower yield is likely caused by a lower binding strength of the 
strep tag at elevated salt concentrations. 
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Figure 3 – In vitro activity assays. FokI-Cascade complex activity is tested on plasmid DNA. Unless 
otherwise stated reactions are run for 30 minutes at 37 °C in a buffer containing 50mM Tris-HCl (pH 
7.5), 100 mM NaCl, 10 mM MgCl2 and 0.1 mg/ml BSA. For reference, a marker is included consisting 
of the three possible plasmid topologies (from top to bottom: Open circular (OC), linear, negatively 
supercoiled (nSC)). Vertical black lines indicate removal of gel lanes. A) Comparison of 5 buffers for 
optimal cleavage activity. Buffer 1 (10 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 50 mM NaCl, 0.1 mg/
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ml BSA), buffer 2 (50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 100 mM NaCl, 0.1 mg/ml BSA), buffer 3 
(10 mM Tris-HCl (pH 7.5 at 37°C), 10 mM MgCl2, 0.1 mg/ml BSA), buffer 4 (10 mM Tris-HCl (pH 8.5), 
10 mM MgCl2, 100 mM KCl, 0.1 mg/ml BSA), buffer 5 (50 mM KAc, 20 mM Tris-Ac (pH 7.9), 10 mM 
MgAc, 1 mM DTT). B) pTarget35 is incubated with FokIKKR/ELD-Cascade at a range of salt concentrations 
as indicated. C) pTarget with different distances between binding sites (25-50 nt) is incubated with 
FokIKKR/ELD-Cascade. D) pTarget35 is incubated with different amounts of either or with both FokIKKR/
ELD-Cascade complexes. A non-target plasmid is incubated with both complexes. E) Activity assay of 
cd8a targeting complexes.
In vitro cleavage activity
To assess the functionality of the FokI-Cascade complexes, we performed in vitro 
plasmid binding and cleavage assays. To this end, plasmids were created carrying 
the G8 and R44 protospacer at different distances (25-50 nt). These plasmids were 
incubated with FokIKKR/ELD-Cascade carrying anti R44 and G8 crRNA respectively. 
Plasmids containing only one or no binding sites served as controls.
DNA binding is not affected by FokI-fusion
Initially, we tested binding of the complexes to plasmid DNA. This was done by 
omitting Mg2+ ions from the incubations, preventing DNA cleavage but allowing 
binding of the FokI-Cascade complexes to the plasmids. We tested the binding 
using electrophoretic mobility shift assays (EMSA) using similar protein to DNA 
molar ratios that lead to full DNA binding with native Cascade complexes (Künne 
et al., 2016; Künne et al., 2015; Westra et al., 2012c). Either complex alone caused 
a single upwards shift of the target DNA, while adding both complexes caused a 
double upwards shift (Figure 2D). Non-target DNA was not shifted. This shows that 
the addition of the FokI domain and peptide linker do not interfere with the DNA 
binding ability of the Cascade complex.
FokI-Cascade cleaves specifically at physiological conditions
First we determined the spectrum of reaction buffers that result in the best 
cleavage performance. To this end we tested a range of commercial restriction 
enzyme buffers (Figure 3A). All tested buffers resulted in the generation of double-
stranded breaks in a target plasmid, with only slightly different efficiencies. 
However, the buffers resulted in different degrees of non-specific nicking of a non-
target plasmid. Especially Buffer 3 resulted in strong non-specific nicking activity. 
Buffer 3 has the lowest salt concentration and thereby likely promotes non-specific 
weak binding of the FokI-Cascade complexes to DNA. To test whether an increase 
in salt concentration can further improve specificity of the system, we performed 
reactions with Buffer 2 (100 mM NaCl) and increased the salt concentration to 150 
and 200 mM (Figure 3B). Increasing the salt concentration had only a mildly positive 
effect on the specificity but also reduced the overall cleavage activity on the target 
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plasmid. No cleavage was observed at 200 mM. FokI-Cascade is therefore able to 
cleave specifically in salt concentrations between 50 mM (Buffer 1) and 150 mM. 
This is well in agreement with physiological salt concentrations in most cell types 
and suggests that the system can produce double stranded breaks at physiological 
conditions with a low risk of off-target cleavage.
FokI-Cascade tolerates flexible target site distances
Next we determined the optimal distance between the two binding sites in the 
DNA that allow binding of the FokIKKR/ELD-Cascade complexes and dimerization of 
the FokI domains for efficient cleavage. We tested distances from 25 to 50 nt in 5 
nt increments (Figure 3C). DSBs are generated efficiently when binding sites were 
separated by 30, 35 and 40 nucleotides. At 25, 45 and 50 nucleotides, the target 
plasmid was mostly nicked. A distance of 30-40 nt is thus ideal to allow correct 
dimerization of the FokI domains and formation of DSBs. Shorter or longer distances 
likely interfere with correct dimerization or binding of the FokI domains to the DNA, 
leading to incomplete cleavage. This flexibility in distance between target sites 
strongly increases the chance to find properly spaced target sites in any given locus.
Ideal conditions result in efficient and highly specific DSB formation
Finally, we tested the system in ideal conditions at different protein concentrations. 
Incubation with either one of the complexes resulted in negligible activity, while 
incubation with both complexes efficiently produced double stranded breaks (Figure 
3D). In addition, the activity on the non-target plasmid is comparable to reactions 
with either of the protein complexes, showing a low degree of non-specific activity. 
Near complete cleavage was achieved after 30 minutes with 3 µg of protein which 
corresponds to a 36 fold molar excess of protein to DNA. In addition to the R44/
G8 targeting complexes we also produced complexes targeting the cd8a gene of 
zebrafish. These complexes exhibited comparable levels of activity and specificity 
in vitro (Figure 3E). 
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Figure 4 – Cleavage site determination. A) Linear plasmid products after in vitro assay were isolated, 
ends filled in with Klenow polymerase, religated and cloned. Klenow fill in introduces extra nucleotides, 
identical to the overhang created by FokI cleavage. B) Cloned plasmids were sequenced and mapped 
to original sequence to reveal extra nucleotides and thereby the cleavage sites. Identically coloured 
scissors represent staggered cut sites in both DNA strands with respective frequencies. Numbers in 
between basepairs represent position in between the two binding sites.
Cleavage site determination
After showing specific cleavage activity of the system, we set out to determine the 
cleavage site. We chose the target plasmid with a 35 nt spacing and isolated the 
linear cleavage products from an agarose gel after a typical cleavage reaction. We 
assumed that FokI cleavage would result in recessed 3’ ends as for the native FokI 
enzyme. We filled in the recessed 3’ ends with the Klenow fragment of the E. coli 
DNA polymerase to create blunt ends (Figure 4A). The linear vector was then self-
ligated, transformed and sequenced. Filling in of recessed 3’ ends and re-ligation 
will lead to extra nucleotides in the sequence that represent the overhang left by 
FokI cleavage. Figure 4B shows the original sequence of pTarget35, with indicated 
top- and bottom-strand cleavage sites. We sequenced seventeen clones and these 
all showed cleavage around the centre in between the two target sites, creating 
varying overhangs between 3 and 5 nt. Overhangs of 4 nt are most abundant 
(cumulatively 88%), while overhangs of 3 nt and 5 nt occur only once (6% each). 
This shows that all observed plasmid cleavage is likely specific to the target region 
and that the majority of the cleavage products have the expected 4 nt overhang.
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Figure 5 – FokI-Cascade-mRFP1. mRFP1 was fused to the C-terminus of Cse1 via a glycin or prolin 
linker. A) SDS-PAGE of FokI-Cascade-mRFP1 showing presence of fusion protein as well as partial 
degradation. B) In vitro activity assay with FokI-Cascade-mRFP1 and plasmid DNA. Target and non-
target plasmids have been incubated with both FokI KKR/ELD-Cascade-mRFP1 complexes.
mRFP1 fusion for visualization
One of the envisaged applications will be to inject or transfect the protein directly 
into prokaryotic and eukaryotic cells. Being able to visualize the protein would 
allow observing and quantifying transfection efficiency, and (in case of eukaryotes) 
nuclear import of the protein. To achieve this, we fused mRFP1 to the C-terminus 
of cse1, using either a glycine linker or a proline linker (Figure 1A). Both constructs 
yielded intact protein complexes with correct subunit stoichiometry (Figure 5A). 
Furthermore, the complexes retained full activity and specificity (Figure 5B). This 
fusion is also a proof of principle, showing that fusions of proteins with alternative 
functionalities can be made to the C-terminus of Cse1 without disrupting Cascade 
stoichiometry and function.
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Preliminary in vivo testing
To test whether our tool is functional in vivo, we tested protein injections into 
zebrafish embryos. We used the cd8a targeting complexes in order to induce indel 
mutations in the cd8a gene. Furthermore, we used the R44/G8 targeting complexes 
as a negative control. The protein was injected into the egg yolk of single cell 
embryos. Initially, we tested three different protein concentrations: 21 ng, 10 ng 
and 2.5ng. Unfortunately, after the first round of injections all injected embryos 
died, while non-injected embryos showed normal survival rates. We performed 
a second round of injections with the buffer flow through of the buffer exchange 
from the original elution buffer to the injection buffer. We did this to test for 
toxicity of buffer components or other possible toxic contaminants in our protein 
preparations. Injections resulted in 80 % mortality, while control injections with 
pure injection buffer resulted in 40-50 % mortality. While the control injections still 
result in unexpectedly high mortality, the purification buffer caused a significantly 
higher mortality. Unfortunately, we were not able to test any further injections and 
the results remain inconclusive at this point.
Discussion
The rapid development and widespread application of Cas9 has revolutionized 
genome editing in many areas of research. Other programmable nucleases such as 
ZFNs and TALENs can target and cleave a specific DNA sequence, however, CRISPR-
Cas9/Cpf1 is favored due to the simplicity of design and workflow and its high 
efficiency and specificity. 
 In this study, we developed a novel RNA-guided programmable nuclease for 
eukaryotic genome editing. We made use of the Cascade complex from the type I-E 
CRISPR-Cas system of E. coli (Brouns et al., 2008a; Jore et al., 2011a), and employed 
the dual FokI strategy similar to ZFNs and TALENs. A set of FokI-Cascade complexes 
has to bind in close proximity of each other (30-40 nt apart) and the target sites 
need to be flanked by inward facing PAMs (Figure 1D). Only when these criteria are 
met, hetero-dimerization of the FokI monomers occurs and the DNA is cleaved. We 
validated the tool in vitro and observed specific cleavage activity with two different 
pairs of guide RNAs.
 The base-pairing segment of the guide RNA of the Cascade complex is 32 
nt as compared to 18-20 nt for Cas9. Moreover, Cascade has been shown to bind 
much more stably to DNA than Cas9 in single molecule studies (Szczelkun et al., 
2014). Although Cascade tolerates mutations during CRISPR immunity in E.coli, and 
has positions in the crRNA that are not involved in base pairing (Fineran et al., 2014; 
Hayes et al., 2016), the binding affinity of Cascade towards mutated targets is strongly 
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reduced (Künne et al., 2016; Semenova et al., 2011; Westra et al., 2012c). Therefore, 
the use of two target sites with increased length lowers the range of potential off-
target sites, likely leading to reduced off-target activity. Cascade tolerates 5 different 
PAMs for CRISPR interference and therefore high binding affinity, while many other 
PAMs are bound with reduced affinity (Fineran et al., 2014; Westra et al., 2013; 
Xue et al., 2015). Whether this promiscuity affects specificity remains to be seen. 
However, the flexibility in PAM choice and the flexibility in distance between target 
sites creates a large pool of potential target sites, potentially enabling the accurate 
editing of any locus on a genome. 
 The double FokI fusion strategy has recently been successfully applied to 
Cas9 (Guilinger et al., 2014; Tsai et al., 2014). At the same time, Cas9 has been applied 
in a double nickase strategy, where two Cas9 monomers nick opposite strands 
independent of each other (Ran et al., 2013a; Shen et al., 2014). The FokI-Cas9 
strategy resulted in a lower frequency of undesired deletions, insertions and base-
pair substitutions than other techniques (Tsai et al., 2014). This is likely due to the 
obligate dimerization, while Cas9 nickases can cleave independently. Additionally, 
FokI-Cas9 is more stringent towards PAM orientation and target distance to allow 
for proper dimerization, which reduces the range of potential off-target sites (Ran 
et al., 2013a). These findings suggest that the dual FokI strategy can be superior to 
monomer-based approaches even for the appraised Cas9 tool. Taken together, it 
could therefore be interesting to have tools in addition to Cas9 in the form of other 
programmable RNA-guided proteins as the DNA binding module. 
 For practical application in genome editing, the FokI-Cascade system should 
be expressed and purified from E. coli. Purified protein can then be delivered into 
target cells by a range of techniques, including electroporation, microinjection, 
protein transfection and induced micropinocytosis (iTOP) (D’Astolfo et al., 2015). 
Studies on Cas9 have shown that direct introduction of protein into cells instead of 
expression constructs leads to highly efficiency editing (Kim et al., 2014; Lin et al., 
2014; Liu et al., 2015; Ramakrishna et al., 2014; Zuris et al., 2015). Furthermore, 
they revealed that off-target effects are lower when introducing protein, due to the 
limited lifetime of protein in the cell and better control over the dosage. Furthermore, 
introducing pre-assembled complexes prevents the risk of formation of guide free 
complexes, which in case of Cas9 have been found to cause DNA damage (Van der 
Oost, personal communication, June 18 2017). While expression constructs will 
lead to a permanent high level of Cas9 in the cell, which increases the chance for 
unwanted activity, injected protein will be broken down in the cells more rapidly, 
reducing the chance for off-target activity. The expression and purification of FokI-
Cascade is simple and fast although the proteolytic cleavage of the FokI domain still 
has to be addressed. An alternative linker sequence might be sufficient to achieve 
this, since there is no evidence for instability of the FokI domain itself. Minimal 
Chapter 7
7
180
CRISPR arrays carrying the desired guide RNA sequence can be made synthetically, 
cloned into an expression vector and included for protein expression. 
 Cascade has previously been shown to be capable of inducing stable, long-
lasting and multiplexed gene silencing when binding to the promoter region of a 
bacterial gene (Chang et al., 2016; Luo et al., 2015; Rath et al., 2014). Furthermore, 
a type I-A Cascade-like complex from Sulfolobus islandicus has been used to target 
its own genome to select for recombinants after genome editing by homologous 
recombination (Li et al., 2015). This shows that Cascade is able to stably and lastingly 
bind to genomic DNA at least in prokaryotes. 
 Another interesting application for this tool could be in vitro DNA assembly 
and editing. Recently, Cpf1 has been used to develop a new standard for DNA 
assembly called C-Brick (Li et al., 2016) and a method for efficient editing of large 
DNA constructs called “Cpf1-assisted cutting and Taq DNA ligase-assisted ligation” 
(CCTL) (Lei et al., 2017). Both methods make use of the ability of Cpf1 to introduce 
a staggered cut at any desired target site. The resulting sticky ends enable easy 
in vitro DNA assembly with minimal scars. This method is superior to restriction 
enzyme based methods as it does not require the removal of extra restriction sites 
from constructs. Similarly FokI-Cascade could be employed to cleave DNA parts 
in vitro, creating staggered ends for assembly or sub-cloning. One disadvantage, 
however, would be the need for sufficient flanking sequence on both sides of the 
desired cut site to allow binding of both FokI-Cascade complexes.
 In conclusion, we developed a novel programmable RGEN that introduces 
staggered cuts with high specificity in vitro. Attempts are currently ongoing to 
see whether this tool can be successfully applied in genome editing or in vitro 
applications.
Materials and Methods
Strains used in this study. E. coli BL21-AI/E. coli T7-express (protein expression), E. 
coli DH5α (cloning)
Plasmid construction. pWUR811/812 were constructed by replacing the Cas3 
sequence in pWUR657 (NcoI/BamHI) (Westra et al., 2012c) with an E. coli codon 
optimized FokI sequence, carrying the sharkey mutations and either the ELD or 
KKR dimerization interface mutations (Synthesized at GeneArt). Poly His-tag and 
dual monopartite SV40 NLS were added to make pWUR813/814 by digesting 
pWUR811/812 with NcoI and ligating annealed oligonucleotides carrying NcoI 
compatible overhangs (BG4112/4113) in front of the FokI sequence. pWUR815/816 
(glycine linker) and pWUR922/923 (proline linker) were made by PCR amplifying 
the FokI-Cse1 sequence lacking the stop codon (BG4899/5096 or BG4899/5098) 
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and ligating it together with the PCR amplified mRFP1 sequence (BG5097/4970 
or BG5099/4970) into pET52b (PscI/SalI/AvrII). pWUR 817-822 were synthesized 
at GeneArt, the non-target plasmid was made by digesting pT25 with EcoRI and 
SpeI to remove the target sites, blunting with Klenow polymerase and religation. 
pWUR918-921 were made by cloning a synthetic CRISPR array with 4 identical 
spacers (R44, G8, cd8a-1, cd8a-2 respectively) into pACYC (NcoI/XhoI). The cd8a 
target plasmid was constructed by PCR amplifying the cd8a gene from zebrafish 
genomic DNA using BG4905/4906 and cloning it into pUC19 (SmaI).
Preparation of Proteins. FokI-Cse1(-mRFP1), the strep-tagged Cas operon and one 
CRISPR array were co-expressed in fresh transformants of E. coli strain BL21 AI or 
E. coli strain T7 express. Complexes form in vivo and were subsequently affinity 
purified. Briefly, cells were collected by centrifugation and re-suspended in ice cold 
Buffer A (20 mM HEPES (pH 7.5), 75 mM NaCl, 1 mM DTT). Cells were lysed in a 
pre-cooled French press and kept on ice at all times. The lysate was cleared by 
centrifugation and filtering (0.45 µm pores). The clear lysate was incubated with 
strep tactin beads (IBA) at 4 °C for 20 minutes. The beads were collected by gentle 
centrifugation and loaded onto a gravity column. The beads were washed with 
Buffer A (then with 300 mM NaCl) and eluted in buffer B (20 mM HEPES (pH 7.5), 
75 mM NaCl, 1 mM DTT, 2.5 mM Desthiobiotin). Elutions were pooled and buffer 
exchanged/concentrated into Buffer A using Amicon Ultra filters (100 kDa MWCO). 
All proteins were flash frozen in liquid nitrogen and stored at -80 °C.
Proteolytic cleavage site determination. Discrete protein bands were cut from SDS-
PAGE and analyzed by MS-MS as previously described (Jore et al., 2011). 
In vitro activity assays. Activity assays were performed with the following conditions 
unless otherwise noted: Reactions were performed in a buffer containing 50 mM 
Tris-HCl (pH 7.5), 10 mM MgCl2, 100 mM NaCl, 0.1 mg/ml BSA for 30 minutes at 37 
°C. 1.5 µg of each FokI-Cascade complex was added to 200ng DNA (20:1 molar ratio 
protein:DNA). Reactions were stopped on ice and immediately processed by PCI 
extraction to separate protein and DNA. DNA was analyzed on a 0.8% agarose gel 
stained with SYBR Safe (Thermo Scientific), the gel was visualized using a UV-imager 
(Syngene/Bio-Rad). 
Cleavage site determination. After regular activity assays, the linearized plasmid 
fraction was isolated from an agarose gel (GeneJet gel isolation Kit, Thermo 
Scientific) and treated with the Klenow fragment of DNA polymerase I (Thermo 
Scientific) according to manufacturer’s protocol to fill in the recessed 3’ ends. 
Blunt ends were re-ligated using T4 DNA ligase (Thermo Scientific) according to 
manufacturer’s protocol. Re-circularized plasmids were transformed into E. coli 
and individual clones were sequenced (GATC Biotech). Sequences were mapped 
to the original plasmid to reveal the extra nucleotides incorporated by the Klenow 
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fragment. 
Electrophoretic mobility shift assay. Plasmids and purified protein complexes were 
incubated for 30 minutes at 37 °C to reach binding equilibrium. Reactions were 
performed in a buffer containing 20 mM HEPES (pH 7.5), 75 mM NaCl and 1 mM 
DTT. Samples were run on a native 0.8% agarose gel for 18 h at 20 mA in sodium 
borate buffer. After electrophoresis the gel was stained with SYBR Safe (Thermo 
Scientific) for 20 minutes, rinsed with demineralized water and visualized using a 
UV-imager (Syngene/Bio-Rad).
Zebrafish injections. Purified protein was buffer exchanged into egg buffer (60 µg/
ml Instant Ocean® Sea Salt) and concentrated using Amicon Ultra filters (100 kDa 
MWCO). The buffer flow through of the buffer exchange/concentration step was 
collected and used as a buffer toxicity control for injections. The protein solution 
was supplemented with phenol red as tracking dye and 1x Tango buffer (Thermo 
Scientific). 1 nl of the final solution was microinjected into the yolk of single cell 
zebrafish embryos.
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Figure S1 – MS analysis of FokI-Cse1 fusion protein. The full FokI-Cse1 protein band and the smaller 
extra band were cut from an SDS PAGE gel and analyzed by MS-MS. Mapping of peptides detected in 
MS-MS (yellow) on FokI-Cse1 fusion protein sequence. The linker sequence is in bold and underlined.
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Table 1: Plasmids used in this study
Plasmid Backbone Description Source
pWUR656 pCDF1b Cas operon without Cse1 (Cse2-Cas5-Cas7-
Cas6e), N-terminal strep-tag on Cse2.
(Jore et al., 2011a)
pWUR811 pWUR657 pET52b-FokI-CseI (sharkey, KKR) This study
pWUR812 pWUR657 pET52b-FokI-CseI (sharkey, ELD) This study
pWUR813 pWUR811 pET52b-HIS-NLS-FokI-CseI (KKR) 6xHIS+sv40NLS This study
pWUR814 pWUR812 pET52b-HIS-NLS-FokI-CseI  (ELD) 6xHIS+sv40NLS This study
pWUR815 pET52b His-NLS-FokI-Cse1-mRFP1 (KKR, glycine linker) This study
pWUR816 pET52b His-NLS-FokI-Cse1-mRFP1 (ELD, glycine linker) This study
pWUR817 pMA-T pT25, P7(R44)/M13(G8) target sites, 25nt spacing This study
pWUR818 pMA-T pT30, P7(R44)/M13(G8) target sites, 30nt spacing This study
pWUR819 pMA-T pT35, P7(R44)/M13(G8) target sites, 35nt spacing This study
pWUR820 pMA-T pT40, P7(R44)/M13(G8) target sites, 40nt spacing This study
pWUR821 pMA-T pT45, P7(R44)/M13(G8) target sites, 45nt spacing This study
pWUR822 pMA-T pT50, P7(R44)/M13(G8) target sites, 50nt spacing This study
pWUR823 pMA-T pNon-target, Target sites removed This study
pWUR918 pACYC CRISPR array with 4x R44 spacer This study
pWUR919 pACYC CRISPR array with 4x G8 spacer This study
pWUR920 pACYC CRISPR array with 4x cd8a-1 spacer This study
pWUR921 pACYC CRISPR array with 4x cd8a-2 spacer This study
pWUR922 pET52b His-NLS-FokI-Cse1-mRFP1 (KKR, proline linker) This study
pWUR923 pET52b His-NLS-FokI-Cse1-mRFP1 (ELD, proline linker) This study
pWUR924 pUC19 Cd8a target plasmid This study
Table 2: Oligonucleotides used in this study
Name Sequence Description
BG4112 CATGcatcaccatcatcaccacCCGAAAAAAAAGCGCAAAGTG-
GATCCGAAGAAAAAACGTAAAGTTGAAGATCCGAAAGA
HIS tag+SV40 NLS fw
BG4113 CATGTCTTTCGGATCTTCAACTTTACGTTTTTTCTTCGGATC-
CACTTTGCGCTTTTTTTTCGGgtggtgatgatggtgatg
HIS tag+SV40 NLS rv
BG4899 AGTACATGTTGCATCACCATCATCACCACCCGAA Fok1-Cse1(HIS/NLS) fw PscI
BG4905 TTTATTAGGCATTCAGCATGAAATA Cd8 target fw
BG4906 TGCAGACATGGTCAGTTTTTCT Cd8 target rv
BG4970 Gcgcctagggttattaagcaccggtggagtga mRFP1 rv
BG5096 ccagtcgacccgccgccaccagaGCCATTTGATGGCCCTCCTT Fok1-Cse1 reverse (glycine-SalI)
BG5097 cgggtcgactggtATGGCTTCCTCCGAAGA mRFP1 forward (glycine-salI)
BG5098 ggggtcgacggggttggtgtGCCATTTGATGGCCCTCCTTG Fok1-Cse1 reverse (proline-SalI)
BG5099 cccgtcgaccccaATGGCTTCCTCCGAAGA mRFP1 forward (proline-salI)
Chapter 8
Thesis summary
Chapter 8
 186
8
Host-pathogen interactions are among the most prevalent and evolutionary 
important interactions known today. The predation of prokaryotes by their 
viruses is happening on an especially large scale and had a major influence on the 
evolutionary history of prokaryotes. Since most viruses are lytic at some point in 
their life-cycle, there is a high selection pressure for prokaryotes to develop defense 
mechanisms. As described in Chapter 1, the CRISPR-Cas system is a relatively recently 
discovered defense system and is also the first adaptive defense system discovered 
in prokaryotes. CRISPR-Cas systems are widespread, occurring in the majority of 
archaea and also a considerable fraction of bacteria. This diversity is also reflected 
in the diversity of different types of CRISPR-Cas systems, currently being divided into 
6 major types with a large number of subtypes. The type I-E system of Escherichia 
coli is a well-studied model system and of high relevance, since it is a major subtype 
of type I systems which make up around 50 % of all discovered CRISPR-Cas systems. 
CRISPR-Cas systems basically comprise the CRISPR array, made up of repeats and 
foreign derived spacers, and a set of cas genes. Immunity is commonly divided into 
three functional stages, adaptation, expression and interference. Adaptation is the 
acquisition of new spacers from the foreign nucleic acid and its incorporation into 
the CRISPR array. During expression, the CRISPR array is transcribed, processed and 
assembled with Cas proteins into CRISPR RNA (crRNA) guided ribonucleoprotein 
complexes (crRNP). Interference is the detection, binding and destruction of foreign 
nucleic acids by the crRNP and in type I systems the Cas3 nuclease. The type I-E 
system contains another function, called primed adaptation. Primed adaptation is 
a more rapid and efficient version of regular (naïve) adaptation. In addition to the 
adaptation machinery, primed adaptation also requires the interference machinery.
Chapter 2 describes and compares a fundamental feature of most, if not all, 
CRISPR-Cas systems and also many other small RNA based systems. The mode of 
action of small RNAs relies on protein-assisted base pairing of the guide RNA with 
target mRNA or DNA to interfere with their transcription, translation or replication. 
Several unrelated classes of small non-coding RNAs have been identified including 
eukaryotic RNA silencing associated small RNAs, prokaryotic small regulatory RNAs 
and prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats) 
RNAs. All three groups identify their target sequence by base pairing after finding 
it in a pool of millions of other nucleotide sequences in the cell. In this complicated 
target search process, a region of 6 to 12 nucleotides of the small RNA termed the 
‘seed’ plays a critical role. The seed is often a structurally pre-ordered region that 
increases accessibility and lowers the energy barrier of RNA-DNA duplex formation. 
Furthermore, the length of the seed is optimally chosen to allow rapid probing and 
also rejection of potential target sites. The seed is a perfect example of parallel 
evolution, showing that nature comes up with the same strategy independently 
multiple times.
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Chapter 3 provides a description and protocol of the Electrophoretic Mobility 
Shift Assay (EMSA) and its use for studying crRNPs. EMSA is a straightforward and 
inexpensive method for the determination and quantification of protein–nucleic 
acid interactions. It relies on the different mobility of free and protein-bound nucleic 
acid in a gel matrix during electrophoresis. Nucleic acid affinities of crRNPs can be 
quantified by calculating the dissociation constant (Kd ). Protocols for two types 
of EMSA assays are described using the Cascade ribonucleoprotein complex from 
Escherichia coli as an example. One protocol uses plasmid DNA as substrate, while 
the other uses short linear oligonucleotides. Plasmids can be easily visualized with 
traditional DNA staining, while oligos have to be radioactively labelled using the 
32Phosphate isotope. The EMSA method and these protocols are applied throughout 
the other chapters of this thesis.
Chapter 4 focusses on the processes of interference and primed adaptation, 
specifically on their tolerance of mutations. Invaders can escape Type I-E CRISPR-
Cas immunity in E. coli by making point mutations in the protospacer (especially 
in the seed) or its adjacent motif (PAM), but hosts quickly restore immunity by 
integrating new spacers in a positive feedback process termed priming. Here, we 
provide a systematic analysis of the constraints of both direct interference and 
subsequent priming in E. coli. We have defined a high-resolution genetic map 
of direct interference by Cascade and Cas3, which includes five positions of the 
protospacer at 6 nt intervals that readily tolerate mutations. Importantly, we show 
that priming is an extremely robust process capable of utilizing degenerate target 
regions with up to at least eleven mutations throughout the PAM and protospacer 
region. Priming is influenced by the number of mismatches, their position and is 
nucleotide dependent. Our findings imply that even out-dated spacers containing 
many mismatches can induce a rapid primed CRISPR response against diversified or 
related invaders, giving microbes an advantage in the co- evolutionary arms race 
with their invaders.
In Chapter 5 we elucidate the mechanism of priming. Specifically, we determine how 
new spacers are produced and selected for integration into the CRISPR array during 
priming. We show that priming is directly dependent on interference. Rapid priming 
occurs when the rate of interference is high, delayed priming occurs when the rate 
of interference is low. Using in vitro assays and next generation sequencing, we show 
that Cas3 couples CRISPR interference to adaptation by producing DNA breakdown 
products that fuel the spacer integration process in a two-step, PAM-associated 
manner. The helicase-nuclease Cas3 pre-processes target DNA into fragments of 
about 30–100 nt enriched for thymine-stretches in their 3’ ends. By reconstituting 
the spacer integration process in vitro, we show that the Cas1-2 complex further 
processes these fragments and integrates them sequence- specifically into CRISPR 
repeats by coupling of a 3’ cytosine of the fragment. Our results highlight that the 
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selection of PAM-compliant spacers during priming is enhanced by the combined 
sequence specificities of Cas3 and the Cas1-2 complex, leading to an increased 
propensity of integrating functional CTT-containing spacers.
In Chapter 6 we look deeper into a nucleotide specific effect on priming that 
was discovered in Chapter 4. Immunity is based on the complementarity of host 
encoded spacer sequences with protospacers on the foreign genetic element. The 
efficiency of both direct interference and primed acquisition depends on the degree 
of complementarity between spacer and protospacer. Previous studies focused 
on the amount and positions of mutations, not the identity of the substituted 
nucleotide. In Chapter 4, we describe a nucleotide bias, showing a positive effect on 
priming of C substitutions and a negative effect on priming of G substitutions in the 
basepairing strand of the protospacer. Here we show that these substitutions rather 
directly influence the efficiency of interference and therefore indirectly influence 
the efficiency of interference dependent priming. We show that G substitutions 
have a profoundly negative effect on interference, while C substitutions are readily 
tolerated when in the same positions. Furthermore, we show that this effect is 
based on strongly decreased binding of the effector complex Cascade to G mutants, 
while C mutants only minimally affect binding. In Chapter 5 we showed a connection 
between the rate of interference and the time of occurrence of priming. Here, we 
also quantify the extent of priming and show that priming is very prevalent in a 
population that shows intermediate levels of interference, while high or low levels 
of interference lead to a lower prevalence of priming.
Chapter 7 describes an attempt to make use of our knowledge about the Cascade 
complex and develop it into a genome editing tool. The development of genome 
editing tools has made major leaps in the last decade. Recently, RNA guided 
endonucleases (RGENs) such as Cas9 or Cpf1 have revolutionized genome editing. 
These RGENs are the hallmark proteins of class II CRISPR-Cas systems. Here, we have 
explored the possibility to develop a new genome editing tool that makes use of the 
Cascade complex from E. coli. This RNA guided protein complex is fused to a FokI 
nuclease domain to sequence specifically cleave DNA.  We validate the tool in vitro 
using purified protein and two sets of guide RNAs, showing specific cleavage activity. 
The tool requires two target sites of 32 nt each at a distance of 30-40 nt and inward 
facing three nucleotide flexible PAM sequences. Cleavage occurs in the middle 
between the two binding sites and primarily creates 4 nt overhangs. Furthermore, 
we show that an additional RFP can be fused to FokI-Cascade, allowing visualization 
of the complex in target cells. Unfortunately, we were not able to successfully apply 
the tool in vivo in eukaryotic cells.
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The CRISPR hype
CRISPR-Cas systems have just been discovered around 15 years ago and their 
research has already made an amazing journey. Everything started with just a 
handful of people, excited by these hypothetical prokaryotic defence systems and 
driving forward the fundamental understanding of their function and mechanisms. 
Initially, the field only grew slowly as more groups joined in. However, in 2013 the 
field exploded due to the discovery that Cas9 can be used for precision genome 
editing. However, despite the genome editing hype, fundamental research into the 
mechanisms of CRISPR-Cas for all known systems remains important. In this thesis, 
I elucidated molecular mechanisms of the type I-E CRISPR-Cas system in Escherichia 
coli and I developed the Cascade complex into a Cas9-like RNA guided nuclease for 
genome editing purposes.
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Archaea Bacteria
Figure 1 – Distribution of CRISPR-Cas systems. Adapted from (Makarova et al., 2015). Chart de-
picting the proportions of most currently known CRISPR-Cas systems, including subtypes, among 
archaea (left) and bacteria (right).
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Regulation and ecological significance of CRISPR-Cas
Many organisms contain highly active CRISPR-Cas systems, that are either 
constitutively expressed or upregulated upon phage infection (Agari et al., 2010; 
Barrangou et al., 2007; Deltcheva et al., 2011; Shinkai et al., 2007). In addition, 
several systems are regulated by quorum sensing, leading to upregulation at high 
cell densities (Hoyland-Kroghsbo et al., 2017; Patterson et al., 2016). Few additional 
regulatory pathways have been discovered, showing a lack of understanding of 
CRISPR-Cas regulation (Patterson et al., 2017). 
Type I-E in E. coli
The type I-E system in E. coli on the other hand, is tightly regulated and cas gene 
expression is almost completely repressed under laboratory conditions (Pul et al., 
2010; Westra et al., 2010). The global regulatory protein HNS is responsible for this 
repression and de-repression is possible via the transcriptional activators LeuO and 
BaeS (Perez-Rodriguez et al., 2011; Westra et al., 2010). The latter is part of the 
BaeSR system that is involved in sensing membrane stress. This might suggest that 
the CRISPR-Cas system in E. coli can be upregulated by sensing membrane stress 
following phage infection. Another gene product required for an efficient immune 
response is the chaperone HtpG, which is essential for Cas3 stability and activity 
(Yosef et al., 2011). Cas3 has been shown to be a limiting factor in type I-E immunity 
in E. coli and HtpG can be induced by phage infection (Majsec et al., 2016; Poranen 
et al., 2006). Interestingly, expression of the CRISPR array seems to be constitutive 
in E. coli, although it can be modulated by regulatory proteins (Pul et al., 2010). 
 Despite the identification of a number of regulators, to date no growth 
conditions have been identified that lead to active expression of cas genes in E. 
coli. Instead, overexpression has to be conducted either with ΔHNS strains or with 
strains in which the native cas promoter has been substituted by a constitutive/
inducible counterpart. This raises the question whether the system is active at 
all in nature and in how far experiments using artificial expression levels reflect 
the natural situation. One way to analyse the activity of the system in nature is 
to look at the diversity of spacers in different E. coli isolates, which should mirror 
the spacer acquisition activity. A few studies have analysed the spacer diversity 
in reference strains and natural isolates, revealing a very low diversity in spacer 
content (Diez-Villasenor et al., 2010; Savitskaya et al., 2016; Touchon et al., 2011). 
Moreover these studies showed that the spacer content between strains was either 
highly similar or completely different, suggesting only rare but radical turnover of 
spacers rather than gradual acquisition. This suggests that the type I-E system in E. 
coli might not function like a traditional CRISPR-Cas immune system. However, the 
system is functionally conserved and when expressed, it functions like a traditional 
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CRISPR-Cas immune system. Therefore, there must be a certain selection pressure 
in the natural environments of E. coli to maintain the functionality of the type I-E 
system.
 The type I-E system is not limited to E. coli, it is rather wide spread among 
bacteria (Figure 1) (Makarova et al., 2015). For example, Streptococcus thermophilus 
and Thermus thermophilus both contain type I-E systems, in addition to a number 
of other systems, and both have been shown to up-regulate type I-E expression 
during phage infection (Agari et al., 2010; Young et al., 2012). Furthermore, the high 
prevalence of type I systems in prokaryotes, the mechanistic similarities between 
type I systems, and the importance of E. coli as a model system, have made the type 
I-E system a very well-studied CRISPR-Cas model. 
 Prokaryotes possess a multitude of defence strategies against phage 
infection, most of which are less complex than CRISPR-Cas. Examples of more simple 
strategies include receptor masking or loss, or blocking of phage DNA injection 
(Westra et al., 2012b). This brings up the question of the relative impact of each of 
these strategies on cell survival and on population dynamics. Undoubtedly, some of 
these strategies can work together as subsequent layers of defence, cumulatively 
reducing the risk of infection. But the relative ecological significance of the different 
defence strategies, especially CRISPR-Cas, remains largely unstudied. Recently, 
efforts have been made to study the fitness cost, selective advantage and ecological 
significance of the type I-F system in Pseudomonas aeruginosa (van Houte et al., 
2016; Westra et al., 2015). The authors compared the evolution of constitutive 
defence strategies such as receptor modification with the inducible CRISPR-Cas 
defence. These systems have a constitutive and induced fitness cost for the host, 
respectively (Agari et al., 2010; Lenski, 1988; Quax et al., 2013; Young et al., 2012). 
Initially, theoretical modelling and experimental evolution experiments revealed 
that constitutive defence is strongly favoured in high resource environments (>95%), 
while inducible defence is strongly favoured in low resource environments (>95%) 
(Westra et al., 2015). The authors then linked this behaviour to the differences in 
cell and phage density in the different environments. High resource environments 
produce high cell densities and high virus titres, which creates a high infection risk, 
while low resource environments produce low cell densities and low virus titres, 
which creates a low infection risk. Finally, increasing virus concentrations were 
shown to gradually decrease the prevalent evolution of CRISPR-Cas defence in low 
resource environments and instead lead to the evolution of receptor modification. 
Furthermore, cells that carry receptor modifications show a fitness advantage 
over cells that carry CRISPR-Cas defence, outcompeting them in a high phage 
environment. This shows that, while the inducible CRISPR-Cas system can be an 
energy efficient alternative to constitutive defence, it suffers from high relative 
fitness costs at high virus pressures. In conclusion, CRISPR-Cas defence is likely 
General discussion
193
9
only of ecological significance in environments with relatively low cell and phage 
densities. This might explain the higher relative prevalence of CRISPR-Cas systems 
in archaea compared to bacteria, since archaea typically occur in low density 
environments with less phage exposure (Weinberger et al., 2012). 
 In this context, it would be very interesting to study the evolution of CRISPR-
Cas defence in E. coli in response to phage exposure, granting that laboratory 
conditions can be found that allow activation of the system. The natural environment 
of E. coli, the gut, has the highest bacterial density of any known environment, with 
likely high phage prevalence (Actis, 2014). The CRISPR-Cas system might therefore 
not be the defence strategy of choice for E. coli, which might explain why it seems 
to be inactive. This still leaves us with the question, why the system is functionally 
conserved in E. coli and supports the idea that it might have alternative functions. 
With the advent of human microbiome studies in recent years, a lot of metagenomics 
data is becoming available that includes E. coli and phage sequences. This data 
might help with our understanding of the phage-host interaction and ecological 
relevance of the CRISPR-Cas system in the natural environment of E. coli.
Seed sequences in crRNA guided effector complexes
The increasing number of crystal structures of crRNPs with or without their nucleic 
acid targets enabled a more detailed description of the seed sequences in CRISPR-
Cas systems (see also Chapter 2). To date, seed sequences have been identified 
in type I, type II and type V systems, which are also the systems that make use 
of PAM sequences (Jinek et al., 2012; Semenova et al., 2011; Swarts et al., 2017; 
Wiedenheft et al., 2011b). In addition a potential seed was recently described for 
the RNA-targeting type VI system (Abudayyeh et al., 2016). The RNPs in all these 
systems have very diverse architectures and also the crRNA conformations vary 
strongly. While the crRNA in the type I-E system is tightly bound to the protein by its 
5’ end, its 3’ end and several positions throughout the crRNA (Jackson et al., 2014; 
Mulepati et al., 2014; Zhao et al., 2014), type II and type V systems only anchor the 
crRNA at its 3’ end or 5’ end, respectively (Dong et al., 2016; Gao et al., 2016; Hirano 
et al., 2016; Jinek et al., 2014; Nishimasu et al., 2015; Nishimasu et al., 2014; Swarts 
et al., 2017; Yamada et al., 2017; Yamano et al., 2016). This also has consequences 
for the mechanism of target DNA binding and seed sequence identity. The crRNA 
in Cas9 only has a 3’ repeat handle that is duplexed with the anti-repeat part of 
the tracrRNA and tightly bound to the protein. At the 3’ end of the spacer, next 
to the repeat handle, the ~10 nt seed is located that is pre-ordered in an A-form 
helix, while the 5’ part of the spacer is flexible and not tightly associated to the 
protein. Target DNA binding is achieved by PAM recognition in the DNA, subsequent 
strand separation and base-pairing with the pre-ordered seed (Hayes et al., 
2016; Sternberg et al., 2014; Szczelkun et al., 2014). Base pairing then continues 
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throughout the rest of the spacer to form a complete duplex. This is achieved by 
wrapping of the flexible 5’ end of the crRNA around the DNA target strand. Cpf1 
employs a similar mechanism, although PAM-protospacer are mirrored compared 
to Cas9 and details between Cpf1 homologs vary. While Francisella novicida Cpf1 
uses a preordered seed for DNA binding (Swarts et al., 2017), Lachnospiraceae 
bacterium and Acidaminococcus sp. Cpf1 both contain disordered seeds (Dong et 
al., 2016; Gao et al., 2016). However, in these two cases the seed is speculated to 
become ordered upon PAM binding (Gao et al., 2016). 
 The type I-E Cascade complex on the other hand contains a 5’ and a 3’ 
repeat handle that are both tightly bound to the protein (Wiedenheft et al., 2011a). 
Furthermore the crRNA extensively interacts with a thumb-domain of the Cas7 
backbone subunits at every 6th base (Jackson et al., 2014; Mulepati et al., 2014; 
Zhao et al., 2014). The 5 nucleotide segments in between these positions are all 
preordered in a near-A form helix, while the interacting bases are flipped and not 
available for base pairing (see also Chapter 4). Although this may suggest that 
all segments are potential seed sequences, only the first 2 segments are easily 
accessible for target DNA, while the other segments are partially obstructed by the 
Cse2 dimer (Zhao et al., 2014). In addition, like in Cas9 and in Cpf1, the seed in 
Cascade is adjacent to the PAM and target binding has been shown to initiate at the 
PAM and continue with the seed (Redding et al., 2015; Szczelkun et al., 2014). An 
interesting question remains: why does the seed include positions 1-5 and 7-8 and 
not the entire first 2 segments or only the first segment? This might be explained 
by the structure as well, since bases 7 and 8 point in a similar direction as bases 
1-5 (Zhao et al., 2014). Another explanation is that 7 base pairs have been shown 
to be the optimal length to produce a thermodynamically stable interaction while 
still being short enough to allow rapid association and dissociation (Cisse et al., 
2012). In addition it has been shown for human Argonaute that 7 base pairs make 
a stable interaction, while 6 base pairs rapidly dissociate again (Chandradoss et al., 
2015). This behaviour cannot be explained by thermodynamics alone and is actually 
influenced by amino acid residues of the Argonaute protein. As a consequence of 
the rigid crRNA structure in Cascade, complete base pairing with the target DNA is 
not possible. Instead, the non-contiguous segments of 5 bases each pair with the 
target DNA, without RNA and DNA forming a double helix (as in Cas9 and Cpf1) . 
 For Cascade also PAM and seed-independent binding was described (Blosser 
et al., 2015). While this binding is shorter lived than canonical binding, it still is a 
specific interaction. It remains unknown how and where the base-pairing interaction 
is initiated in the absence of a PAM and seed match. The PAM has been described 
to be an essential mechanistic element in dsDNA binding, since it is required for 
initial strand invasion and local unwinding of the DNA strands to allow pairing with 
the crRNA (Hayes et al., 2016). It is therefore unclear how PAM-independent dsDNA 
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binding of Cascade is achieved. Cascade prefers negatively-supercoiled (nSC) target 
DNA, and it has been shown that the supercoiling energy helps with local unwinding 
of the DNA, making it more accessible (Westra et al., 2012c). This feature might be 
especially relevant in PAM-independent binding, by allowing the crRNA to pair with 
the target strand without prior PAM assisted strand invasion. 
 The definition of the seed is very clear from a structural point of view. But 
a number of studies have shown that the seed is not clearly defined based on its 
mutation tolerance. Initially the seed was believed to be completely intolerant to 
mutations and was therefore defined to a certain length (Jinek et al., 2012; Semenova 
et al., 2011; Wiedenheft et al., 2011b). Recently, the plethora of genome editing 
applications of Cas9 and a systematic study of many different spacer sequences 
in Cascade have shown that the mutation tolerance of the seed is dependent on 
the individual spacer sequence and possibly the conditions of the experiment 
(Hsu et al., 2013; Xue et al., 2015). It is possible that a GC-rich seed can tolerate 
mutations better than an AT-rich seed due to higher thermodynamic stability, 
although experimental evidence to support this is currently lacking. In conclusion, 
the seed plays a primary role in facilitating the rapid target search, by allowing fast 
probing and fast rejection of potential target sites near canonical PAMs. This effect 
is accomplished by the structural accessibility and the pre-ordering of the seed that 
decreases the entropic penalty of dsDNA unwinding and R-loop formation.
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Figure 2 – Cascade binding saturation. A) Examples of two binding curves, one with an amplitude 
of ~1, and one with an amplitude of <1. Reference points for Kd determination are indicated. B) Two 
formulas for regression analysis of Cascade-DNA binding curves. In the past, the simplified formula 
was often used, because the amplitude was assumed to be 1. 
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DNA binding property of Cascade
One intriguing observation that we and others made when performing EMSAs with 
Cascade, is that some protospacer mutants do not reach full binding/saturation 
with protein-guide complexes (Chapter 5/6) (Hochstrasser et al., 2014). In some 
cases, even at very high protein to DNA ratios, less than 50 % of the DNA was bound 
by protein (Figure 2A). The shape of the binding curve in these cases also suggests 
that maximal binding is reached. Usually the Kd is considered as the protein 
concentration at which half of the DNA is bound and therefore the amplitude is 
assumed to be 1 (see Chapter 3). But technically the Kd is the concentration where 
half of the maximal binding is reached. Since we are dealing with a non-constant 
amplitude (maximum fraction of bound DNA), this adds another variable in the 
binding formula (Figure 2B). Therefore, if the maximum is not constant, we cannot 
fairly compare the Kd values with each other, because they have different reference 
points. This may lead to overestimation of the affinity when the maximum binding 
is low (Figure 2A, right graph). To circumvent this problem, we decided to represent 
the affinity by a ratio of the Kd and the amplitude rather than the Kd alone. No matter 
how the affinity is represented in the end, both parameters (Kd and amplitude) need 
to be considered to allow fair comparison of affinities. 
 There is currently no biochemical explanation that might explain why some 
protospacer mutants cannot be saturated to 100% binding even at high protein 
concentrations. It is, however, possible that this is an artefact of the EMSA and that 
these targets are saturated in solution. This could be connected to the different 
binding modes of Cascade with targets, which will be discussed in detail in the 
following paragraphs. Briefly, Cascade likely binds targets in a mixture of different 
binding modes, dependent on the mutations (Blosser et al., 2015; Rutkauskas et 
al., 2015; Xue et al., 2016). While the canonical binding mode is very stable, non-
canonical binding modes are short-lived. Thus, during EMSA, non-canonical binding 
potentially dissociates, leaving only a fraction of canonically bound targets intact. 
Whether this is true remains to be tested.
Priming acquisition
Ecological importance of naïve and primed adaptation
Naïve spacer acquisition in E. coli is very slow and inefficient, usually being virtually 
undetectable after 48 h both in ΔHNS as well as in the overexpression strains used 
in this thesis. This is in stark contrast to the rapid naïve spacer acquisition in many 
other organisms, especially with type II systems (Fineran and Charpentier, 2012). 
Interestingly, type II systems require Cas9 in addition to Cas1-2 for naïve acquisition, 
although Cas9 does not need to carry a spacer targeting the invader (Heler et al., 
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2015; Wei et al., 2015b). The mechanism and activity of spacer acquisition in all 
systems is likely tuned for an optimal balance between providing efficient immunity 
and reducing the risk of lethal self-spacer acquisition. Maybe type II systems have 
found a way to increase their naïve acquisition activity without increasing the risk 
for self-spacer acquisition using Cas9. It is also possible that in organisms with type 
II systems the benefits of a highly active naïve acquisition outweigh the cost of self-
spacer acquisition in light of a high virus burden. Several type I systems seem to 
have solved this problem by employing a low activity naïve acquisition mechanism 
that has a minimal risk for self-spacer acquisition. Naive acquisition is then 
supplemented by the highly active and highly target specific priming process, which 
leads to a rapid diversification of the spacer content. It is possible that the virus 
burden on organisms with type I systems is generally lower, making them prioritize 
low self-spacer acquisition over rapid immunization. While a single spacer might be 
sufficient to provide initial immunity against a particular virus or plasmid, escape 
mutants will quickly arise. The priming process is therefore vital to rapidly restore 
immunity against these escapers. But priming is not only important as a rapid 
response mechanism to escape mutants. By integrating additional spacers from a 
group of invaders that differ between host cells, a highly diverse immune repertoire 
is created. A recent study has shown that spacer diversity is a major determinant of 
population resistance to virus infection (van Houte et al., 2016). Bacterial populations 
with a high diversity in spacer content are able to drive viruses to extinction, while 
populations with low spacer diversity allow for the virus to coevolve and persist. The 
high-diversity-generating priming process therefore greatly reduces the success of 
viral escape by simple mutations. Consequently, viruses are under strong selection 
pressure to evolve sophisticated escape strategies, such as anti-CRISPR proteins 
(Bondy-Denomy et al., 2013; Pawluk et al., 2014; Pawluk et al., 2016), extensive 
genome recombination (Paez-Espino et al., 2015), or hijacked CRISPR-Cas systems 
(Seed et al., 2013).
Self-regulation and energy efficiency
The priming process in E. coli has been shown to be extremely robust and active 
against invaders, tolerating up to 13 mutations in their primed protospacer (Chapter 
4). Thus, priming is potentially active against invaders with only 60% sequence 
similarity to the spacer. However, priming can also be triggered by perfectly matching 
protospacers (Semenova et al., 2016; Staals et al., 2016; Swarts et al., 2012). 
Actually, it was shown that, when correcting for the copy number of an invader, 
perfectly matching protospacers trigger priming more efficiently than escape 
mutants (Semenova et al., 2016). However, when the copy number is considered, 
escape mutants trigger priming more efficiently. This is because escape mutants 
are degraded slower by the interference machinery and therefore persist in the 
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cell for a longer time, while perfect targets are rapidly cleared. Combined with the 
continuous replication in parallel to degradation, escape targets therefore present 
much more potential spacer substrates and more time for the acquisition machinery 
(Semenova et al., 2016; Severinov et al., 2016; Staals et al., 2016) (see also Chapter 
5). Thus priming acquisition is active against invaders that have recently donated a 
spacer (perfect match), against invaders that had time to accumulate some or many 
escape mutations, and even against related invaders that share sufficient sequence 
similarity. At the same time, the extent of priming is controlled by a combination of 
interference efficiency and target copy number/replication. This results in a system 
that is perfectly balanced to preserve energy by not acquiring extra spacers from 
targets that are already efficiently cleared from the cell, while maintaining the 
ability to rapidly acquire spacers if targeting is insufficient, for example when the 
target interference is reduced due to mutations or increased copy numbers.
Two distinct models of priming
It remains difficult to formulate a unified model of priming acquisition in E. coli. A 
number of studies all supply small parts of the puzzle that add up to our current 
understanding (Jackson et al., 2017). In the beginning, some of these studies 
seemed slightly contradicting, offering alternative models, but eventually lead 
us to believe that priming is a more complex process than initially anticipated. 
Currently, these contradictions are solved by a model that accepts the presence 
of two separate mechanisms of primed spacer acquisition, one being interference 
associated and one being interference independent (Figure 3). The interference-
dependent model was originally proposed by Swarts et al in our lab (Swarts et al., 
2012). This model has since been supported in E. coli by the work presented in 
this thesis (Chapter 5; (Künne et al., 2016)) and by others (Semenova et al., 2016); 
in addition, a similar mechanism has been demonstrated in the type I-F system 
of Pectobacterium atrosepticum (Staals et al., 2016). These studies show a direct 
quantitative connection between direct interference and resulting primed spacer 
acquisition, and we have shown for E. coli that Cas3-derived DNA degradation 
products can directly be used by Cas1 and Cas2 for spacer integration (Chapter 
5). This model holds true for protospacer mutants, but not PAM mutants. Many 
PAM mutants have been shown to be unable to trigger direct interference, because 
they are unable to trigger Cas3-mediated DNA degradation (Blosser et al., 2015; 
Hochstrasser et al., 2014; Mulepati and Bailey, 2013; Rutkauskas et al., 2015; Xue 
et al., 2015). These mutants are, however, still able to trigger priming acquisition 
(interference-independent priming). 
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Figure 3 – Two modes of priming. Schematic illustration showing the two current models of primed 
spacer acquisition and how they may be connected. We distinguish interference-dependent and 
independent priming. The former is triggered by any target that still causes (partial) interference, 
while the latter is dominantly triggered by PAM mutants that do not trigger interference. Interference 
permissible protospacers are dominantly forming a “locked” or canonical binding mode, while 
interference impermissible protospacer are dominantly forming “unlocked” or non-canonical binding 
modes. However, protospacers exist in an equilibrium of both binding modes with varying relative 
contributions. Canonical binding modes trigger Cas3 recruitment and target DNA degradation (direct 
interference). During DNA degradation, spacer precursors are generated by Cas3 that are captured 
by Cas1-2 and processed into spacers. Non-canonical binding modes trigger Cas1-2 dependent Cas3 
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recruitment, however, Cas3 is nuclease inactive. A hypothetical Cas1-2-3 supercomplex is formed 
and scans the DNA for PAMs/protospacers using Cas3 helicase activity. Either Cas3 or Cas1-2 directly 
cleave the spacer precursor from the target DNA.
Therefore, another priming model has been proposed in a single molecule study 
(Redding et al., 2015). The study shows that PAM mutants are only able to recruit 
Cas3 in the presence of Cas1-2 and that Cas3 is only displaying helicase activity, 
therefore being nuclease inactive. Their model predicts a supercomplex of Cas1-2-3, 
as originally suggested by (van der Oost et al., 2009), that is using the Cas3 helicase 
to move along the DNA while Cas1-2 is looking for potential new spacers. We initially 
hypothesized that this model might apply specifically to PAM mutants, since these 
are mechanistically different from protospacer mutants. However, recent studies 
have since provided evidence that suggests a more dynamic relationship between 
mutations (in PAM and protospacer) and the resulting immune response. 
Conformational effects
Especially the combination of three single molecule studies strongly suggests that 
there is a dynamic equilibrium of different Cascade (mainly the Cse1 subunit) 
conformations leading to different binding modes that determine the outcome 
(Blosser et al., 2015; Rutkauskas et al., 2015; Xue et al., 2016). A canonical, perfectly 
matching target, will almost exclusively lead to the ‘closed’ Cse1 conformation; this 
canonical binding mode triggers rapid direct interference. However, any mutation 
might, to a varying degree, shift this balance towards the ‘open’ Cse1 conformation 
(non-canonical binding mode). It seems that PAM mutants are especially powerful 
at shifting this balance, followed by seed mutants and at last non-seed protospacer 
mutants. The extent to which each mutant skews the balance between binding 
modes likely also depends on the relative binding affinities of the modes for each 
particular mutant. Blosser et al. have shown that the non-canonical binding mode 
is much shorter lived when compared to the canonical binding mode (Blosser et al., 
2015). This shows that the canonical binding mode is intrinsically preferred when 
the target allows it. This makes sense, since the primary objective is to degrade the 
invader and only if this process is insufficient, priming becomes the priority.
Mix of immune responses
This balance of binding modes shows that any target likely produces a mixture of 
different responses depending on the balance of conformations or binding modes. 
This is biologically relevant especially for the defence against multicopy invaders, 
which will trigger different responses in each host cell. Both plasmids and viruses 
are typically replicating to copy numbers of a few to several hundred copies per 
cell, in a few cases even up to a few thousand copies (Brock, 1990; Shao and Wang, 
2009). Studies have always classified mutants as either triggering interference or 
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not. Later priming was added as another option. However, in reality all responses 
are occurring simultaneously with different relative contributions and efficiencies. 
Just because we classify a particular mutant as an escape mutant in a plaque assay 
or transformation assay, does not mean that the virus or plasmid is not being 
targeted and degraded at all. In other words, just because we consider a mutant not 
to trigger interference, does not mean it does not trigger interference at all. Thus, 
the definition of interference can be very misleading. Still, for the sake of continuity 
we have continued to define interference as the successful removal of the invader, 
while we considered target degradation separately.
 In chapter 5, we have found that the Cas3 activity matches very well with 
both interference and priming. More Cas3 activity leads to better interference 
(faster plasmid loss), which in turn results in faster priming. Thus, in our case all 
mutants seem to dominantly trigger the interference-dependent priming process, 
since the interference-independent process would show priming in the absence of 
Cas3 activity. We therefore suggested that this is the result of keeping the canonical 
PAM for all mutants that we tested. We do, however, include seed mutants, which 
have been reported to skew the balance of conformations towards the ‘open’ mode 
that is thought to trigger interference independent priming (Xue et al., 2016). It is 
possible, that the amount of seed- or overall mutations is relatively low in our study 
and therefore the mutants still retain a large fraction of ‘closed’ conformations 
leading to interference. 
 In conclusion, the actual outcome of an immune response is determined 
by many factors such as the target copy number and replication speed, the binding 
affinities of Cascade to the target, the balance of binding modes and the efficiency 
in Cas3 recruitment and activity. All these will influence the overall time the cell 
needs to get rid of the invader, thereby influencing both interference-dependent 
and independent priming processes.
Spacer precursor generation
The least well-described part of spacer acquisition is still the generation of spacer 
precursors. The crystal structures of the Cas1-2 complex, binding studies and in vitro 
spacer acquisition experiments have revealed the basic architecture of the spacer 
precursor molecules in E. coli (Nunez et al., 2015a; Nunez et al., 2014; Nunez et al., 
2015b; Rollie et al., 2015; Wang et al., 2015). These precursors have to be partially 
double stranded, contain single stranded 3’ ends, and carry a PAM sequence on 
one 3’ end. It is not really clear yet whether there is a length restriction for the 
precursors, but Cas1-2 might favour precursors of near-spacer length (Chapter 
5) (Fagerlund et al., 2017). How are precursors with such specific requirements 
produced? The first proposed model suggested that, for naïve acquisition, spacer 
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precursors are left-over products generated by RecBCD during DNA repair of DSBs at 
stalled replication forks (Levy et al., 2015). However, there is still no direct evidence 
for this and acquisition is still present, although reduced, in the absence of RecBCD. 
RecBCD degrades both DNA strands next to the DSB and degradation fragments are 
thought to serve as spacer precursors. This model assumes that ssDNA degradation 
fragments reanneal to form partial dsDNA duplexes and that PAMs will be present 
by chance. Furthermore RecBCD must degrade the DNA in fragments of at least 
spacer length. The DNA fragment length after RecBCD activity in vivo is not known 
and fragment lengths in vitro are strongly dependent on experimental conditions 
(Wigley, 2013). Since this process is proposed to be responsible for the majority of 
naïve spacer acquisition, taken together this might explain why naïve acquisition is 
so slow/inefficient in E. coli. 
 In chapter 5 we have validated our early theory on the production of 
spacer precursors during primed adaptation (Swarts et al., 2012). Here, precursors 
are generated directly during direct interference, thus DNA degradation by Cas3. 
Our data suggests that Cas3 by itself is able to generate DNA fragments that fulfil 
the requirements of spacer precursors. The single stranded DNA degradation 
products of Cas3 only need to anneal back together with fragments from the other 
strand such that 3’ overhangs are created. This part of the proposed mechanism is 
dependent on chance though, as Cas3 is thought to process each of the two strands 
independently. This is also true for RecBCD, but Cas3 has the additional ability to 
enrich for PAMs at the 3’ ends of fragments and Cas3 produces fragments of near-
spacer length (Chapter 5). These features, and the proposed formation of Cas1-2-
3- supercomplexes (Fagerlund et al., 2017; Rollins et al., 2017), likely contribute 
to the high efficiency and high PAM specificity of priming. It remains possible that 
reannealing of precursor fragments is actually assisted or controlled by the Cas1-2 
complex. Cas1 has been shown to catalyse annealing of oligos and more recently 
Cas1 was shown to associate with non-double-stranded spacer-sized DNA during 
primed adaptation in vivo (Babu et al., 2011; Musharova et al., 2017). These non-
double-stranded spacer-sized fragments are reported to be excised from longer 
non-double stranded fragments produced by Cas3. This suggests that Cas1-2 
might initially bind to longer single stranded spacer precursors directly generated 
by Cas3, trim these fragments to near-spacer length (possibly assisted by distinct 
nucleases) and then find fitting complementary fragments and actively participate 
in duplex formation. This could increase the chance for the formation of proper 
sized duplexes with single stranded 3’ ends. Furthermore, this mechanism would 
be universally applicable to both primed adaptation and naïve adaptation, since 
also RecBCD produces single stranded DNA fragments that are likely not of exact 
spacer length. Despite all these recent studies, we still do not know whether Cas1-2 
in the type I-E system forms a supercomplex with Cas3 during primed acquisition 
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or just scavenges the single stranded intermediates from its environment. We do 
know, however, that Cas1-2 is required for Cas3 recruitment during interference-
independent priming and that type I-F systems carry fusions of Cas2-3 (Redding et 
al., 2015; Makarova et al., 2017; van der Oost et al., 2009). Thus, direct interaction 
between Cas1-2 and Cas3 also in interference-dependent priming is very likely. 
Cas1-2   +         -        +        -        +        -
Cas1-2   +         -        +        -        +        -  DN
A 
on
lyCas1-2 added last   
DNA added last 
      Mg               Ca              MnMetal   
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Figure 4 – Cas1-2 interacts with Cascade. EMSA assay of plasmid with protospacer and Cascade with 
matching crRNA in the presence of different metals and in the presence or absence of Cas1-2 as 
indicated. Upwards shifted DNA is bound by Cascade. A) Cascade and plasmid were incubated first to 
allow R-loop formation, Cas1-2 was added last. B) Cascade and Cas1-2 were pre-incubated, then DNA 
was added. No shift is observed in the presence of Cas1-2.
 During the development of our in vitro acquisition assays we observed that 
when Cascade and Cas1-2 were incubated together before the addition of target 
DNA (PAM mutant), no binding of the DNA by Cascade could be detected with EMSA. 
Cascade-DNA binding was unimpaired when incubated before the addition of Cas1-
2 (Figure 4). This shows that Cas1-2 can either block Cascade from binding to DNA, 
or possibly Cas1-2 can skew the binding mode balance towards the non-canonical 
mode that may not be detectable in EMSA. This would suggest that Cas1-2 can 
actively control the immune response towards interference independent priming. 
Whether this is true or not, it clearly implies an interaction between Cascade and 
Cas1-2. 
 Finally, CRISPR-Cas function is usually described as three consecutive stages, 
adaptation, expression and interference. The priming process forms a feedback 
connection from interference to adaptation, therefore creating a circle of immunity 
(Figure 5).
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Figure 5 – The circle of CRISPR-Cas defence. Schematic overview of the three stages in CRISPR-Cas 
immunity and the priming process, forming a circle. From top to bottom: 1) Phage or plasmid DNA 
enters the cell. A protospacer is selected by the acquisition machinery, including the Cas1-2 complex, 
and integrated as a new spacer in the CRISPR array. 2) CRISPR array is transcribed into pre-crRNA from 
the leader and cas genes are expressed. The pre-crRNA is processed into mature crRNA and assembles 
with the effector proteins to form the Cascade complex. 3) Cascade detects invaders by base pairing 
of the guide RNA with the target DNA. The target DNA gets degraded by Cas3 (indicated by black and 
red triangles). Degradation fragments are fed back to the acquisition machinery (Cas1-2) creating new 
spacers.
Strand bias of priming
Based on current literature, there is still no mechanistic model that can explain 
the origin of the strand bias of new spacers. The strand bias requires the fragment 
carrying the CTT PAM to be selected from the target strand. We could not reproduce 
the in vivo-observed strand bias (Swarts et al., 2012) in in vitro acquisition assays. 
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This might be caused by two possible issues with these bulk biochemical assays, 
(i) the bi-directional integration of spacers that cause targeting of either strand, 
or (ii) the erroneous production and processing of precursors. We do actually see 
a difference in fragment sizes produced by Cas3 between target and non-target 
strand, suggesting that Cas3 degrades the two strands differently. However, how this 
can play a role in creating a strand bias is unclear. Furthermore, bulk assays are likely 
less specific due to high concentrations of the components. High expression levels 
of Cas1-2 for example negatively impact the PAM specificity during naïve spacer 
acquisition in vivo (Staals et al., 2016). Additional insights into this mechanism 
could be gained by a more thorough understanding of the Cas3 mechanism, and 
by Cas1-2-3 interaction studies. One of the open questions regarding the Cas3 
mechanism is for example whether it moves along the DNA freely, or rather stays 
attached to Cascade and actively pulls the DNA strand towards its nuclease site. 
A recent single molecule study has indeed seen indications of the latter process 
(including looping of the other strand) at least in a fraction of cases (Redding et 
al., 2015), and recent unpublished work using single molecule FRET shows this in 
great detail (L. Loeff, personal communication, June 13, 2017). In this case, the non-
target strand is pulled through Cas3 in steps of 3 nt and degraded into pieces of 
defined length (~90 nt). This size matches well with the size of the in vitro generated 
spacer precursors in chapter 5. The target strand is looped out next to the Cascade-
Cas3 supercomplex. The looped out ssDNA might be a substrate for the same Cas3 
molecule, another free Cas3 molecule or a co-localized Cas1-2 complex. Either way, 
cleavage or selection of fragments from the target strand would have to be PAM 
associated, while the primary degradation of the non-target strand could be PAM 
independent.
 Type I-F and type I-B systems are both capable of primed acquisition. Both 
do produce a strand bias of new spacers, but it differs from the type I-E system 
(Li et al., 2014; Richter et al., 2014). In type I-E, >90% of new spacers target the 
same strand as the spacer that triggered priming and protospacers are distributed 
throughout the whole target. However, spacer acquisition experiments using larger 
phages instead of plasmids also revealed a preference for new spacer selection 
close to the original protospacer. Spacer sampling is most active 5’ of the original 
protospacer on the non-target strand. Type I-F/I-B systems produce spacers in equal 
amounts from both strands. However, spacers are distributed strand specifically 
around the original spacer. This means, that they preferably acquire spacers from 
protospacers that are located close to the original protospacer and that acquisition 
is unidirectional in a 3’ to 5’ direction on both strands. The single strand bias in E. 
coli suggests that the degradation/acquisition machinery only moves 3’ to 5’ on 
the non-target strand. As mentioned before, it seems obvious that the complex 
interactions and mechanisms of Cascade, Cas3 and Cas1-2 during priming cannot 
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be elucidated in bulk biochemical assays, but that this rather requires a number of 
detailed studies to generate a more complete and unified model.
 Details about the timing of spacer precursor trimming are also scarce. Our 
data and recent literature suggest that the size of Cas3-generated fragments is 
bigger than the spacer length (Chapter 5)(Musharova et al., 2017). Spacers have 
to be trimmed to both the correct size as well as the correct PAM terminal end. 
To this end the PAM containing 3’ end of the precursor is cleaved such that the 
cytosine of the CTT PAM remains as the terminal nucleotide (Wang et al., 2015). The 
other side of the precursor is then likely cleaved according to a ruler mechanism, 
ensuring the correct length. A similar ruler mechanism was recently demonstrated 
for Cas1-2 which is responsible for the correct choice of integration sites in the 
array, and as such for the repeat length of the newly generated repeat after spacer 
integration (Goren et al., 2016). In Chapter 5 we analysed half-site integration 
products by sequencing. Unfortunately we could not determine the actual length 
of the integrated fragments, due to the unintegrated end being cut off by the PCR 
primer. Still, we found that the sizes of a considerable fraction of the fragments were 
bigger than the spacer size. This suggests that these spacers are not yet properly 
processed by Cas1-2 into mature spacers. We therefore suggested that processing 
of the unintegrated site might only occur at full integration. Thus, whatever missing 
factor is limiting the in vitro assays to half-site integration, likely also limits precursor 
processing to one half. This short coming of these assays also explains why we 
observe half site integrations at both possible integration sites and in both possible 
orientations, while correct integration initiates at the leader-repeat boundary with 
the non-PAM containing end of the precursor (Nunez et al., 2016). Some (but not 
all) type I, type II and type V systems actually encode an additional cas gene, cas4, in 
their adaptation module (i.e. associated to cas1 and cas2) (Makarova et al., 2017a, 
b). In addition cas4 is sometimes fused to cas1 (van der Oost et al., 2009). This 
shows that cas4 is very likely involved in the spacer acquisition process. Indeed, it 
has been shown that cas4 is required for primed spacer acquisition in the type I-B 
system in Haloarcula hispanica and that Cas4 interacts with the Cas1-2 complex in 
the type I-A system of Thermoproteus tenax (Li et al., 2014; Plagens et al., 2012). 
Although the RecB-like Cas4 proteins seem to be functionally diverse, they are 
generally characterized as exo- or endonucleases on ssDNA or dsDNA (Lemak et 
al., 2013; Lemak et al., 2014; Zhang et al., 2012). Consequently Cas4 has been 
hypothesized to be involved in precursor generation or processing. In the systems 
that do not contain a cas4 gene, this function must then be either contained in 
Cas1-2 or carried out by other unknown (RecB-like, or analogous) host factors. If 
the latter is the case, this would explain the failure of in vitro integration assays to 
produce complete integration.
General discussion
207
9
Nucleotide bias of priming
In chapter 6, we describe a surprising nucleotide bias that strongly affects the 
efficiency of direct interference and therefore interference-dependent priming. 
Cytosine substitutions in the base pairing strand of the protospacer hardly affect 
the immune response while Guanine substitutions have a detrimental effect. 
As mentioned in chapter 6, this cannot be explained by simple base pairing 
thermodynamics. Instead this effect is likely influenced by interactions with the 
Cascade protein, such as direct interactions with amino acid residues or steric 
effects. This bias also has consequences for the success of viral escape from the 
type I-E system. Obviously, viruses have no use of preferring G mutations over 
C mutations, since these occur together in dsDNA and spacers can target either 
strand. But at least viruses with G substitutions in the target strand of a protospacer 
should have a selective advantage and should therefore be overrepresented 
in a viral population. Therefore, we are currently analyzing metagenomic data, 
which allows us to analyze spacer sequences of host organisms and protospacer 
sequences of their phages from one environment, assuming that host and phage 
have co-evolved. We will extract spacer sequences from type I-E systems and map 
them to potential protospacers allowing mismatches. Here, we anticipate to find 
an overrepresentation of G substitutions in the base pairing strand of the viral 
protospacers.
Genome editing
The history of genome editing has seen many steps of evolution and revolution (Kim, 
2016). After the initial discovery that endogenous DNA repair pathways can be used 
to edit genomes (Rudin and Haber, 1988), the first evolution was the application of 
meganucleases to induce DSBs which greatly stimulated editing at the target locus 
(Rouet et al., 1994). Meganucleases, however, are not programmable with respect 
to target sequence specificity and therefore of very limited value for widespread 
application. The first revolution was the utilization of zinc-finger domains for 
programmable DNA targeting, combined with the FokI nuclease domain to create 
ZFNs (Kim et al., 1996). Although technically challenging, the freely programmable 
ZFNs allowed genome editing to be applied in many cell types and in any locus 
(Bibikova et al., 2003; Bibikova et al., 2002; Desjarlais and Berg, 1992; Rebar and 
Pabo, 1994). ZFNs were then outcompeted by TALENs which were slightly easier to 
reprogram, although still labour intense (Briggs et al., 2012; Cermak et al., 2011; 
Kim et al., 2013; Miller et al., 2011; Reyon et al., 2012). Furthermore TALENs had a 
higher specificity, reducing toxicity and off-target editing. The development of Cas9 
into a genome editing tool was the next big revolution (Cho et al., 2013; Cong et 
al., 2013; Jinek et al., 2013; Mali et al., 2013). Reprogramming Cas9 proteins is very 
easy and fast, and these CRISPR-associated nucleases have shown great efficiency 
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and specificity in a vast range of cell types and organisms (Kim, 2016). The massive 
boost of genome editing research utilizing Cas9 is proof that this tool has really 
made genome editing feasible and accessible. But after every revolution there must 
be evolution, since nothing is without flaws. Evolution came in the form of protein 
modifications to improve and fine tune Cas9 (Fu et al., 2014; Guilinger et al., 2014; 
Kleinstiver et al., 2016; Slaymaker et al., 2016; Tsai et al., 2014), in the form of novel 
Cas9 proteins (Hou et al., 2013; Kleinstiver et al., 2015), or in the form of alternative 
CRISPR-effector proteins such as Cpf1 (Kim et al., 2016; Zetsche et al., 2015; Zetsche 
et al., 2017). Having a large pool of tools to choose from is very beneficial, since 
every tool might have advantages and disadvantages for a given application. 
Although the CRISPR class 2 RGENs have conceptual advantages over Cascade, such 
as being much smaller and a single protein, Cascade might still prove superior in 
other aspects due to its radically different architecture and stronger DNA binding 
characteristics (Szczelkun et al., 2014). Potential advantages and disadvantages of 
Cascade have already been discussed in Chapter 7, but recent developments have 
indicated more potential problems with Cas9. A genome editing study in mice has 
found a plethora of Cas9 induced SNPs throughout the entire genome by whole 
genome sequencing. The majority of these sites are not predicted by off-target 
site prediction software, as they carry no or insufficient homology (Schaefer et 
al., 2017). This study is, however, being heavily criticized for a poor execution and 
missing controls.  Furthermore, a role of Cas9 has recently been implicated in the 
virulence of bacterial pathogens, where it can cause DNA damage in the host cell. 
It is thought that Cas9 does so by scavenging cellular RNAs of the host as guide 
RNAs instead of using crRNA, however, this problem can be solved by saturating the 
nuclease with an appropriate crRNA guide (Van der Oost, personal communication, 
June 18 2017). These findings indicate that this new technology is not yet perfect, 
which further strengthens the need for alternatives. Finally, it is obvious that the 
development of a new tool requires significant manpower and could therefore not 
be completed in this thesis. Additionally, there is always the risk that a tool might 
not be functional in vivo. Likewise, screenings for new Cas9 and Cpf1 variants have 
shown that only part of the tested proteins were successful in genome editing in 
vivo (Ran et al., 2015; Zetsche et al., 2015).
 The success of the FokI-Cascade tool developed in this thesis is currently 
limited by the instability of the linker and/or the protein fusion. The FokI subunit 
is hydrolysed or being cleaved off from the complex, likely somewhere in its 
C-terminus. Complexes lacking FokI can block the binding sites on the target DNA, 
preventing cleavage. In addition, loose FokI subunits, in case they remain intact, 
could lead to unwanted random DNA cleavage. While we did not observe the latter 
in vitro, it remains possible that this causes problems in vivo. FokI is a widely used 
restriction enzyme, and its nuclease domain has been applied in genome editing as 
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part of ZFNs, TALENs and even Cas9. Even though the break does not occur within 
the linker peptide, the linker might still be responsible for the instability of the 
adjacent FokI residues. The sequence of the linker peptide has been taken from a 
naturally occurring Cas3-Cse1 fusion in Streptomyces griseus (Westra et al., 2012c), 
and might therefore have unknown effects on the linked proteins. It is conceivable 
that the linker might have conformational effects on Cas3 in S. griseus, since Cas3 
nuclease activity needs to be controlled to prevent unwanted DNA degradation until 
a bona fide target is detected. Changing the linker to a well-characterized one, such 
as glycine or proline-threonine linkers, is therefore the first priority in the future 
of this project. The instability of the fused FokI domain might also be caused by 
incomplete folding of the protein. This could be prevented by codon optimizing the 
linker (bad codons) to slow down translation and allow proper folding of the FokI 
domain.
 Another important experiment would be to use standalone Cascade in vivo 
in eukaryotic cells to bind to promotor sequences and block gene expression. This 
could validate the ability of Cascade to remain functional in eukaryotic cells and to 
stably bind to genomic DNA. This has already been successfully done in prokaryotic 
cells, such as E. coli and Salmonella typhimurium (Chang et al., 2016; Luo et al., 
2015; Rath et al., 2014). Cascade could be used as a DNA binding platform for 
other functional proteins, such as epigenetic factors (DNA or histone modifying 
enzymes), transcriptional regulators or simply fluorescent proteins/probes for locus 
visualization.
 Ultimately, Cas proteins can be used in many applications that require 
specific interactions with nucleic acids, be it DNA or RNA. Possible functions include 
the detection, manipulation, regulation, visualization of specific targets in a pool of 
nucleic acid. These abilities are not limited to fundamental research and the curing of 
genetic diseases, but can be applied in many more areas such as crop improvement 
or trace pathogen detection in hospitals or even in the field (Gootenberg et al., 
2017; Khatodia et al., 2016). In essence, the CRISPR-Cas toolbox is to us now, what 
hammer and knife were to our ancestors. The versatility of these tools opens up new 
ways to manipulate our environment. However, with new possibilities come new 
risks and responsibilities. Just like a hammer and knife, CRISPR-Cas may be abused 
or turned into a weapon (DiEuliis and Giordano, 2017). Thus, proper regulation and 
oversight is essential to protect us from this technology.
Concluding remark
Our understanding of CRISPR-Cas based defence in prokaryotes has greatly improved 
over the last decade. Extensive knowledge was gathered on function, mechanisms, 
protein structures and more. Sometimes it seemed as if we were reaching a point 
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where there is little new to describe, but the constant discovery of new systems, 
new mechanisms and even entirely new functions of CRISPR-Cas systems make 
this field more exciting than ever. We know now that these systems are not only 
functioning as immune systems, but are implicated in many additional processes 
such as virulence in pathogens. Furthermore, genome editing will not remain the 
only practical application of Cas effector proteins, especially with the discovery of 
new proteins with versatile functions. Finally, CRISPR-Cas systems exemplify that 
the central dogma of ‘survival of the fittest’ should really be ‘survival of the most 
adaptive’.
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PROPOSITIONS
1. The CRISPR system exempliﬁ es that ‘survival of the ﬁ � est’ should be 
‘survival of the most adap� ve’. 
(this thesis)
2. Seed sequences are essen� al for all RNA-mediated target search 
processes. 
(t his thesis)
3. Applied research brings progress, fundamental research revolu� onizes 
the world.
4. Liga� on independent cloning technologies are superior to classical 
restric� on liga� on methods.
5. Nature is migh� er than human technology.
6. Text neck and dry eye disease are a greater threat to society than the 
use of GMOs.
7. The advance of genome edi� ng technology will make a gene� c two 
class society inevitable.
Proposi� ons belonging to the thesis, en� tled
‘Adap� ng to Change, on the mechanism of type I-E CRISPR-Cas defence’
Tim A. Künne
Wageningen, 4 October 2017
